
<html lang="en"     class="pb-page"  data-request-id="c4062c12-47f1-4f4a-b0a2-f77d6d93aaf7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm4011753;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models" /></meta><meta name="dc.Creator" content="Elisa  Nuti" /></meta><meta name="dc.Creator" content="Francesca  Casalini" /></meta><meta name="dc.Creator" content="Salvatore  Santamaria" /></meta><meta name="dc.Creator" content="Marina  Fabbi" /></meta><meta name="dc.Creator" content="Grazia  Carbotti" /></meta><meta name="dc.Creator" content="Silvano  Ferrini" /></meta><meta name="dc.Creator" content="Luciana  Marinelli" /></meta><meta name="dc.Creator" content="Valeria  La Pietra" /></meta><meta name="dc.Creator" content="Ettore  Novellino" /></meta><meta name="dc.Creator" content="Caterina  Camodeca" /></meta><meta name="dc.Creator" content="Elisabetta  Orlandini" /></meta><meta name="dc.Creator" content="Susanna  Nencetti" /></meta><meta name="dc.Creator" content="Armando  Rossello" /></meta><meta name="dc.Description" content="Activated leukocyte cell adhesion molecule (ALCAM) is expressed at the surface of epithelial ovarian cancer (EOC) cells and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding. This..." /></meta><meta name="Description" content="Activated leukocyte cell adhesion molecule (ALCAM) is expressed at the surface of epithelial ovarian cancer (EOC) cells and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding. This..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 4, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4011753" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4011753" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4011753" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4011753" /></link>
        
    
    

<title>Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4011753" /></meta><meta property="og:title" content="Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0013.jpeg" /></meta><meta property="og:description" content="Activated leukocyte cell adhesion molecule (ALCAM) is expressed at the surface of epithelial ovarian cancer (EOC) cells and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding. This process is relevant to EOC cell motility and invasiveness, which is reduced by inhibitors of ADAM-17. In addition, ADAM-17 plays a key role in EGFR signaling and thus may represent a useful target in anticancer therapy. Herein we report our hit optimization effort to identify potent and selective ADAM-17 inhibitors, starting with previously identified inhibitor 1. A new series of secondary sulfonamido-based hydroxamates was designed and synthesized. The biological activity of the newly synthesized compounds was tested in vitro on isolated enzymes and human EOC cell lines. The optimization process led to compound 21, which showed an IC50 of 1.9 nM on ADAM-17 with greatly increased selectivity. This compound maintained good inhibitory properties on sALCAM shedding in several in vitro assays." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4011753"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4011753">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4011753&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4011753&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4011753&amp;href=/doi/10.1021/jm4011753" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8089-8103</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4011302" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401206t" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Nuti">Elisa Nuti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Casalini">Francesca Casalini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Santamaria">Salvatore Santamaria</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Fabbi">Marina Fabbi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grazia++Carbotti">Grazia Carbotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvano++Ferrini">Silvano Ferrini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luciana++Marinelli">Luciana Marinelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++La+Pietra">Valeria La Pietra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Novellino">Ettore Novellino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caterina++Camodeca">Caterina Camodeca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisabetta++Orlandini">Elisabetta Orlandini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susanna++Nencetti">Susanna Nencetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Armando++Rossello">Armando Rossello</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Dipartimento di Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli “Federico II”, Via Domenico Montesano 49, 80131 Napoli, Italy</span></div><div class="corresp-info"><strong>*</strong>Phone: +39 050 2219562. Fax: +39 050 2219605. E-mail: <a href="/cdn-cgi/l/email-protection#6001120f13200601120d4e150e0910094e0914"><span class="__cf_email__" data-cfemail="0f6e7d607c4f696e7d62217a61667f6621667b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4011753&amp;href=/doi/10.1021%2Fjm4011753" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8089–8103</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 17, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 August 2013</li><li><span class="item_label"><b>Published</b> online</span>4 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4011753" title="DOI URL">https://doi.org/10.1021/jm4011753</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8089%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElisa%2BNuti%252C%2BFrancesca%2BCasalini%252C%2BSalvatore%2BSantamaria%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm4011753%26title%3DSelective%2BArylsulfonamide%2BInhibitors%2Bof%2BADAM-17%253A%2BHit%2BOptimization%2Band%2BActivity%2Bin%2BOvarian%2BCancer%2BCell%2BModels%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8103%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4011753"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1171</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4011753" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Nuti&quot;},{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Casalini&quot;},{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Santamaria&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Fabbi&quot;},{&quot;first_name&quot;:&quot;Grazia&quot;,&quot;last_name&quot;:&quot;Carbotti&quot;},{&quot;first_name&quot;:&quot;Silvano&quot;,&quot;last_name&quot;:&quot;Ferrini&quot;},{&quot;first_name&quot;:&quot;Luciana&quot;,&quot;last_name&quot;:&quot;Marinelli&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;La Pietra&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Novellino&quot;},{&quot;first_name&quot;:&quot;Caterina&quot;,&quot;last_name&quot;:&quot;Camodeca&quot;},{&quot;first_name&quot;:&quot;Elisabetta&quot;,&quot;last_name&quot;:&quot;Orlandini&quot;},{&quot;first_name&quot;:&quot;Susanna&quot;,&quot;last_name&quot;:&quot;Nencetti&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;Rossello&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;8089-8103&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4011753&quot;},&quot;abstract&quot;:&quot;Activated leukocyte cell adhesion molecule (ALCAM) is expressed at the surface of epithelial ovarian cancer (EOC) cells and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding. This process is relevant to EOC cell motility and invasiveness, which is reduced by inhibitors of ADAM-17. In addition, ADAM-17 plays a key role in EGFR signaling and thus may represent a useful target in anticancer therapy. Herein we report our hit optimization effort to identify potent and selective ADAM-17 inhibitors, starting with previously identified inhibitor 1. A new series of secondary sulfonamido-based hydroxamates was designed and synthesized. The biological activity of the newly synthesized compounds was tested in vitro on isolated enzymes and human EOC cell lines. The optimization process led to compound 21, which showed an IC50 of 1.9 nM on ADAM-17 with greatly increased selectivity. This compound maintained good inhibitory properties on sALCAM shedding in several in vitro assays.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011753&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011753" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011753&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011753" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011753&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011753" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4011753&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011753&amp;href=/doi/10.1021/jm4011753" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4011753" /></input><a href="/doi/pdf/10.1021/jm4011753" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4011753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4011753%26sid%3Dliteratum%253Aachs%26pmid%3D24044434%26genre%3Darticle%26aulast%3DNuti%26date%3D2013%26atitle%3DSelective%2BArylsulfonamide%2BInhibitors%2Bof%2BADAM-17%253A%2BHit%2BOptimization%2Band%2BActivity%2Bin%2BOvarian%2BCancer%2BCell%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D8089%26epage%3D8103%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Activated leukocyte cell adhesion molecule (ALCAM) is expressed at the surface of epithelial ovarian cancer (EOC) cells and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding. This process is relevant to EOC cell motility and invasiveness, which is reduced by inhibitors of ADAM-17. In addition, ADAM-17 plays a key role in EGFR signaling and thus may represent a useful target in anticancer therapy. Herein we report our hit optimization effort to identify potent and selective ADAM-17 inhibitors, starting with previously identified inhibitor <b>1</b>. A new series of secondary sulfonamido-based hydroxamates was designed and synthesized. The biological activity of the newly synthesized compounds was tested in vitro on isolated enzymes and human EOC cell lines. The optimization process led to compound <b>21</b>, which showed an IC<sub>50</sub> of 1.9 nM on ADAM-17 with greatly increased selectivity. This compound maintained good inhibitory properties on sALCAM shedding in several in vitro assays.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ADAM-17 or tumor necrosis factor α converting enzyme (TACE) is an integral plasma membrane zinc-dependent metalloprotease and member of the a disintegrin and metalloprotease (ADAM) family of molecules. ADAM-17 is produced as an inactive proenzyme of 120 kDa, which is physiologically activated via stimulation of G-protein-coupled receptors and furin-like enzyme cleavage of the ADAM-17 prodomain leading to generation of the 100 kDa active enzyme. ADAM-17 is a sheddase and/or activator of several biologically important membrane-anchored proteins, including TNF, epithelial cell growth factors, and cell adhesion molecules.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In recent years, we focused our attention on studying the interaction between ADAM-17 and cell adhesion molecules (CAMs) of the immunoglobulin superfamily. In particular, we have shown that activated leukocyte cell adhesion molecule (ALCAM or CD166) is expressed at the surface of epithelial ovarian cancer (EOC) cells, can be internalized following soluble ligand engagement,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and is released in a soluble form (sALCAM) by ADAM-17-mediated shedding.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This process is relevant to EOC cell motility, which is reduced by inhibitors of ADAM-17. In addition, ADAM-17 plays a key role in epidermal growth factor receptor (EGFR) signaling<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and thus may represent a useful target in anticancer therapy in EGF-dependent tumors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recently, we have reported the synthesis and biological evaluation of a series of arylsulfonamide hydroxamates as potent ADAM-17 inhibitors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Among these, compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) showed nanomolar activity for ADAM-17 isolated enzyme. This compound proved to be also potent in inhibiting soluble ALCAM release in cancer cells, showing a nanomolar activity on A2774 and SKOV3 cell lines. No toxicity for this compound was detected on parallel cultures by MTT assay. In addition, it inhibited the EGF-triggered invasive properties of ovarian cancer cells in vitro.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These preliminary results allowed us to validate ADAM-17/ALCAM pathway as new target in anticancer therapy and prompted us to undertake a structural optimization of <b>1</b> in order to find out more selective ADAM-17 inhibitors. In fact, compound <b>1</b> also inhibited other metalloproteases such as MMP-2, MMP-9, and MMP-14 and it is widely believed that some side effects that have been clinically observed with the use of broad spectrum MMP inhibitors, such as musculoskeletal syndrome (MSS), could be related to MMP-1/MMP-14 inhibition.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Moreover, a more target-directed inhibition could be helpful to discern the actual ADAM-17 biological activity from overlapping effects due to other metalloproteases and to reduce toxicity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Progression of the SAR: from the hit compound <b>1</b> to the ADAM-17 selective inhibitor <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the present paper, on the basis of recent SAR data from our lab and others,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> we designed and synthesized a series of secondary sulfonamido-based inhibitors, compounds <b>2</b>–<b>13</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), with bended P1′ substituents different from the highly exploited 4-(but-2-ynyloxy)benzene group. In fact, as revealed by X-ray crystal structure of catalytic domain,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> ADAM-17 is characterized by an “L-shaped” pocket with a polar access between S1′ and S3′, and this singular shape of the specificity pocket has been largely used to design specific ADAM-17 inhibitors by insertion of bended substituents. Two examples of these selective inhibitors reported in the literature for the treatment of inflammatory diseases are DPC-333<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> from Bristol-Myers Squibb (which entered clinical trials for rheumatoid arthritis) and WAY-281418,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> developed by Wyeth researchers (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of ADAM-17 selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Hydroxamates <b>2</b>–<b>13</b> were screened against recombinant human ADAM-17 in order to select the P1′ substituent able to give the best results of selectivity for ADAM-17 over MMPs. After the most suitable and innovative P1′ substituent has been found, we sought to improve activity against ADAM-17 by introducing an amidic chain in the α position relative to the hydroxamate (P1), compounds <b>19</b>–<b>21</b><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In fact, as previously shown,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> an α substituent in this arylsulfonamidic scaffold could highly increase potency against ADAM-17. The compounds that gave the best results on isolated enzymes were finally tested on human EOC cell lines (A2774, SKOV3-luc, and A2780), which express ADAM-17 and its substrate ALCAM.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) has been synthesized as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Benzyloxybenzene derivatives <b>3</b>–<b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and <b>16</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) have been prepared as reported in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>3</b>–<b>13</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) the appropriate substituted benzyl bromide, NaOH, <i>i</i>-PrOH, 70 °C; (b) (COCl)<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) glycine, TEA, H<sub>2</sub>O, dioxane; (d) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (f) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (g) 4 N HCl, dioxane, MeOH.</p></p></figure><div class="NLM_p">Sulfonyl chlorides <b>33</b>–<b>43</b> were synthesized starting from sodium 4-hydroxybenzenesulfonate dihydrate, which was alkylated with the appropriate aryl bromides using sodium hydroxide as base. Reaction of sodium salts <b>22</b>–<b>32</b> with oxalyl chloride in the presence of DMF in dichloromethane afforded sulfonyl chlorides <b>33</b>–<b>43</b>, which were coupled with glycine to give carboxylic acids <b>44</b>–<b>53</b> and <b>16</b>. Carboxylates <b>44</b>–<b>46</b> and <b>49</b>–<b>53</b> were condensed with <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine in the presence of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) to give silyl intermediates <b>54</b>–<b>61</b>, which afforded hydroxamates <b>3</b>–<b>5</b> and <b>8</b>–<b>12</b> after acid cleavage with TFA. Alternatively, carboxylates <b>47</b>, <b>48</b>, and <b>16</b> were first converted into protected hydroxamates <b>62</b>–<b>64</b> by condensation with <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (THP-hydroxylamine) in the presence of EDC and then hydrolyzed with 4 N HCl to hydroxamates <b>6</b>, <b>7</b>, and <b>13</b>, respectively.</div><div class="NLM_p">Compounds <b>17</b> and <b>18</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), close analogues of <b>13</b>, were synthesized according to the route described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 4-(3,5-Dibromobenzyloxy)benzene-1-sulfonyl chloride <b>43</b> was converted into the sulfonamide <b>65</b> by reaction with glycine <i>tert</i>-butyl ester hydrochloride in H<sub>2</sub>O and dioxane in the presence of TEA. This ester was successively converted by Pd-catalyzed Suzuki coupling to monosubstituted biaryl derivatives <b>66</b> and <b>67</b>, which were hydrolyzed to carboxylic acids <b>68</b> and <b>69</b>, respectively. These carboxylates were finally converted to their corresponding hydroxamates <b>17</b> and <b>18</b> by condensation with <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine, followed by acid hydrolysis with TFA.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>17</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glycine <i>tert</i>-butyl ester hydrochloride, TEA, H<sub>2</sub>O, dioxane; (b) 3-pyridinylboronic acid or 4-methoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><div class="NLM_p"><i>N</i>-Methyl derivative <b>15</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and the α-substituted analogues of <b>13</b>, compounds <b>19</b>–<b>21</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), were prepared as reported in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. All these compounds were synthesized starting from 4-(3,5-dibromobenzyloxy)benzene-1-sulfonyl chloride <b>43</b>, obtained as described above. <b>43</b> was converted into the corresponding Boc-sulfonamide <b>76</b> by reaction with ammonia, followed by treatment with di-(<i>tert</i>-butyl)dicarbonate. Sulfonamide <b>76</b> underwent Mitsunobu reaction in the presence of diisopropyl azodicarboxylate (DIAD) and triphenylphophine with optically active alcohol <b>77</b><a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> to give ester <b>78</b> of (<i>R</i>) configuration. Acid hydrolysis of <b>78</b> yielded the <i>NH</i>-sulfonamide carboxylate <b>79</b>, which was finally converted into the corresponding hydroxamate <b>19</b> by condensation with THP-hydroxylamine in DMF and acid cleavage with 4 N HCl. The sulfonyl chloride <b>43</b> was also made reacting with non-natural aminoacids such as sarcosine <i>tert</i>-butyl ester hydrochloride or <span class="smallcaps smallerCapital">d</span>-Cbz-ornithine or <span class="smallcaps smallerCapital">d</span>-carbamoylornithine in the presence of TEA to give sulfonamides <b>70</b>, <b>72</b>, and <b>73</b>, respectively. Acid hydrolysis with TFA of <i>tert</i>-butyl ester <b>70</b> afforded carboxylate <b>71</b>. Condensation of <b>71</b> and <b>72</b> with THP-hydroxylamine in the presence of EDC yielded tetrahydropyranyl intermediates <b>74</b> and <b>75</b> which, after mild hydrolysis with 4 N HCl, gave the corresponding hydroxamates <b>15</b> and <b>20</b>. Finally, hydroxamic acid <b>21</b> was obtained from carboxylate <b>73</b> by condensation with <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine, followed by acid hydrolysis with TFA.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>15</b> and <b>19</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) sarcosine <i>tert</i>-butyl ester hydrochloride or H-<span class="smallcaps smallerCapital">d</span>-Orn(Z)-OH or H-<span class="smallcaps smallerCapital">d</span>-Orn(carbamoyl)-OH, TEA, H<sub>2</sub>O, dioxane; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (c) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (d) 4 N HCl, dioxane, MeOH; (e) NH<sub>3</sub> aq, CH<sub>3</sub>CN, 0 °C to rt; (f) (Boc)<sub>2</sub>O, TEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (g) <b>77</b>, PPh<sub>3</sub>, DIAD, THF; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (i) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (l) 4 N HCl, dioxane, MeOH; (m) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (n) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3 Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Activity on Isolated Enzymes</h3><div class="NLM_p">The first series of hydroxamates, compounds <b>2</b>–<b>13</b>, were tested in vitro for their ability to inhibit human recombinant ADAM-17, MMP-1, -2, -9, and -14 by a fluorimetric assay, which uses a fluorogenic peptide<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> as the substrate (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>14</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> previously reported by Wyeth researchers as ADAM-17 inhibitor and bearing the highly exploited 4-(but-2-ynyloxy)benzene group in P1′, was taken as reference compound to evaluate the effect of the different R groups on the simple glycine-like scaffold. On the basis of our previous results,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> we focused our attention on secondary sulfonamides because the substitution of sulfonamide NH was seen to be detrimental to ADAM-17 inhibitory activity.</div><div class="NLM_p">Among the substituted benzyloxy derivatives, the best results of activity were achieved by compound <b>3</b>, which was as potent as the reference compound <b>14</b> on ADAM-17 (IC<sub>50</sub> = 16 nM). Unfortunately, this 4-bromobenzyloxy derivative was poorly selective, showing nanomolar activity also against MMP-2 and MMP-9. The replacement of the bromine atom with a fluorine or a trifluoromethoxy group in the para-position led to a drop of activity for ADAM-17, with the 4-phenyl derivative <b>6</b> being the worst of the series (IC<sub>50</sub> = 640 nM). The introduction of the same substituents in the meta-position of the benzyl moiety resulted in a general improvement of ADAM-17 inhibitory activity with respect to the unsubstituted analogue <b>2</b>, without any significant improvement in selectivity. Finally, the presence of a 4-quinoline group as in <b>11</b> led to a decrease of activity against all tested enzymes, probably due to an excessive bulkiness of the substituent.</div><div class="NLM_p">At this point the introduction of a second halogen atom on the benzyl moiety was considered and the 3,5-dihalo substituted compounds <b>12</b> and <b>13</b> were synthesized. Both compounds had the same activity toward ADAM-17 with respect to their 3-monosubstituted analogues (<b>7</b> and <b>8</b>) but presented an increased selectivity over the MMPs tested. In particular, the 3,5-dibromobenzyloxy derivative <b>13</b> was the most promising of this first series, with good activity for ADAM-17 (IC<sub>50</sub> = 105 nM) and the best selectivity profile obtained so far over MMPs (a >500-fold selectivity over MMP-9, -14, and -1), even compared to the reference compound <b>14</b>. These data suggested that the 3,5-dibromobenzyloxybenzene group could be a valid alternative to the use of the 4-(but-2-ynyloxy)benzene group as P1′ substituent, and therefore, <b>13</b> became the focus of additional efforts to improve activity toward ADAM-17.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Enzymatic<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> Activity (IC<sub>50</sub>, nM) of Glycine-like Compounds <b>2</b>–<b>13</b> and the Reference Compound <b>14</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0010.gif" alt="" id="GRAPHIC-d1425e1003-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> values are the average of three determinations with SD of <10%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Data from our lab.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>15</b>–<b>18</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were subsequently synthesized as close analogues of <b>13</b>, introducing some modifications on this promising scaffold. We first synthesized the <i>N</i>-methyl analogue of <b>13</b> (<b>15</b>), which showed a decrease of ADAM-17 inhibitory activity compared to <b>13</b>. Then we tested the carboxylate analogue of <b>13</b>, compound <b>16</b>, in order to evaluate the effect of a different zinc-binding group (ZBG) on this scaffold, but this compound was completely devoid of activity for ADAM-17. This disappointing result discouraged us to change the ZBG at least at this point of the optimization process. Finally, we replaced a bromine atom of <b>13</b> with a pyridin-3-yl moiety (<b>18</b>) or a 4-methoxyphenyl group (<b>17</b>) in order to better explore the S1′–S3′ pocket space. Both compounds showed a reduced inhibitory activity against ADAM-17, with <b>18</b> being 5-fold less active than <b>13</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Enzymatic Activity<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (IC<sub>50</sub>, nM) of Close Analogues of <b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> values are the average of three determinations with SD of <10%. Nd: not determined.</p></div></div><div></div></div><div class="NLM_p">On the basis of these findings, in order to further increase activity on ADAM-17 of this class of inhibitors, we decided to keep the compound <b>13</b> scaffold unchanged and to introduce different amidic chains in P1. In fact, as previously shown,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> an α substituent in this arylsulfonamidic scaffold could highly increase potency against ADAM-17. First, we chose to insert a benzyloxycarbonylaminoethyl chain in P1 because this was the group originally present in our previous compound <b>1</b>. As expected, compound <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) was 2.5-fold more active than its unsubstituted analogue <b>13</b>, showing IC<sub>50</sub> = 43 nM on ADAM-17, without any loss in selectivity. Encouraged by these data, we put a longer chain in P1 and synthesized compound <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) with a benzyloxycarbonylaminopropyl chain. We thus obtained a further increase of ADAM-17 inhibitory potency (IC<sub>50</sub> = 11 nM) still maintaining a strong selectivity over MMPs, even compared to <b>19</b>. In particular, the selectivity for ADAM-17 over MMP-2 progressively increased from 16-fold for compound <b>13</b> to 130-fold for <b>20</b>. Finally, as the last step of our optimization process, we tried to improve the hydrophilicity of our inhibitor by replacing the benzyloxycarbonylamino (Cbz) moiety of <b>20</b> with a ureidic group (compound <b>21</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Enzymatic<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> Activity (IC<sub>50</sub>, nM) of P1-Substituted Analogues of <b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">ADAM-17</th><th class="colsep0 rowsep0" align="center" char=".">ADAM-10</th><th class="colsep0 rowsep0" align="center" char=".">MMP-1</th><th class="colsep0 rowsep0" align="center" char=".">MMP-2</th><th class="colsep0 rowsep0" align="center" char=".">MMP-9</th><th class="colsep0 rowsep0" align="center" char=".">MMP-14</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="char" char=".">39000</td><td class="colsep0 rowsep0" align="char" char=".">>500000</td><td class="colsep0 rowsep0" align="char" char=".">1750</td><td class="colsep0 rowsep0" align="char" char=".">51000</td><td class="colsep0 rowsep0" align="char" char=".">113000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>NHCbz</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char=".">8200</td><td class="colsep0 rowsep0" align="char" char=".">400000</td><td class="colsep0 rowsep0" align="char" char=".">4100</td><td class="colsep0 rowsep0" align="char" char=".">11000</td><td class="colsep0 rowsep0" align="char" char=".">104000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>NHCbz</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">370000</td><td class="colsep0 rowsep0" align="char" char=".">1440</td><td class="colsep0 rowsep0" align="char" char=".">4400</td><td class="colsep0 rowsep0" align="char" char=".">68000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>NHCONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">>500000</td><td class="colsep0 rowsep0" align="char" char=".">240</td><td class="colsep0 rowsep0" align="char" char=".">1630</td><td class="colsep0 rowsep0" align="char" char=".">19500</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The IC<sub>50</sub> values are the average of three determinations with SD of <10%.</p></div></div></div><div class="NLM_p">For <b>21</b> and its analogue <b>20</b>, the physicochemical properties influencing metabolism, cell permeation, and bioavailability were evaluated with QikProp software (Schrödinger, LLC, New York). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, while <b>20</b> possesses a high molecular weight, high number of H-bond acceptors, and a log <i>S</i> that is quite far from ideal values, <b>21</b> has a lower molecular weight, appropriate number of H-bond donors and acceptors, and a good log <i>S</i>. Thus, the replacement of the Cbz moiety in <b>20</b> with a ureidic group (<b>21</b>) should lead to an improvement of the physicochemical properties of the inhibitor.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Properties of Tested Compounds Calculated by QikProp</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MW<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">QPlogPo/w<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">QPlogS<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">no. of primary metabolites<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">no. H-bond donor<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">no. H-bond acceptor<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">685.4</td><td class="colsep0 rowsep0" align="char" char=".">4.03</td><td class="colsep0 rowsep0" align="char" char=".">–7.5</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">594.3</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">–3.7</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Lipinski’s rule of 5 (<500).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Log of the octanol/water partition coefficient, range 95% of drugs (−2/6.5).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Log of aqueous solubility <i>S</i> (mol/L), range 95% of drugs (−6.5/0.5).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Range 95% of drugs (<sup>1</sup>/<sub>8</sub>).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Lipinski’s rule of 5 (<5).</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Lipinski’s rule of 5 (<10).</p></div></div></div><div class="NLM_p">Unpredictably, this ureidic derivative was optimal for this series exhibiting a 6-fold increase in inhibitory potency against ADAM-17 (IC<sub>50</sub> = 1.9 nM) with respect to <b>20</b> and a comparable selectivity profile. In fact, <b>21</b> displayed a 126-fold selectivity for ADAM-17 over MMP-2, a 860-fold selectivity over MMP-9, a 10000-fold selectivity over MMP-14, and no measurable inhibitory activity toward MMP-1 (IC<sub>50</sub> > 500 μM). Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> shows a direct comparison between the selectivity profiles of <b>21</b> and of our previous compound <b>1</b>. <b>21</b> was as potent as <b>1</b> on ADAM-17 (with an IC<sub>50</sub> of 1.9 and 1.6 nM, respectively) but showed a greatly improved selectivity over the tested MMPs.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity Profile of Compound <b>21</b> in Comparison with <b>1</b><sup>6</sup></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">IC<sub>50</sub> <a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MMP-1</th><th class="colsep0 rowsep0" align="center" char=".">MMP-2</th><th class="colsep0 rowsep0" align="center" char=".">MMP-9</th><th class="colsep0 rowsep0" align="center" char=".">MMP-14</th><th class="colsep0 rowsep0" align="center" char=".">ADAM-17</th><th class="colsep0 rowsep0" align="center" char=".">ADAM-10</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">1100</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">>500000</td><td class="colsep0 rowsep0" align="char" char=".">240</td><td class="colsep0 rowsep0" align="char" char=".">1630</td><td class="colsep0 rowsep0" align="char" char=".">19500</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">150</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The IC<sub>50</sub> values are the average of three determinations with SD of <10%.</p></div></div></div><div class="NLM_p last">All these P1-substituted compounds (<b>19</b>–<b>21</b>) and their unsubstituted analogue <b>13</b> were also screened against human recombinant ADAM-10, which has the highest amino acid sequence homology compared to ADAM-17 among all known MMPs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> ADAM-10 is not implicated in ALCAM ectodomain shedding but is able to cleave another cell–cell adhesion molecule, desmoglein 2 (Dsg-2), together with ADAM-17.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Moreover, ADAM-10 is considered a target in anticancer therapy for its ability to shed the human epidermal growth factor receptor 2 (HER-2), a tyrosine kinase receptor that is associated with cancer proliferation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Among the tested compounds, <b>21</b> was found to be the most active on this enzyme, with IC<sub>50</sub> = 150 nM.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biological Activity on Ovarian Cancer Cell Lines</h3><div class="NLM_p">The activity of compounds <b>1</b>, <b>13</b>, <b>19</b>–<b>21</b> was then evaluated in living cancer cells. As described before,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> modulation of sALCAM release can be used as readout test to score the inhibition of ADAM-17 activity in cells. Ovarian cancer cells (A2774, SKOV3-luc, and A2780) express high cell surface levels of ALCAM, which is shed in soluble form constitutively and even more following tyrosine kinase receptor (e.g., EGFR) activation. sALCAM can be easily assessed by ELISA of cell culture conditioned media.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> When assayed for inhibition of constitutive or EGF-induced sALCAM release, each compound was tested at 10 μM, 1 μM, 100 nM, and 10 nM with overnight incubation. Multiple tyrosine kinase activation can be mimicked by treatment with pervanadate (PV), which is a general phosphotyrosine phosphatase inhibitor that leads to activation of metalloproteases. As controls, cultures treated with the corresponding amounts of solvent (DMSO) were used. Cell morphology was monitored by microscopy, and cell viability was assessed on parallel cultures by MTT assay (data not shown), which showed no significant toxic effects on cells. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, among the new derivatives with greatly increased selectivity on isolated enzymes, compound <b>21</b> maintained good inhibitory properties on sALCAM shedding in any condition, displaying a similar IC<sub>50</sub> in the nanomolar range when PV was used as stimulus in the three cell lines (a representative dose/response experiment is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Consistent with data obtained on the ADAM-17 isolated enzyme, compounds <b>1</b> and <b>21</b> showed comparable IC<sub>50</sub>, while compounds <b>13</b>, <b>19</b>, and <b>20</b> showed higher IC<sub>50</sub>. Similar results were obtained using EGF as stimulus, although the IC<sub>50</sub> values observed were in general higher. The different sensitivity of PV-induced versus EGF-induced sALCAM release to the compounds studied may reflect the different levels of tyrosine phosphorylation achieved with the two stimuli and the resulting levels of ADAM-17 activation. Indeed, PV behaves as a stronger stimulus, achieved by its broad ability to block phosphotyrosine phosphatases, resulting in a maximal activation of ADAM-17 and sALCAM shedding in a short time frame (90 min of test). On the other hand, EGF is a more specific stimulus acting on a single TK receptor, which requires a longer incubation time (18 h) during which redundant and ADAM-17-independent mechanisms of shedding may be operative.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Cellular Activity<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> of Synthesized Compounds <b>13</b> and <b>19</b>–<b>21</b> and the Reference Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">inhibition of sALCAM release, IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">A2774</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">SKOV3-luc</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">A2780</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PV<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EGF<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">PV<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EGF<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">PV<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EGF<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">5301</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">840</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">1391</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">2096</td><td class="colsep0 rowsep0" align="char" char=".">9519</td><td class="colsep0 rowsep0" align="char" char=".">825</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">274</td><td class="colsep0 rowsep0" align="char" char=".">7626</td><td class="colsep0 rowsep0" align="char" char=".">350</td><td class="colsep0 rowsep0" align="char" char=".">5641</td><td class="colsep0 rowsep0" align="char" char=".">349</td><td class="colsep0 rowsep0" align="char" char=".">10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">651</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">4272</td><td class="colsep0 rowsep0" align="char" char="."><10</td><td class="colsep0 rowsep0" align="char" char=".">845</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">419</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">966</td><td class="colsep0 rowsep0" align="char" char="."><10</td><td class="colsep0 rowsep0" align="char" char=".">1436</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Whole cells assays were performed in duplicates. SD was generally within ±10%. One experiment, representative of three, is shown.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Inhibition of pervanadate-induced sALCAM release.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Inhibition of EGF-induced sALCAM release.</p></div></div></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of soluble ALCAM release. SKOV3-luc EOC cells were treated with the indicated amounts of compound <b>1</b> or <b>21</b> and then stimulated with pervanadate or EGF for 90 min or 18 h, respectively. Conditioned media were then harvested and tested by ELISA for sALCAM levels. Data are expressed as % of control cultures treated with solvent (DMSO). Whole cell assays were performed and tested in duplicates. A representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">4 Molecular Modeling: Docking Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To get an insight into the binding mode of <b>21</b> into the ADAM-17 active site, ensemble-docking studies were performed by means of the Glide 5.5 program.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Five X-ray structures representative of the enzyme flexibility (PDB codes <a href="https://" class="ext-link">2DDF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47">2I47</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EDZ">3EDZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ">3EWJ</a>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> were used. Docking of <b>21</b> in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DDF">2DDF</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47">2I47</a> structures resulted in poorly ranked and not fully convincing poses because the 3,5-dibromobenzyloxy P1′ group did not occupy the S1′ pocket. This is not surprising because in these two structures the S1′ loop is in a closed conformation with not enough room to permit the allocation of such a bulky moiety. Otherwise, docking of <b>21</b> using <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EDZ">3EDZ</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ">3EWJ</a> structures converged on similar and more convincing binding poses, where the P1′ substituent properly fits in the S1′ cavity. Particularly, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>), the hydroxamate group chelates the zinc ion in a bidentate fashion, the phenyl ring stacks with the H405 and interacts with V402 and L348 side chains, while the 3,5-dibromobenzyloxy group is well inserted in the S1′ pocket where multiple hydrophobic contacts are detected with V434, L401, A439, V440, L401, N447 side chains and with E398 β- and γ-carbons. Moreover, one sulfonamide oxygen establishes the commonly found bifurcated H-bond with L348 and Gly349 backbone NH. The propylurea moiety lies along the S1 pocket establishing hydrophobic contacts with the L350 and V314 side chains, while multiple H-bonds are detected between the two urea NH and T347 hydroxyl group and between the urea carbonyl oxygen and the K315 side chain. Clearly, all these interactions endowed <b>21</b> with a low nanomolar inhibitory activity toward ADAM-17.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of <b>21</b> (gold sticks) within the active site of ADAM-17, from docking calculations (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>). H-bonds are depicted as dashed black lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">With regard to the activity of <b>21</b> toward MMPs, it is well-known that different substitutions on the P1′ group can be successfully used to design selective inhibitors for MMPs. Indeed, the analysis of the MMPs X-ray structures reveals that the length of the S1′ pocket increases in the following order: MMP-1 < MMP-14 < MMP-2 ∼ MMP-9. The SAR herein presented (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) corroborates this consideration; in fact the activity on MMP-1 drops abruptly by just introducing a bended P1′ group (<b>2</b>), while MMP-14 can tolerate para and meta halogenated phenyl decorations (<b>2</b>, <b>3</b>, <b>4</b>, <b>8</b>, <b>12</b>). On the contrary, MMP-9 and -2 are able to allocate almost all the inhibitors synthesized except for <b>13</b> and its derivatives (<b>15</b>–<b>21</b>). Thus, docking studies of <b>21</b> into the aforementioned MMPs were performed with the aim to better clarify the structural features responsible for the observed inactivity toward these enzymes. Unsurprisingly, for MMP-1 and -14 (1HFC<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and 3MA2,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> respectively), the docking program is incapable of finding a pose where the P1′ group is inserted into the S1′ pocket, thus leaving most of the <b>21</b> poses largely solvent exposed. Conversely, in the lowest energy binding poses of <b>21</b> into the active sites of MMP-2 and -9 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AYU">3AYU</a><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H3X">4H3X</a>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> respectively), the 3,5-dibromobenzyloxy group fits in the S1′ pocket and the hydroxamate group chelates the zinc ion, although the sulfonamide geometry is gravely distorted. However, the bottom part of the S1′ pocket of both enzymes is open and solvent exposed, with a predominance of hydrophilic residues (T143, T145, K146, N147, R149, and S151 in MMP-2; E132, R140, T142, E143, and D150 in MMP-9); consequently, it can be assumed that the large and hydrophobic 3,5-dibromobenzyloxy moiety is not well tolerated in such a region, thus accounting for the higher IC<sub>50</sub> on MMP-2 and -9 found for <b>21</b>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">5 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting with our previously published molecule <b>1</b>, we carried out a systematic SAR investigation of the P1′ substituent in order to find out a moiety different from the highly exploited 4-(but-2-ynyloxy)benzene group able to improve the selectivity for ADAM-17 over MMPs. Optimization of the benzyloxyphenyl portion led to the identification of the 3,5-dibromobenzyloxyphenyl group, which afforded improved ADAM-17 selectivity (compound <b>13</b>). Furthermore, introduction of an amidic chain in the α position relative to the hydroxamate (P1 group) greatly increased potency against ADAM-17 (compounds <b>19</b>–<b>21</b>). In particular, the ureidic derivative <b>21</b> resulted the best of the series being as potent as <b>1</b> on ADAM-17 (IC<sub>50</sub> = 1.9 nM) and showing a greatly improved selectivity over the tested MMPs. In fact, <b>21</b> displayed a 126-fold selectivity for ADAM-17 over MMP-2, a 860-fold selectivity over MMP-9, a 10000-fold selectivity over MMP-14, and no measurable inhibitory activity toward MMP-1 (IC<sub>50</sub> > 500 μM). Finally, the compounds, which gave the best results on isolated enzymes (<b>13</b>, <b>19</b>–<b>21</b>), were tested on human EOC cell lines (A2774, SKOV3-luc, and A2780), which express ADAM-17 and its substrate ALCAM. <b>21</b> maintained good inhibitory properties on sALCAM shedding in any condition, displaying a similar IC<sub>50</sub> in the nanomolar range when PV was used as stimulus in the three cell lines. Consistent with data obtained on the ADAM-17 isolated enzyme, compounds <b>1</b> and <b>21</b> also showed comparable IC<sub>50</sub> on living cancer cells, suggesting that selective inhibition of ADAM-17 activity might be sufficient to block sALCAM release in cells. Further investigations are necessary to assess the effect of the improved ADAM-17 selectivity in ovarian cancer models in vivo.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">6 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">Melting points were determined on a Kofler hot-stage apparatus and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR spectra were determined with a Varian Gemini 200 MHz spectrometer. Chemical shifts (δ) are reported in parts per million downfield from tetramethylsilane and referenced from solvent references. Coupling constants <i>J</i> are reported in hertz; <sup>13</sup>C NMR spectra were fully decoupled. The following abbreviations are used: singlet (s), doublet (d), triplet (t), double–doublet (dd), broad (br), and multiplet (m). Where indicated, the elemental compositions of the compounds agreed to within ±0.4% of the calculated value. Chromatographic separations were performed on silica gel columns by flash column chromatography (Kieselgel 40, 0.040–0.063 mm; Merck) or using ISOLUTE Flash Si II cartridges (Biotage). Reactions were followed by thin-layer chromatography (TLC) on Merck aluminum silica gel (60 F254) sheets that were visualized under a UV lamp, and hydroxamic acids were visualized with FeCl<sub>3</sub> aqueous solution. Evaporation was performed in vacuo (rotating evaporator). Sodium sulfate was always used as the drying agent. <span class="smallcaps smallerCapital">d</span>-Cbz-ornithine (H-<span class="smallcaps smallerCapital">d</span>-Orn(Z)-OH) and <span class="smallcaps smallerCapital">d</span>-carbamoylornithine (H-<span class="smallcaps smallerCapital">d</span>-Cit-OH) were purchased from Bachem (Switzerland). 3,5-Dibromobenzyl bromide and 4-bromomethylbiphenyl were purchased from ABCR (Germany). 1-(Bromomethyl)-3-(trifluoromethoxy)benzene, 1-(bromomethyl)-4-fluorobenzene, 1-(bromomethyl)-4-(trifluoromethoxy)benzene, 1-(bromomethyl)-3,5-difluorobenzene, and 8-(bromomethyl)quinoline were purchased from Maybridge (U.K.). All other commercially available chemicals were purchased from Sigma-Aldrich.</div><div class="NLM_p last">The purity of the final compounds was determined by reverse-phase HPLC on a Merck Hitachi D-7000 liquid chromatograph. HPLC purity was determined to be >95% for all final products using a Discovery C18 column (250 mm × 4.6 mm, 5 μm, Supelco), with a mobile phase of 40% water/60% methanol at a flow rate of 1.4 mL/min, with UV monitoring at a fixed wavelength of 256 nm. See the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for compound purity analysis data for final compounds.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Synthesis of Benzyloxybenzene Sodium Salts <b>22</b>–<b>32</b></h3><div class="NLM_p last">To a suspension of sodium 4-hydroxybenzenesulfonate dihydrate (1.3 g, 5.6 mmol) in isopropanol (25 mL), containing 5.6 mL of 1 N NaOH freshly prepared, the appropriate substituted benzyl bromide (11.2 mmol) was added. The mixture was refluxed (70 °C) overnight. Isopropanol was evaporated, and the precipitate was collected by filtration and washed with isopropanol. The solid was dried in vacuo.</div></div><div id="sec6_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Sodium 4-(4-Bromobenzyloxy)benzenesulfonate (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared from 4-bromobenzyl bromide following the general procedure. White solid (79% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.10 (s, 2H); 7.38–7.42 (m, 4H); 7.49–7.60 (m, 4H).</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Sodium 4-(4-Fluorobenzyloxy)benzenesulfonate (<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-(bromomethyl)-4-fluorobenzene following the general procedure. White solid (74% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.08 (s, 2H); 6.90–6.96 (m, 2H); 7.18–7.26 (m, 2H); 7.37–7.52 (m, 4H).</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Sodium 4-(4-(Trifluoromethoxy)benzyloxy)benzenesulfonate (<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-(bromomethyl)-4-(trifluoromethoxy)benzene following the general procedure. White solid (69% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.14 (s, 2H); 7.36–7.42 (m, 4H); 7.50–7.59 (m, 4H).</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Sodium 4-(Biphenyl-4-ylmethoxy)benzenesulfonate (<b>25</b>)</h3><div class="NLM_p last">The title compound was prepared from 4-bromomethylbiphenyl following the general procedure. White solid (70% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.17 (s, 2H); 6.94–6.98 (m, 2H); 7.38–7.47 (m, 6H); 7.51–7.55 (m, 5H).</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Sodium 4-(3-Bromobenzyloxy)benzenesulfonate (<b>26</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-bromo-3-(bromomethyl)benzene following the general procedure. White solid (76% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.13 (s, 2H); 6.91–6.96 (m, 2H); 7.35–7.39 (m, 1H); 7.42–7.43 (m, 1H); 7.47–7.54 (m, 3H); 7.65–7.66 (m, 1H).</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Sodium 4-(3-Fluorobenzyloxy)benzenesulfonate (<b>27</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-(bromomethyl)-3-fluorobenzene following the general procedure. White solid (65% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.14 (s, 2H); 6.92–6.96 (m, 2H); 7.11–7.20 (m, 1H); 7.26–7.30 (m, 2H); 7.38–7.46 (m, 1H); 7.50–7.54 (m, 2H).</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Sodium 4-(3-(Trifluoromethoxy)benzyloxy)benzenesulfonate (<b>28</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-(bromomethyl)-3-(trifluoromethoxy)benzene following the general procedure. White solid (61% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.18 (s, 2H); 6.92–6.96 (m, 2H); 7.31–7.34 (m, 1H); 7.44–7.54 (m, 5H).</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Sodium 4-(Biphenyl-3-ylmethoxy)benzenesulfonate (<b>29</b>)</h3><div class="NLM_p last">The title compound was prepared from 3-(bromomethyl)biphenyl following the general procedure. White solid (62% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.19 (s, 2H); 6.95–6.99 (m, 2H); 7.34–7.55 (m, 7H); 7.61–7.74 (m, 4H).</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Sodium 4-(Quinolin-8-ylmethoxy)benzenesulfonate (<b>30</b>)</h3><div class="NLM_p last">The title compound was prepared from 8-(bromomethyl)quinoline following the general procedure. Yellow solid (80% yield). <sup>1</sup>H NMR (MeOD-<i>d</i><sub>6</sub>) δ: 5.79 (s, 2H); 7.75–8.16 (m, 5H); 8.88–8.96 (m, 1H); 9.01–9.09 (m, 1H).</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Sodium 4-(3,5-Difluorobenzyloxy)benzenesulfonate (<b>31</b>)</h3><div class="NLM_p last">The title compound was prepared from 1-(bromomethyl)-3,5-difluorobenzene following the general procedure. White solid (69% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.15 (s, 2H); 6.92–6.96 (m, 2H); 7.15–7.19 (m, 3H); 7.50–7.54 (m, 2H).</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Sodium 4-(3,5-Dibromobenzyloxy)benzenesulfonate (<b>32</b>)</h3><div class="NLM_p last">The title compound was prepared from 3,5-dibromobenzyl bromide following the general procedure. White solid (84% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 5.13 (s, 2H); 6.92–6.96 (m, 2H); 7.50–7.54 (m, 2H); 7.67–7.68 (m, 2H); 7.80–7.81 (m, 2H).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure for the Synthesis of Benzyloxybenzenesulfonyl Chlorides <b>33</b>–<b>43</b></h3><div class="NLM_p last">To a 0 °C solution of oxalyl chloride (1.3 mL, 15.3 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (5.1 mL) under Ar atmosphere, DMF was added dropwise (1.2 mL, 15.3 mmol) followed by the appropriate benzyloxybenzene sodium salt <b>22</b>–<b>32</b> (5.11 mmol). The mixture was stirred at 0 °C for 10 min and then at room temperature for 2 days. The crude was poured into ice, and the product was extracted with EtOAc. Organic layers were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give sulfonyl chlorides <b>33</b>–<b>43</b>.</div></div><div id="sec6_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(4-Bromobenzyloxy)benzene-1-sulfonyl Chloride (<b>33</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>22</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 14:1) using a Isolute Flash Si II cartridge to give <b>33</b> as a white solid (32% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.10 (s, 2H); 7.06–7.10 (m, 2H); 7.26–7.30 (m, 2H); 7.51–7.55 (m, 2H); 7.94–7.98 (m, 2H).</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(4-Fluorobenzyloxy)benzene-1-sulfonyl Chloride (<b>34</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>23</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 3:1) using a Isolute Flash Si II cartridge to give <b>34</b> as a white solid (68% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.13 (s, 2H); 7.07–7.15 (m, 4H); 7.37–7.44 (m, 2H); 7.95–8.02 (m, 2H).</div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(4-(Trifluoromethoxy)benzyloxy)benzene-1-sulfonyl Chloride (<b>35</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>24</b> following the general procedure. White solid (65% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.17 (s, 2H); 7.09–7.14 (m, 2H); 7.26–7.29 (m, 2H); 7.45–7.49 (m, 2H); 7.98–8.02 (m, 2H).</div></div><div id="sec6_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-(Biphenyl-4-ylmethoxy)benzene-1-sulfonyl Chloride (<b>36</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>25</b> following the general procedure. White solid (70% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.22 (s, 2H); 6.98–7.02 (m, 2H); 7.12–7.16 (m, 2H); 7.37–7.52 (m, 4H); 7.58–7.67 (m, 3H); 7.93–8.02 (m, 2H).</div></div><div id="sec6_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-(3-Bromobenzyloxy)benzene-1-sulfonyl Chloride (<b>37</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>26</b> following the general procedure. Yellow oil (76% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.14 (s, 2H); 7.09–7.14 (m, 2H); 7.28–7.37 (m, 2H); 7.49–7.53 (m, 1H); 7.59–7.60 (m, 1H); 7.97–8.01 (m, 2H).</div></div><div id="sec6_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(3-Fluorobenzyloxy)benzene-1-sulfonyl Chloride (<b>38</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>27</b> following the general procedure. White solid (92% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.17 (s, 2H); 6.97–7.25 (m, 5H); 7.34–7.44 (m, 1H); 7.91–8.01 (m, 2H).</div></div><div id="sec6_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-(3-(Trifluoromethoxy)benzyloxy)benzene-1-sulfonyl Chloride (<b>39</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxy-benzene sodium salt <b>28</b> following the general procedure. White solid (86% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.19 (s, 2H); 7.10–7.14 (m, 2H); 7.22–7.50 (m, 4H); 7.98–8.02 (m, 2H).</div></div><div id="sec6_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(Biphenyl-3-ylmethoxy)benzene-1-sulfonyl Chloride (<b>40</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>29</b> following the general procedure. Yellow oil (98% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.23 (s, 2H); 6.97–7.02 (m, 2H); 7.11–7.17 (m, 2H); 7.37–7.64 (m, 8H); 7.91–8.01 (m, 2H).</div></div><div id="sec6_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-(Quinolin-8-ylmethoxy)benzene-1-sulfonyl Chloride (<b>41</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>30</b> following the general procedure. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 14:1) to give <b>41</b> as a white solid (15% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.96 (s, 2H); 7.22–7.26 (m, 2H); 7.46–7.63 (m, 2H); 7.83–7.89 (m, 2H); 7.95–7.99 (m, 2H); 8.20–8.25 (m, 1H); 8.95–8.98 (m, 1H).</div></div><div id="sec6_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(3,5-Difluorobenzyloxy)benzene-1-sulfonyl Chloride (<b>42</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>31</b> following the general procedure. White solid (68% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.15 (s, 2H); 6.77–6.85 (m, 1H); 6.94–6.97 (m, 2H); 7.08–7.13 (m, 2H); 7.97–8.02 (m, 2H).</div></div><div id="sec6_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(3,5-Dibromobenzyloxy)benzene-1-sulfonyl Chloride (<b>43</b>)</h3><div class="NLM_p last">The title compound was prepared from benzyloxybenzene sodium salt <b>32</b> following the general procedure. Yellow oil (82% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 5.11 (s, 2H); 7.08–7.12 (m, 2H); 7.51–7.52 (m, 2H); 7.67–7.69 (m, 2H); 7.98–8.02 (m, 2H).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure for the Synthesis of Carboxylic Acids <b>44</b>–<b>53</b> and <b>16</b></h3><div class="NLM_p last">To a solution of glycine (68.61 mg, 0.91 mmol) in H<sub>2</sub>O (0.9 mL) and dioxane (0.9 mL) containing TEA (0.25 mL, 1.828 mmol), the appropriate sulfonyl chloride (1.83 mmol) was added. The mixture was stirred at room temperature overnight. Dioxane was evaporated, and the residue was treated with EtOAc and washed with 1 N HCl, brine, and a saturated solution of NaHCO<sub>3</sub>. Aqueous basic phases were then acidified with 1 N HCl until pH 4 was obtained, and the product was extracted with EtOAc. Organic layers were collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo.</div></div><div id="sec6_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-(4-(4-Bromobenzyloxy)phenylsulfonamido)acetic Acid (<b>44</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>33</b> following the general procedure. White solid (88% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 5.86 Hz, 2H); 5.18 (s, 2H); 7.15–7.19 (m, 2H); 7.41–7.45 (m, 2H); 7.60–7.64 (m, 2H); 7.71–7.75 (m, 2H); 7.89 (t, <i>J</i> = 5.86 Hz, 1H).</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(4-(4-Fluorobenzyloxy)phenylsulfonamido)acetic Acid (<b>45</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>34</b> following the general procedure. White solid (73% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 6.04 Hz, 2H); 5.16 (s, 2H); 7.14–7.18 (m, 2H); 7.24–7.28 (m, 2H); 7.49–7.56 (m, 2H); 7.70–7.74 (m, 2H); 7.89 (t, <i>J</i> = 6.04 Hz, 1H).</div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-(4-(4-(Trifluoromethoxy)benzyloxy)phenylsulfonamido)acetic Acid (<b>46</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>35</b> following the general procedure. White solid (80% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 5.67 Hz, 2H); 5.22 (s, 2H); 7.15–7.19 (m, 2H); 7.39–7.43 (m, 2H); 7.58–7.62 (m, 2H); 7.71–7.75 (m, 2H); 7.89 (t, <i>J</i> = 5.67 Hz, 1H).</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(4-(Biphenyl-4-ylmethoxy)phenylsulfonamido)acetic Acid (<b>47</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>36</b> following the general procedure. Pinkish solid (45% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.54 (d, <i>J</i> = 6.02 Hz, 2H); 5.24 (s, 2H); 7.18–7.22 (m, 2H); 7.37–7.57 (m, 5H); 7.66–7.76 (m, 6H); 7.89 (t, <i>J</i> = 6.02 Hz, 1H).</div></div><div id="sec6_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(4-(3-Bromobenzyloxy)phenylsulfonamido)acetic Acid (<b>48</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>37</b> following the general procedure. White solid (81% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.54 (d, <i>J</i> = 6.02 Hz, 2H); 5.19 (s, 2H); 7.16–7.20 (m, 2H); 7.33–7.58 (m, 3H); 7.68–7.72 (m, 2H); 7.75–7.76 (m, 1H); 7.89 (t, <i>J</i> = 6.02 Hz, 1H).</div></div><div id="sec6_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(4-(3-Fluorobenzyloxy)phenylsulfonamido)acetic Acid (<b>49</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>38</b> following the general procedure. White solid (76% yield). <sup>1</sup>H NMR (MeOD-<i>d</i><sub>6</sub>) δ: 3.67 (s, 2H); 5.1 (s, 2H); 7.03–7.29 (m, 5H); 7.35–7.46 (m, 1H); 7.78–7.82 (m, 2H).</div></div><div id="sec6_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(4-(3-(Trifluoromethoxy)benzyloxy)phenylsulfonamido)acetic Acid (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>39</b> following the general procedure. White solid (75% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 6.04 Hz, 2H); 5.25 (s, 2H); 7.16–7.20 (m, 2H); 7.34–7.37 (m, 1H); 7.49–7.60 (m, 3H); 7.71–7.75 (m, 2H); 7.89 (t, <i>J</i> = 6.04 Hz, 1H).</div></div><div id="sec6_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(4-(Biphenyl-3-ylmethoxy)phenylsulfonamido)acetic Acid (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>40</b> following the general procedure. White solid (60% yield). <sup>1</sup>H NMR (MeOD-<i>d</i><sub>6</sub>) δ: 3.64 (s, 2H); 5.17 (s, 2H); 7.15–7.19 (m, 2H); 7.29–7.48 (m, 6H); 7.58–7.65 (m, 3H); 7.70 (s, 1H); 7.79–7.83 (m, 2H).</div></div><div id="sec6_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(4-(Quinolin-8-ylmethoxy)phenylsulfonamido)acetic Acid (<b>52</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>41</b> following the general procedure. White solid (72% yield). <sup>1</sup>H NMR (acetone-<i>d</i><sub><i>6</i></sub>) δ: 3.65 (s, 2H); 5.84 (s, 2H); 7.18–7.22 (m, 2H); 7.57–7.67 (m, 2H); 7.77–7.81 (m, 2H); 7.92–7.97 (m, 2H); 8.40–8.45 (m, 1H); 8.93–8.95 (m, 1H).</div></div><div id="sec6_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-(4-(3,5-Difluorobenzyloxy)phenylsulfonamido)acetic Acid (<b>53</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>42</b> following the general procedure. White solid (81% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 5.13 Hz, 2H); 5.22 (s, 2H); 7.16–7.22 (m, 5H); 7.72–7.75 (m, 2H); 7.89 (t, <i>J</i> = 5.13 Hz, 1H).</div></div><div id="sec6_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)acetic Acid (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared from sulfonyl chloride <b>43</b> following the general procedure. Pale pink solid (79% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.54 (d, <i>J</i> = 6.02 Hz, 2H); 5.20 (s, 2H); 7.16–7.20 (m, 2H); 7.70–7.71 (m, 2H); 7.72–7.76 (m, 2H); 7.83–7.85 (m, 1H); 7.90 (t, <i>J</i> = 6.02 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 44.58; 69.079; 115.801; 123.521; 130.021; 130.185; 134.009; 142.275; 162.213; 170.207.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure for the Synthesis of Benzyloxyphenylsulfonamido <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)acetamides <b>54</b>–<b>61</b></h3><div class="NLM_p last">Carboxylates <b>44</b>–<b>46</b> and <b>49</b>–<b>53</b> (0.32 mmol) were suspended in dry CH<sub>2</sub>Cl<sub>2</sub> (8.5 mL) and <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine (47.9 mg 0.32 mmol) and EDC (93.5 mg, 0.48 mmol) were added. After being stirred at room temperature overnight, the mixture was washed with water and the organic phases were dried and evaporated in vacuo.</div></div><div id="sec6_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-(4-(4-Bromobenzyloxy)phenylsulfonamido)-<i>N</i>-(<i>tert</i>-butyldimethylsilyloxy)acetamide (<b>54</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>44</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:1) using a Isolute Flash Si II cartridge to give <b>54</b> as a white solid (43% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.15 (s, 6H); 0.94 (s, 9H); 3.57 (br s, 1H); 3.77 (br s, 1H); 5.01 (s, 2H); 5.24 (br s, 1H); 7.01–7.05 (m, 2H); 7.27–7.31 (m, 2H); 7.51–7.55 (m, 2H); 7.77–7.81 (m, 2H); 8.43 (br s, 1H).</div></div><div id="sec6_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(4-fluorobenzyloxy)phenylsulfonamido)acetamide (<b>55</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>45</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:1) using a Isolute Flash Si II cartridge to give <b>55</b> as a white solid (26% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.15 (s, 6H); 0.94 (s, 9H); 3.57 (br s, 1H); 3.79 (br s, 1H); 5.08 (s, 2H); 5.28 (br s, 1H); 7.02–7.14 (m, 4H); 7.37–7.43 (m, 2H); 7.77–7.82 (m, 2H); 8.43 (br s, 1H).</div></div><div id="sec6_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(4-(trifluoromethoxy)benzyloxy)phenylsulfonamido)acetamide (<b>56</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>46</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:1) using a Isolute Flash Si II cartridge to give <b>56</b> as a white solid (52% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.15 (s, 6H); 0.94 (s, 9H); 3.58 (br s, 1H); 3.79 (br s, 1H); 5.11 (s, 2H); 7.03–7.07 (m, 2H); 7.24–7.27 (m, 2H); 7.44–7.48 (m, 2H); 7.78–7.82 (m, 2H); 8.41 (br s, 1H).</div></div><div id="sec6_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(3-fluorobenzyloxy)phenylsulfonamido)acetamide (<b>57</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>49</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 3:1) using a Isolute Flash Si II cartridge to give <b>57</b> as a white solid (57% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.14 (s, 6H); 0.94 (s, 9H); 3.57 (br s, 1H); 3.79 (br s, 1H); 5.12 (s, 2H); 5.28 (br s, 1H); 7.02–7.20 (m, 5H); 7.32–7.43 (m, 1H); 7.77–7.82 (m, 2H), 8.53 (br s, 1H).</div></div><div id="sec6_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(3-(trifluoromethoxy)benzyloxy)phenylsulfonamido)acetamide (<b>58</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>50</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:1) using a Isolute Flash Si II cartridge to give <b>58</b> as a colorless oil (41% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.15 (s, 6H); 0.94 (s, 9H); 3.57 (br s, 1H); 3.77 (br s, 1H); 5.13 (s, 2H); 7.03–7.07 (m, 2H); 7.20–7.48 (m, 4H); 7.79–7.83 (m, 2H); 8.44 (brs, 1H).</div></div><div id="sec6_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-(4-(Biphenyl-3-ylmethoxy)phenylsulfonamido)-<i>N</i>-(<i>tert</i>-butyldimethylsilyloxy)acetamide (<b>59</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>51</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 3:1) using a Isolute Flash Si II cartridge to give <b>59</b> as a colorless oil (21% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.14 (s, 6H); 0.93 (s, 9H); 3.58 (br s, 1H); 3.78 (br s, 1H); 5.17 (s, 2H); 5.61 (br s, 1H); 7.05–7.09 (m, 2H); 7.36–7.51 (m, 5H); 7.57–7.64 (m, 4H); 7.77–7.81 (m, 2H); 8.84 (br s, 1H).</div></div><div id="sec6_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(quinolin-8-ylmethoxy)phenylsulfonamido)acetamide (<b>60</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>52</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>60</b> as a colorless oil (15% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.14 (s, 6H); 0.92 (s, 9H); 3.56 (br s, 1H); 3.80 (br s, 1H); 5.55 (br s, 1H); 5.88 (s, 2H); 7.13–7.17 (m, 2H); 7.43–7.60 (m, 2H); 7.75–7.88 (m, 2H); 8.17–8.22 (m, 1H); 8.85 (br s, 1H); 8.92–8.95 (m, 1H).</div></div><div id="sec6_5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(3,5-difluorobenzyloxy)phenylsulfonamido)acetamide (<b>61</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>53</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:1) using a Isolute Flash Si II cartridge to give <b>61</b> as a white solid (53% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.15 (s, 6H); 0.94 (s, 9H); 3.59 (br s, 1H); 3.79 (br s, 1H); 5.10 (s, 2H); 5.23 (br s, 1H); 6.74–6.83 (m, 1H); 6.94–7.06 (m, 4H); 7.79–7.83 (m, 2H); 8.41 (br s, 1H).</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure for the Synthesis of Benzyloxyphenylsulfonamido-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acetamides <b>62</b>–<b>64</b></h3><div class="NLM_p last">Carboxylic acids <b>47</b>, <b>48</b>, and <b>16</b> (0.46 mmol) were dissolved in dry DMF (1 mL), and <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (166.7 mg, 1.42 mmol), <i>N</i>-methylmorpholine redistilled (0.15 mL, 1.38 mmol), HOBT (74.6 mg, 0.55 mmol), and EDC (123.5 mg, 0.64 mmol) were added under N<sub>2</sub> atmosphere. After being stirred for 2 h, the reaction mixture was diluted with EtOAc and washed with water, saturated solution of NaHCO<sub>3</sub>, and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo.</div></div><div id="sec6_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-(4-(Biphenyl-4-ylmethoxy)phenylsulfonamido)-<i>N</i>-(tetrahydro-2H-pyran-2-yloxy)acetamide (<b>62</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>47</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>62</b> as a colorless oil (61% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.67–1.81 (m, 6H); 3.62 (s, 2H); 3.81–3.99 (m, 2H); 4.81–4.92 (m, 1H); 5.16 (s, 2H); 7.06–7.10 (m, 2H); 7.36–7.51 (m, 5H); 7.57–7.66 (m, 4H); 7.79–7.83 (m, 2H); 8.91 (br s, 1H).</div></div><div id="sec6_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-(4-(3-Bromobenzyloxy)phenylsulfonamido)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acetamide (<b>63</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>48</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>63</b> as a colorless oil (86% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.68–1.82 (m, 6H); 3.62 (s, 2H); 3.75–3.93 (m, 2H); 4.81–4.89 (m, 1H); 5.08 (s, 2H); 5.40 (br s, 1H); 7.01–7.05 (m, 2H); 7.29–7.35 (m, 2H); 7.46–7.49 (m, 1H); 7.56–7.57 (m, 1H); 7.78–7.82 (m, 2H); 9.13 (br s, 1H).</div></div><div id="sec6_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acetamide (<b>64</b>)</h3><div class="NLM_p last">The title compound was prepared from carboxylic acid <b>16</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>64</b> as a colorless oil (82% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.67–1.81 (m, 6H); 3.64 (s, 2H); 3.61–3.99 (m, 2H); 4.79–4.91 (m, 1H); 5.05 (s, 2H); 5.27 (br s, 1H); 7.01–7.05 (m, 2H); 7.51–7.52 (m, 2H); 7.65–7.66 (m, 1H); 7.80–7.84 (m, 2H); 8.98 (br s, 1H).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> General Procedure for the Synthesis of Benzyloxyphenylsulfonamido-<i>N</i>-hydroxyacetamides <b>3</b>–<b>5</b>, <b>8</b>–<b>12</b></h3><div class="NLM_p last">Silyl precursors (0.05 mmol) were dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (0.4 mL), and TFA (0.22 mL, 2.8 mmol) was added dropwise at 0 °C. After the mixture was stirred for 5 h, TFA was evaporated. The crude products were purified by trituration with <i>n</i>-hexane/Et<sub>2</sub>O to give the desired hydroxamates <b>3</b>–<b>5</b> and <b>8</b>–<b>12</b>.</div></div><div id="sec6_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-(4-(4-Bromobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>3</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>54</b> following the general procedure. White solid (85% yield). Mp: 135–137 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.27 (d, <i>J</i> = 5.31 Hz, 2H); 5.18 (s, 2H); 7.15–7.19 (m, 2H); 7.41–7.45 (m, 2H); 7.59–7.63 (m, 2H); 7.71–7.75 (m, 2H); 8.86 (br s, 1H); 10.53 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.11, 68.78, 114.98, 121.15, 128.70, 129.91, 131.38, 132.18, 135.77, 160.93, 164.28. Elemental analysis for C<sub>15</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>5</sub>S, calculated: % C, 43.39; % H, 3.64; % N, 6.75. Found: % C, 43.54; % H, 3.81; % N, 6.56.</div></div><div id="sec6_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-(4-(4-Fluorobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>4</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>55</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:3) using a Isolute Flash Si II cartridge to give <b>4</b> as a white solid (36% yield). Mp: 128–130 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.27 (d, <i>J</i> = 5.9 Hz, 2H); 5.17 (s, 2H); 7.15–7.19 (m, 2H); 7.24–7.28 (m, 2H); 7.49–7.56 (m, 2H); 7.71–7.75 (m, 2H); 7.81 (t, <i>J</i> = 5.9 Hz, 1H); 8.87 (br s, 1H); 10.53 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 40.71, 70.83, 114.61, 115.73, 128.34, 128.75, 132.09, 136.84, 161.82, 163.74, 166.68. Elemental analysis for C<sub>15</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>5</sub>S, calculated: % C, 50.84; % H, 4.27; % N, 7.91. Found: % C, 50.97; % H, 4.31; % N, 7.77.</div></div><div id="sec6_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-Hydroxy-2-(4-(4-(trifluoromethoxy)benzyloxy)phenylsulfonamido)acetamide (<b>5</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>56</b> following the general procedure. White solid (87% yield). Mp: 114–116 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.28 (d, <i>J</i> = 6.04 Hz, 2H); 5.23 (s, 2H); 7.16–7.20 (m, 2H); 7.39–7.43 (m, 2H); 7.59–7.63 (m, 2H); 7.72–7.76 (m, 2H); 7.82 (t, <i>J</i> = 6.04 Hz, 1H); 8.88 (br s, 1H); 10.54 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.11, 68.65, 114.94, 121.06, 128.72, 129.69, 132.22, 135.82, 147.90, 160.95, 164.28. Elemental analysis for C<sub>16</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S, calculated: % C, 45.72; % H, 3.60; % N, 6.66. Found: % C, 45.83; % H, 3.81; % N, 6.30.</div></div><div id="sec6_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-(4-(3-Fluorobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>8</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>57</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:3) using a Isolute Flash Si II cartridge to give <b>8</b> as a yellow solid (45% yield). Mp: 98–100 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.27 (s, 2H); 5.21 (s, 2H); 7.16–7.20 (m, 3H); 7.29–7.32 (m, 2H); 7.41–7.51 (m, 1H); 7.72–7.76 (m, 2H); 9.04 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.13, 68.73, 114.14, 114.57, 114.97, 123.61, 123.66, 128.70, 130.42, 130.58, 132.22, 139.12, 139.26, 159.64, 160.90, 164.50. Elemental analysis for C<sub>15</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>5</sub>S, calculated: % C, 50.84; % H, 4.27; % N, 7.91. Found: % C, 50.93; % H, 4.34; % N, 7.57.</div></div><div id="sec6_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-Hydroxy-2-(4-(3-(trifluoromethoxy)benzyloxy)phenylsulfonamido)acetamide (<b>9</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>58</b> following the general procedure. The crude product was purified by flash chromatography (CHCl<sub>3</sub>/MeOH 36:1) using a Isolute Flash Si II cartridge to give <b>9</b> as a white solid (42% yield). Mp: 83–85 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.27 (d, <i>J</i> = 5.31 Hz, 2H); 5.25 (s, 2H); 7.17–7.21 (m, 2H); 7.31–7.38 (m, 1H); 7.48–7.56 (m, 3H); 7.72–7.76 (m, 2H); 9.04 (br s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.65, 29.07, 75.44, 80.54, 80.96, 87.20, 89.19, 91.00, 92.77, 99.62, 108.83, 121.34, 124.67. Elemental analysis for C<sub>16</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S, calculated: % C, 45.72; % H, 3.60; % N, 6.66. Found: % C, 45.79; % H, 3.76; % N, 6.49.</div></div><div id="sec6_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-(4-(Biphenyl-3-ylmethoxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>10</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>59</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 2:3) using a Isolute Flash Si II cartridge to give <b>10</b> as a foaming pink solid (50% yield). Mp: 54–55 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.26 (s, 2H); 5.27 (s, 2H); 7.19–7.23 (m, 2H); 7.37–7.51 (m, 5H); 7.62–7.76 (m, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.13, 69.58, 114.99, 126.19, 126.37, 126.68, 126.86, 127.55, 128.72, 128.92, 129.12, 132.05, 137.03, 139.77, 140.34, 161.15, 164.26. Elemental analysis for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>S, calculated: % C, 61.15; % H, 4.89; % N, 6.79. Found: % C, 61.23; % H, 4.96; % N, 6.78.</div></div><div id="sec6_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-Hydroxy-2-(4-(quinolin-8-ylmethoxy)phenylsulfonamido)acetamide (<b>11</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>60</b> following the general procedure. The crude product was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 18:1) using a Isolute Flash Si II cartridge to give <b>11</b> as a white solid (70% yield). Mp: 165–167 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.29 (s, 2H); 5.82 (s, 2H); 7.22–7.26 (m, 2H); 7.59–7.68 (m, 2H); 7.73–7.77 (m, 2H); 7.88–7.92 (m, 1H); 7.99–8.02 (m, 1H); 8.42–8.46 (m, 1H); 8.91 (br s, 1H); 8.96–8.98 (m, 1H); 10.56 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.14, 66.05, 114.90, 121.73, 126.30, 128.25, 128.43, 128,80, 131.99, 133.78, 136.48, 145.18, 150.15, 161.41, 164.34. Elemental analysis for C<sub>18</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S, calculated: % C, 55.80; % H, 4.42; % N, 10.85. Found: % C, 55.63; % H, 4.69; % N, 10.68.</div></div><div id="sec6_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-(4-(3,5-Difluorobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>12</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>O</i>-silylate derivative <b>61</b> following the general procedure. White solid (85% yield). Mp: 125–127 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.27 (d, <i>J</i> = 6.04 Hz, 2H); 5.23 (s, 2H); 7.16–7.27 (m, 5H); 7.72–7.76 (m, 2H); 7.83 (t, <i>J</i> = 6.04 Hz, 2H); 10.54 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.11, 68.18, 103.38, 110.33, 110.82, 114.99, 128.74, 132.42, 160.70, 164.26. Elemental analysis for C<sub>15</sub>H<sub>14</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S, calculated: % C, 48.39; % H, 3.79; % N, 7.52. Found: % C, 48.66; % H, 3.91; % N, 7.46.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> General Procedure for the Synthesis of Benzyloxyphenylsulfonamido-<i>N</i>-hydroxyacetamides <b>6</b>, <b>7</b>, <b>13</b></h3><div class="NLM_p last">Protected hydroxamates <b>62</b>–<b>64</b> (0.33 mmol) were dissolved in dioxane (0.6 mL) and a solution of 4 N HCl (5.94 mL) was added dropwise followed by MeOH (1.32 mL). After being stirred for 30 min, the mixture was evaporated in vacuo.</div></div><div id="sec6_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-(4-(Biphenyl-4-ylmethoxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>6</b>)</h3><div class="NLM_p last">The title compound was prepared from the THP-protected hydroxamate <b>62</b> following the general procedure. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>6</b> as a white solid (39% yield). Mp: 163–165 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.25 (s, 2H); 5.23 (s, 2H); 7.18–7.22 (m, 2H); 7.33–7.57 (m, 5H); 7.66–7.76 (m, 6H); 8.97 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 30.70, 69.29, 114.94, 126.61, 126.76, 127.49, 128.39, 128.70, 128.89, 132.15, 135.46, 139.65, 139.85, 161.10. Elemental analysis for C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>S, calculated: % C, 61.15; % H, 4.89; % N, 6.79. Found: % C, 61.21; % H, 4.99; % N, 6.66.</div></div><div id="sec6_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-(4-(3-Bromobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>7</b>)</h3><div class="NLM_p last">The title compound was prepared from the THP-protected hydroxamate <b>63</b> following the general procedure. Hydroxamate <b>7a</b> was obtained after trituration with Et<sub>2</sub>O as a white crystalline solid (79% yield). Mp: 124–125 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.28 (d, <i>J</i> = 6.02 Hz, 2H); 5.20 (s, 2H); 7.17–7.21 (m, 2H); 7.34–7.58 (m, 3H); 7.68–7.69 (m, 1H); 7.72–7.76 (m, 2H); 7.80–7.86 (t, <i>J</i> = 6.02 Hz, 1H); 8.88 (br s, 1H); 10.55 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.10, 68.60, 114.96, 121.66, 126.68, 128.72, 130.32, 130.67, 130.83, 132.25, 139.10, 160.89, 164.28. Elemental analysis for C<sub>15</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>5</sub>S, calculated: % C, 43.39; % H, 3.64; % N, 6.75. Found: % C, 43.41; % H, 3.75; % N, 6.49.</div></div><div id="sec6_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>13</b>)</h3><div class="NLM_p last">The title compound was prepared from the THP-protected hydroxamate <b>64</b> following the general procedure. Hydroxamate <b>13</b> was obtained after trituration with Et<sub>2</sub>O as a white solid (77% yield). Mp: 94–96 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.28 (d, <i>J</i> = 6.02 Hz, 2H); 5.20 (s, 2H); 7.17–7.21 (m, 2H); 7.70–7.72 (m, 3H); 7.76–7.77 (m, 1H); 7.80–7.86 (m, 2H); 10.55 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 43.11, 67.80, 114.96, 122.50, 128.72, 129.47, 132.42, 132.87, 141.10, 160.68, 164.25. Elemental analysis for C<sub>15</sub>H<sub>14</sub>Br<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S, calculated: % C, 36.46; % H, 2.86; % N, 5.67. Found: % C, 36.51; % H, 2.93; % N, 5.43.</div></div><div id="sec6_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>tert</i>-Butyl 2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)acetate (<b>65</b>)</h3><div class="NLM_p last">To a solution of glycine <i>tert</i>-butyl ester hydrochloride (176 mg, 1.05 mmol) in H<sub>2</sub>O (1.0 mL) and dioxane (5.0 mL) containing TEA (0.44 mL, 3.15 mmol) was added sulfonyl chloride <b>43</b> (500 mg, 1.05 mmol). The mixture was stirred at room temperature overnight. Dioxane was evaporated, and the residue was diluted with EtOAc and washed with H<sub>2</sub>O and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give a white solid (512 mg, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.34 (s, 9H); 3.65 (d, <i>J</i> = 5.3 Hz, 2H); 4.99 (t, <i>J</i> = 5.4 Hz, 1H); 5.04 (s, 2H); 6.99–7.04 (m, 2H); 7.50 (m, 2H); 7.65 (s, 1H); 7.79–7.83 (m, 2H).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Procedure for the Synthesis of <i>tert</i>-Butyl Esters <b>66</b> and <b>67</b></h3><div class="NLM_p last">A solution of aryl bromide <b>65</b> (250 mg, 0.48 mmol) in dioxane (4.8 mL)/H<sub>2</sub>O (1.0 mL) was sequentially treated under nitrogen with K<sub>3</sub>PO<sub>4</sub> (306 mg, 1.4 mmol), the appropriate arylboronic acid (0.52 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (22 mg, 0.02 mmol). The resulting mixture was stirred for 1 h at 85 °C. After being cooled to room temperature, the mixture was treated with NaHCO<sub>3</sub> and extracted with CHCl<sub>3</sub>. The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude was purified by flash chromatography on silica gel column.</div></div><div id="sec6_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>tert</i>-Butyl 2-(4-((5-Bromo-4′-methoxybiphenyl-3-yl)methoxy)phenylsulfonamido)acetate (<b>66</b>)</h3><div class="NLM_p last">The title compound was prepared from 4-methoxyphenylboronic acid following the general procedure. Purification was with <i>n</i>-hexane/EtOAc 7:2 (40% yield), giving a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.33 (s, 9H); 3.65 (d, <i>J</i> = 5.5 Hz, 2H); 3.85 (s, 3H); 4.96 (t, <i>J</i> = 5.5 Hz, 1H); 5.12 (s, 2H); 6.94–7.00 (m, 2H); 7.02–7.07 (m, 2H); 7.47–7.51 (m, 4H); 7.66 (s, 1H); 7.77–7.83 (m, 2H).</div></div><div id="sec6_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>tert</i>-Butyl 2-(4-(3-Bromo-5-(pyridin-3-yl)benzyloxy)phenylsulfonamido)acetate (<b>67</b>)</h3><div class="NLM_p last">The title compound was prepared from 3-pyridinylboronic acid following the general procedure. Purification was with <i>n</i>-hexane/EtOAc 2:1 (36% yield), giving a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.32 (s, 9H); 3.63 (d, <i>J</i> = 5.6 Hz, 2H); 5.14 (s, 2H); 5.29 (t, <i>J</i> = 5.4 Hz, 1H); 7.02–7.06 (m, 2H); 7.39–7.71 (m, 4H); 7.78–7.83 (m, 2H); 7.91 (dt, <i>J</i><sub>1</sub> = 8 Hz, <i>J</i><sub>2</sub> = 2 Hz, 1H); 8.64 (d, <i>J</i> = 3.6 Hz, 1H); 8.84 (s, 1H).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> General Procedure for the Preparation of Carboxylic Acids <b>68</b> and <b>69</b></h3><div class="NLM_p last">TFA (10.44 mmol, 0.8 mL) was added dropwise to a stirred, ice-chilled solution of <i>tert</i>-butyl esters <b>66</b> and <b>67</b> (0.18 mmol) in freshly distilled dichloromethane (2.0 mL). The mixture was stirred under these reaction conditions for 5 h, and the solvent was removed in vacuo to give the corresponding carboxylic acids <b>68</b> and <b>69</b>. The crude products were purified by trituration with Et<sub>2</sub>O.</div></div><div id="sec6_10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 2-(4-((5-Bromo-4′-methoxybiphenyl-3-yl)methoxy)phenylsulfonamido)acetic acid (<b>68</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl ester <b>66</b> following the general procedure. White solid (87% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 3.65 (s, 2H); 3.82 (s, 3H); 5.12 (s, 2H); 6.93–6.97 (m, 2H); 7.03–7.08 (m, 2H); 7.45–7.50 (m, 4H); 7.63 (s, 1H); 7.76–7.80 (m, 2H).</div></div><div id="sec6_10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 3-(3-Bromo-5-((4-(<i>N</i>-(carboxymethyl)sulfamoyl)phenoxy)methyl)phenyl)pyridinium 2,2,2-Trifluoroacetate (<b>69</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl ester <b>67</b> following the general procedure. White solid (58% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.53 (d, <i>J</i> = 6.0 Hz, 2H); 5.26 (s, 2H); 7.19–7.23 (m, 2H); 7.57–7.63 (m, 2H); 7.72–7.76 (m, 3H); 7.88–7.97 (m, 3H); 8.24 (d, <i>J</i> = 7.8 Hz, 1H); 8.67 (s, 1H); 8.98 (s, 1H).</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> General Procedure for the Synthesis of Hydroxamates <b>17</b> and <b>18</b></h3><div class="NLM_p last">EDC was added portionwise (92 mg, 0.48 mmol) to a stirred and cooled solution (0 °C) of the appropriate carboxylic acid <b>68</b>, <b>69</b> (0.19 mmol) and <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine (113 mg, 0.77 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL). After being stirred at room temperature overnight, the mixture was washed with water and the organic phase was dried and evaporated in vacuo. Silyl precursors (0.12 mmol) were then dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and TFA (0.5 mL, 6.56 mmol) was added dropwise at 0 °C. After the mixture was stirred for 5 h, TFA was evaporated. The crude products were purified by trituration with <i>n</i>-hexane/Et<sub>2</sub>O to give the desired hydroxamates <b>17</b> and <b>18</b>.</div></div><div id="sec6_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-(4-((5-Bromo-4′-methoxybiphenyl-3-yl)methoxy)phenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>17</b>)</h3><div class="NLM_p">The title compound was prepared from carboxylic acid <b>68</b> following the general procedure. <i>O</i>-Silylate derivative was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 1:1) to give a white solid (60% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 0.02 (s, 6H); 0.85 (s, 9H); 3.65 (s, 2H); 3.82 (s, 3H); 5.16 (s, 2H); 6.93–6.97 (m, 2H); 7.03–7.08 (m, 2H); 7.45–7.50 (m, 4H); 7.63 (s, 1H); 7.76–7.80 (m, 2H); 10.39 (s, 1H).</div><div class="NLM_p last">Hydroxamic acid <b>17</b> was obtained as a white solid (87% yield) after trituration with Et<sub>2</sub>O. Mp: 175–177 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.52 (s, 2H); 3.85 (s, 3H); 5.31 (s, 2H); 7.02–7.08 (m, 2H); 7.20–7.25 (m, 2H); 7.62–7.68 (m, 4H); 7.75 (s, 1H); 7.81–7.86 (m, 2H); 10.20 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 42.10; 57.90; 69.30; 114.95; 122.49; 127.90; 128.72; 129.47; 130.10; 132.42; 132.87; 138.70; 142.20; 159.15; 161.67; 165.21. Elemental analysis for C<sub>22</sub>H<sub>21</sub>BrN<sub>2</sub>O<sub>6</sub>S, calculated: % C, 50.68; % H, 4.06; % N, 5.37. Found: % C, 50.75; % H, 4.19; % N, 5.29.</div></div><div id="sec6_11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 3-(3-Bromo-5-((4-(<i>N</i>-(2-(hydroxyamino)-2-oxoethyl)sulfamoyl)phenoxy)methyl)phenyl)pyridinium 2,2,2-Trifluoroacetate (<b>18</b>)</h3><div class="NLM_p">The title compound was prepared from carboxylic acid <b>69</b> following the general procedure. <i>O</i>-Silylate derivative was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 1:1) to give a white solid (67% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 0.03 (s, 6H); 0.86 (s, 9H); 5.27 (s, 2H); 7.20–7.24 (m, 2H); 7.48–7.63 (m, 3H); 7.72–7.76 (m, 3H); 7.86–7.94 (m, 2H); 8.13 (dt, <i>J</i><sub>1</sub> = 8 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H); 8.61 (dd, <i>J</i><sub>1</sub> = 4.7 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H); 8.92 (d, <i>J</i> = 1.6 Hz, 1H); 10.75 (s, 1H).</div><div class="NLM_p last">Hydroxamic acid <b>18</b> was obtained as a pale yellow solid (37% yield) after flash chromatography (CHCl<sub>3</sub>/MeOH 25:1) using a Isolute Flash Si II cartridge. Mp: 135 °C (dec). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.28 (d, 2H); 5.27 (s, 2H); 7.20–7.24 (m, 2H); 7.47–7.54 (m, 1H); 7.72–7.94 (m, 6H); 8.13 (dt, <i>J</i><sub>1</sub> = 8 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H); 8.61 (dd, <i>J</i><sub>1</sub> = 4.8 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H); 8.88 (s, 1H); 8.92 (d, <i>J</i> = 1.6 Hz, 1H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ: 44.57; 70.30; 116.37; 124.27; 125.42; 125.98; 130.33; 130.64; 131.13; 136.54; 136.83; 141.33; 148.39; 149.49; 163.23; 167.64. Elemental analysis for C<sub>22</sub>H<sub>19</sub>BrF<sub>3</sub>N<sub>3</sub>O<sub>7</sub>S, calculated: % C, 43.58; % H, 3.16; % N, 6.93. Found: % C, 43.75; % H, 3.29; % N, 6.69.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> General Procedure for the Synthesis of Sulfonamides <b>70</b>, <b>72</b>, and <b>73</b></h3><div class="NLM_p last">To a solution of sarcosine <i>tert</i>-butyl ester hydrochloride or H-<span class="smallcaps smallerCapital">d</span>-Orn(Z)-OH or H-<span class="smallcaps smallerCapital">d</span>-Orn(carbamoyl)-OH (0.59 mmol) in H<sub>2</sub>O (1 mL) and dioxane (1 mL) containing TEA (1.76 mmol, 0.25 mL) was added 4-(3,5-dibromobenzyloxy)benzene-1-sulfonyl chloride <b>43</b> (0.59 mmol, 280 mg), and the mixture was stirred at room temperature overnight. Dioxane was then evaporated, and the residue was taken up with EtOAc and washed with 1 N HCl and brine. Organic layers were then dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo to furnish derivatives <b>70</b>, <b>72</b>, and <b>73</b>.</div></div><div id="sec6_12_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>tert</i>-Butyl 2-(4-(3,5-Dibromobenzyloxy)-<i>N</i>-methylphenylsulfonamido)acetate (<b>70</b>)</h3><div class="NLM_p last">The title compound was prepared from sarcosine <i>tert</i>-butyl ester hydrochloride following the general procedure. White solid (93% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.40 (s, 9H); 2.89 (s, 3H); 3.88 (s, 2H); 5.05 (s, 2H): 7.00–7.04 (m, 2H); 7.51–7.52 (m, 2H); 7.64–7.65 (m, 1H); 7.75–7.80 (m, 2H).</div></div><div id="sec6_12_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> (<i>R</i>)-5-(Benzyloxycarbonylamino)-2-(4-(3,5-dibromobenzyloxy)phenylsulfonamido)pentanoic Acid (<b>72</b>)</h3><div class="NLM_p last">The title compound was prepared from H-<span class="smallcaps smallerCapital">d</span>-Orn(Z)-OH following the general procedure. Carboxylic acid <b>72</b> was triturated with Et<sub>2</sub>O and <i>n</i>-hexane to yield a pink solid (62% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.21–1.58 (m, 4H); 2.81–2.96 (m, 2H); 3.57–3.67 (m, 1H); 4.99 (s, 2H); 5.21 (s, 2H); 6.91–6.93 (m, 1H); 7.15–7.19 (m, 2H); 7.33 (s, 5H); 7.70–7.74 (m, 4H); 7.82–7.84 (m, 1H); 7.89–8.15 (m, 1H).</div></div><div id="sec6_12_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> (<i>R</i>)-2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-5-ureidopentanoic Acid (<b>73</b>)</h3><div class="NLM_p last">The title compound was prepared from H-<span class="smallcaps smallerCapital">d</span>-Orn(carbamoyl)-OH (H-<span class="smallcaps smallerCapital">d</span>-Cit-OH) following the general procedure. White solid (47% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.22–1.60 (m, 4H); 2.84 (dd, <i>J</i><sub>1</sub> = 5.8 Hz, <i>J</i><sub>2</sub> = 6.6 Hz, 2H); 3.56–3.67 (m, 1H); 5.18 (s, 2H); 5.36 (s, 2H); 5.88 (t, <i>J</i> = 5.8 Hz, 1 H); 7.13–7.17 (m, 2H); 7.69–7.73 (m, 4H); 7.83 (t, <i>J</i> = 1.4 Hz, 1H); 8.00 (d, <i>J</i> = 8.6 Hz,1H).</div></div><div id="sec6_12_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 2-(4-(3,5-Dibromobenzyloxy)-<i>N</i>-methylphenylsulfonamido)acetic Acid (<b>71</b>)</h3><div class="NLM_p last">TFA (2.25 mL, 29.24 mmol) was added dropwise to a stirred, ice-chilled solution of <i>tert</i>-butyl ester <b>70</b> (300 mg, 0.51 mmol) in dry dichloromethane (4.0 mL). The mixture was stirred under these reaction conditions for 5 h, and the solvent was removed in vacuo to give the carboxylic acid <b>71</b>. White solid (253 mg, 0.51 mmol, quantitative yield). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ: 2.85 (s, 3H); 3.97 (s, 2H); 5.29 (s, 2H); 7.21–7.25 (m, 2H); 7.73–7.74 (m, 2H); 7.75–7.76 (m, 1H); 7.80–7.84 (m, 2H).</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> General Procedure for the Synthesis of 3,5-Dibromobenzyloxyphenylsulfonamido-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acetamides <b>74</b> and <b>75</b></h3><div class="NLM_p last">Protected hydroxamates <b>74</b> and <b>75</b> were obtained from carboxylates <b>71</b> and <b>72</b> following the procedure previously described for <b>62</b>–<b>64</b>.</div></div><div id="sec6_13_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 2-(4-(3,5-Dibromobenzyloxy)-<i>N</i>-methylphenylsulfonamido)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)acetamide (<b>74</b>)</h3><div class="NLM_p last">The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give <b>74</b> as a white solid (39% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.52–1.68 (m, 4H); 1.76–1.88 (m, 2H); 2.82 (s, 3H); 3.67 (s, 2H); 3.90–4.08 (m, 2H); 4.96–5.02 (m, 1H); 5.07 (s, 2H); 7.05–7.09 (m, 2H); 7.52 (s, 2H); 7.66 (s, 1H); 7.74–7.79 (m, 2H); 9.13 (br s, 1H).</div></div><div id="sec6_13_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Benzyl (<i>R</i>)-4-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-5-oxo-5-(tetrahydro-2<i>H</i>-pyran-2-yloxyamino)pentylcarbamate (<b>75</b>)</h3><div class="NLM_p last">The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 3:2) using a Isolute Flash Si II cartridge to give <b>75</b> as a white solid (36% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.76–1.88 (m, 2H); 1.52–1.68 (m, 2H); 3.06–3.14 (m, 2H); 3.54–3.60 (m, 2H); 3.74–3.82 (m, 2H); 3.98–4.02 (m, 2H); 4.35 (s, 1H); 4.95–5.12 (m, 1H); 5.01 (s, 2H); 5.09 (s, 2H); 5.51 (d, <i>J</i> = 9 Hz, 1H); 6.98–7.03 (m, 2H); 7.33–7.34 (m, 5H); 7.51 (s, 2H); 7.66 (s, 1H); 7.78–7.82 (m, 2H); 9.47 (br s, 1H).</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> General Procedure for the Synthesis of 3,5-Dibromobenzyloxyphenylsulfonamido-<i>N</i>-hydroxyacetamides <b>15</b> and <b>20</b></h3><div class="NLM_p last">Hydroxamates <b>15</b> and <b>20</b> were obtained from THP-protected hydroxamates <b>74</b> and <b>75</b> following the procedure previously described for <b>6</b>, <b>7</b>, and <b>13</b>.</div></div><div id="sec6_14_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-(4-(3,5-Dibromobenzyloxy)-<i>N</i>-methylphenylsulfonamido)-<i>N</i>-hydroxyacetamide (<b>15</b>)</h3><div class="NLM_p last">The crude product was purified by trituration with Et<sub>2</sub>O, <i>n</i>-hexane, and acetone to give <b>15</b> as a white solid (55% yield). Mp: 163–165 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 2.67 (s, 3H); 3.52 (s, 2H); 5.21 (s, 2H); 7.20–7.24 (m, 2H); 7.72 (s, 2H); 7.72–7.76 (m, 2H); 7.84 (s, 1H); 8.95 (br s, 1H); 10.65 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 35.81, 50.10, 67.89, 115.18, 122.50, 129.05, 129.43, 129.52, 132.91, 141.01, 161.15, 163.74. Elemental analysis for C<sub>16</sub>H<sub>16</sub>Br<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S, calculated: % C, 37.82; % H, 3.17; % N, 5.51. Found: % C, 37.93; % H, 3.19; % N, 5.47.</div></div><div id="sec6_14_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> (<i>R</i>)-Benzyl 4-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-5-(hydroxyamino)-5-oxopentylcarbamate (<b>20</b>)</h3><div class="NLM_p last">The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to give <b>20</b> as a white solid (95% yield). Mp: 88–90 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.26–1.48 (m, 4H); 2.84 (dd, <i>J</i><sub>1</sub> = 8 Hz, <i>J</i><sub>2</sub> = 14 Hz, 2H); 3.43–3.55 (m, 1H); 4.98 (s, 2H); 5.18 (s, 2H); 7.12–7.16 (m, 2H); 7.22 (t, <i>J</i> = 8 Hz, 1H); 7.33 (s, 5H); 7.68–7.72 (m, 2H); 7.70 (s, 2H); 7.88 (s, 2H); 7.90 (d, <i>J</i> = 8 Hz, 1H); 8.83 (br s, 1H); 10.54 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 25.22; 29.70; 53.08; 64.57; 67.21; 114.24; 121.94; 127.10; 127.73; 127.90; 128.92; 132.30; 133.07; 136.56; 140.53; 155.37; 159.94; 166.52. Elemental analysis for C<sub>26</sub>H<sub>27</sub>Br<sub>2</sub>N<sub>3</sub>O<sub>7</sub>S, calculated: % C, 45.56; % H, 3.97; % N, 6.13. Found: % C, 45.71; % H, 3.99; % N, 6.26.</div></div><div id="sec6_14_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> <i>tert</i>-Butyl 4-(3,5-Dibromobenzyloxy)phenylsulfonylcarbamate (<b>76</b>)</h3><div class="NLM_p">Aqueous ammonia (30% solution) (0.67 mL) was added dropwise to a stirred, ice-chilled solution of sulfonyl chloride <b>43</b> (1 g, 2.1 mmol) in acetonitrile (1.05 mL). The resulting mixture was stirred for 10 min at room temperature, and then it was diluted with water and the precipitate was filtered under vacuum. 4-(3,5-Dibromobenzyloxy)benzenesulfonamide was obtained as a white solid (900 mg, 2.11 mmol, quantitative yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 4.70 (br s, 2H); 5.10 (s, 2H); 7.01–7.05 (m, 2H); 7.51 (s, 2H); 7.65 (s, 1H); 7.86–7.90 (m, 2H).</div><div class="NLM_p last">4-(3,5-Dibromobenzyloxy)benzenesulfonamide (892 mg, 2.11 mmol) was then suspended in dry CH<sub>2</sub>Cl<sub>2</sub> (2.65 mL) containing DMAP (25.9 mg, 0.21 mmol) and TEA (0.33 mL, 2.33 mmol). A solution of di-<i>tert</i>-butyl dicarbonate (531.6 mg, 2.44 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (3.69 mL) was added dropwise, and the mixture was stirred at room temperature overnight. The solution was concentrated in vacuo, and the residue was diluited with CH<sub>2</sub>Cl<sub>2</sub> and treated with 1 N HCl. The organic phase was then washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 7:1) using a Isolute Flash Si II cartridge to give <b>76</b> as a colorless oil (933 mg, 1.80 mmol, 84% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.39 (s, 9H); 5.08 (s, 2H); 7.03–7.08 (m, 2H); 7.27 (s, 1H); 7.51 (s, 2H); 7.65 (s, 1H); 7.95–7.99 (m, 2H).</div></div><div id="sec6_14_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> (<i>R</i>)-<i>tert</i>-Butyl 8-(4-(3,5-Dibromobenzyloxy)phenylsulfonyl)-11,11-dimethyl-3,9-dioxo-1-phenyl-2,10-dioxa-4,8-diazadodecane-7-carboxylate (<b>78</b>)</h3><div class="NLM_p last">To a solution of Boc-sulfonamide <b>76</b> (500 mg, 0.96 mmol) in dry THF (9.6 mL) were added alcohol <b>77</b> (197.84 mg, 0.64 mmol), triphenylphosphine (503.6 mg, 1.92 mmol), and DIAD (0.32 mL, 1.6 mmol). The mixture was stirred under argon atmosphere for 4 h at room temperature, and then it was evaporated under reduced pressure. The crude product was purified by flash chromatography on silica gel (<i>n</i>-hexane/EtOAc 4:1) to give <b>78</b> as a colorless oil (431 mg, 0.53 mmol, 83% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.32 (s, 9H); 1.39 (s, 9H); 2.34–2.48 (m, 2H); 3.18–3.27 (m, 1H); 3.51–3.65 (m, 1H); 4.95 (dd, <i>J</i><sub>1</sub> = 4.76 Hz, <i>J</i><sub>2</sub> = 4.76 Hz, 1H); 5.08 (s, 2H); 5.11 (s, 2H); 5.45 (br s, 1H); 6.99–7.03 (m, 2H); 7.31–7.37 (m, 5H); 7.50 (d, <i>J</i> = 1.6 Hz, 2H); 7.65 (t, <i>J</i> = 1.6 Hz, 1H); 7.95–8.00 (m, 2H).</div></div><div id="sec6_14_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> (<i>R</i>)-8-(4-(3,5-Dibromobenzyloxy)phenylsulfonyl)-11,11-dimethyl-3,9-dioxo-1-phenyl-2,10-dioxa-4,8-diazadodecane-7-carboxylic Acid (<b>79</b>)</h3><div class="NLM_p last">TFA (2.29 mL, 29.67 mmol) was added dropwise to a stirred, ice-chilled solution of <i>tert</i>-butyl ester <b>78</b> (423 mg, 0.52 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (4.0 mL). The mixture was stirred under these reaction conditions for 5 h, and the solvent was removed in vacuo to give the carboxylic acid <b>79</b> as a white solid (291.4 mg, 0.44 mmol, 85% yield) after trituration with Et<sub>2</sub>O and <i>n</i>-hexane. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.56–1.67 (m, 1H); 1.68–1.80 (m, 1H); 2.92–3.02 (m, 2H); 3.68–3.82 (m, 1H); 4.99 (s, 2H); 5.17 (s, 2H); 7.13–7.17 (m, 2H); 7.22 (t, <i>J</i> = 5 Hz, 1H); 7.35 (s. 5H); 7.69 (s, 2H); 7.70–7.74 (m, 2H); 8.07 (d, <i>J</i> = 8.9 Hz, 1H).</div></div><div id="sec6_14_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (<i>R</i>)-Benzyl 3-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-4-(hydroxyamino)-4-oxobutylcarbamate (<b>19</b>)</h3><div class="NLM_p">The THP-protected hydroxamate was obtained from carboxylic acid <b>79</b> following the procedure previously described for compounds <b>62</b>–<b>64</b>. The crude product was purified by flash chromatography (<i>n</i>-hexane/EtOAc 1:1) using a Isolute Flash Si II cartridge to give a white solid (130 mg, 0.17 mmol, 44% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.67–1.81 (m, 6H); 3.07–3.18 (m, 2H); 3.32–3.61 (m, 2H); 3.70–3.86 (m, 2H); 4.42–4.51 (m, 1H); 4.98 (s, 2H); 5.12 (s, 2H); 5.33 (br s, 1H); 5.75 (m, 1H); 6.91–6.95 (m, 2H); 7.36 (s, 5H); 7.49 (s, 2H); 7.65–7.69 (m, 2H); 7.73 (s, 1H); 10.10 (br s, 1H).</div><div class="NLM_p last">Hydroxamate <b>19</b> was obtained from its THP-protected precursor following the procedure previously described for compounds <b>6</b>, <b>7</b>, and <b>13</b>. The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to give <b>19</b> as a white solid (97.3 mg, 0.14 mmol, 91% yield). Mp: 98–100 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.40–1.76 (m, 2H); 2.84 (dd, <i>J</i><sub>1</sub> = 6.7 Hz, <i>J</i><sub>2</sub> = 12.8 Hz, 2H); 3.59–3.61 (m, 1H); 4.98 (s, 2H); 5.18 (s, 2H); 7.12–7.16 (m, 2H); 7.33 (s, 5H); 7.68–7.72 (m, 2H); 7.70 (s, 2H); 7.83 (s, 1H); 8.00 (d, <i>J</i> = 8.6 Hz, 2H); 10.53 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 33.00, 37.15, 51.88, 65.23, 67.82, 114.85, 122.50, 127.68, 128.29, 128.45, 132.87, 133.53, 137.03, 141.09, 155.78, 160.57, 166.70. Elemental analysis for C<sub>25</sub>H<sub>25</sub>Br<sub>2</sub>N<sub>3</sub>O<sub>7</sub>S, calculated: % C, 44.73; % H, 3.75; % N, 6.26. Found % C, 44.81; % H, 3.99; % N, 6.19.</div></div><div id="sec6_14_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> (<i>R</i>)-<i>N</i>-(<i>tert</i>-Butyldimethylsilyloxy)-2-(4-(3,5-dibromobenzyloxy)phenylsulfonamido)-5-ureidopentanamide (<b>80</b>)</h3><div class="NLM_p last">EDC was added portionwise (250 mg, 1.30 mmol) to a stirred and cooled solution (0 °C) of the carboxylic acid <b>73</b> (300 mg, 0.52 mmol) and <i>O</i>-(<i>tert</i>-butyldimethylsilyl)hydroxylamine (305 mg, 2.07 mmol) in freshly distilled CH<sub>2</sub>Cl<sub>2</sub> (13 mL). After being stirred at room temperature overnight, the mixture was washed with water and the organic phase was dried and evaporated in vacuo. The crude was purified by flash chromatography (CHCl<sub>3</sub>/MeOH 50:1) using a Isolute Flash Si II cartridge to afford the <i>O</i>-silylate derivative <b>80</b> as a white solid (296 mg, 80% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 0.03 (s, 6H); 0.85 (s, 9H); 1.25–1.39 (m, 4H); 2.81 (dd, <i>J</i> = 6.0 Hz, 2H); 3.53 (m, 1H); 5.18 (s, 2H); 5.37 (s, 2H); 5.87 (t, <i>J</i> = 6.0 Hz, 1H); 7.12–7.16 (m, 2H); 7.69–7.72 (m, 4H); 7.82 (s, 1H); 7.98 (brs, 1H); 10,72 (brs, 1H).</div></div><div id="sec6_14_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> (<i>R</i>)-2-(4-(3,5-Dibromobenzyloxy)phenylsulfonamido)-<i>N</i>-hydroxy-5-ureidopentanamide (<b>21</b>)</h3><div class="NLM_p last">TFA (1.8 mL, 23.3 mmol) was added dropwise to a stirred and ice-chilled solution of <i>O</i>-silylate derivative <b>80</b> (290 mg, 0.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The solution was stirred under these reaction conditions for 5 h, and the solvent was removed in vacuo. The crude product was purified by trituration with Et<sub>2</sub>O and <i>n</i>-hexane to give the hydroxamate <b>21</b> as a white solid (230 mg, 94.6% yield). Mp: 80–82 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.16–1.39 (m, 4H); 2.80 (m, 2H); 3.50 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 7.6 Hz, 1H); 5.20 (s, 2H); 5.89 (brs, 1H); 7.13–7.18 (m, 2H); 7.69–7.74 (m, 4H); 7.84 (t, <i>J</i> = 1.8 Hz, 1 H); 7.90 (d, <i>J</i> = 8.8 Hz, 1H); 10.54 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 26.15; 30.25; 53.55; 67.72; 114.70; 122.27; 128.30; 129.23; 132.65; 133.69; 141.01; 158.40; 160.38; 167.03. Elemental analysis for C<sub>19</sub>H<sub>22</sub>Br<sub>2</sub>N<sub>4</sub>O<sub>6</sub>S, calculated: % C, 38.40; % H, 3.73; % N, 9.43. Found: % C, 38.55; % H, 3.96; % N, 9.20.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> MMPs and ADAMs Inhibition Assays</h3><div class="NLM_p last">Recombinant human MMP-14 catalytic domain was a kind gift from Prof. Gillian Murphy (Department of Oncology, University of Cambridge, U.K.). Pro-MMP-1, pro-MMP-2, pro-MMP-9, and recombinant human ADAM-17 (PF133) were purchased from Calbiochem. Recombinant human ADAM-10 was purchased from R&D Systems. Proenzymes were activated immediately prior to use with <i>p</i>-aminophenylmercuric acetate (2 mM APMA for 1 h at 37 °C for MMP-2, 2 mM APMA for 2 h at 37 °C for MMP-1, and 1 mM APMA for 1 h at 37 °C for MMP-9). For assay measurements, the inhibitor stock solutions (DMSO, 10 mM) were further diluted in the fluorometric assay buffer (FAB: Tris 50 mM, pH 7.5, NaCl 150 mM, CaCl<sub>2</sub> 10 mM, Brij-35 0.05%, and DMSO 1%). Activated enzyme (final concentrations of 0.56 nM for MMP-2, 1.3 nM for MMP-9, 1.0 nM for MMP-14cd, 2.0 nM for MMP-1, 5 nM for ADAM-17, and 20 nM for ADAM-10) and inhibitor solutions were incubated in the assay buffer for 4 h at 25 °C. ADAM-17 was incubated for 30 min at 37 °C and ADAM-10 for 1 h at 37 °C in a different buffer at pH 9 (Tris 25 mM, ZnCl<sub>2</sub> 25 μM, Brij-35 0.005%). After the addition of 200 μM solution of the fluorogenic substrate Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH<sub>2</sub><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (Bachem) for all the enzymes in DMSO (final concentration of 2 μM for all enzymes and 10 μM for ADAM-10), the hydrolysis was monitored every 15 s for 20 min, recording the increase in fluorescence (λ<sub>ex</sub> = 325 nm, λ<sub>em</sub> = 400 nm) with a Molecular Devices SpectraMax Gemini XS plate reader. The assays were performed in duplicate in a total volume of 200 μL per well in 96-well microtiter plates (Corning black, NBS). Control wells lack inhibitor. The MMP inhibition activity was expressed in relative fluorescent units (RFU). Percent of inhibition was calculated from control reactions without the inhibitor. IC<sub>50</sub> was determined using the formula <i>v</i><sub>i</sub>/<i>v</i><sub>o</sub> = 1/(1 + [I]/IC<sub>50</sub>), where <i>v</i><sub>i</sub> is the initial velocity of substrate cleavage in the presence of the inhibitor at concentration [I] and <i>v</i><sub>o</sub> is the initial velocity in the absence of the inhibitor. Results were analyzed using SoftMax Pro software<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and GraFit software.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Cells and Reagents</h3><div class="NLM_p last">The human EOC cell lines SKOV3-luc (INT, Milan, Italy), A2774 (IST Genoa), and A2780 (ICLC Cell Bank, Genoa, Italy) were grown in RPMI 1640, with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 10% heat-inactivated fetal calf serum, and 100 μg/mL penicillin–streptomycin (Lonza, Milan, Italy) at 37 °C in a 5% CO<sub>2</sub> incubator. Cell line identity was confirmed by genotyping through the Cell IDTM System (Promega) and the GeneMapper software, version 4.0. Recombinant human EGF was from PeproTech EC (London, U.K.). PV was prepared by mixing sodium orthovanadate (0.1 M) and H<sub>2</sub>O<sub>2</sub> (0.1 M) and was used within 20 min of preparation. Metalloproteinase inhibitors were dissolved in DMSO as 10 mM stock solution and stored in aliquots at −20 °C.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Cell Treatments and ELISA</h3><div class="NLM_p last">Cells were seeded in 24-well plates and assays performed in duplicate. Subconfluent cultures were challenged with the indicated amounts of metalloproteinase inhibitors or the equivalent amount of their solvent as control. After 30 min PV (200 μM) or EGF (100 ng/mL) was added and incubation prolonged for 90 min or 18 h, respectively. Conditioned media were collected, centrifuged at 1000<i>g</i>, and used undiluted for sALCAM detection by ELISA (DuoSet ELISA development kit, R&D Systems). After background subtraction, data were expressed as the mean ± SD and analyzed by two-tailed Student’s <i>t</i> test.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> MTT Assay</h3><div class="NLM_p last">To test cell viability during treatment with the metalloproteinase inhibitors, parallel cultures were set up for evaluation with a microculture tetrazolium reduction assay using MTT [3-(4,5-dimethyltiazol-2-yl)2,5-diphenyltetrazolium bromide, Sigma], as previously described.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> X-ray Structures Selection for Docking Studies</h3><div class="NLM_p">The superposition of the 14 ADAM-17 X-ray structures available in the PDB, on the α-carbon atoms, reveals that the overall fold of the catalytic domain is well conserved, but a noteworthy flexibility of the S1′ and S2 (Tyr352-Gly363) loops exists. Thus, as already described in our previous work,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> a deeper analysis, based on the rmsd values calculated for every possible combination of alignment and on the S1′ and S2 loops shapes, identified five different clusters. From each identified cluster, the X-ray structure with the highest resolution (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47">2I47</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EDZ">3EDZ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ">3EWJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DDF">2DDF</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>) was chosen for subsequent molecular docking calculations.</div><div class="NLM_p last">For MMP-1, -2, -9, and -14, the analysis of the available X-ray structures reveals that the overall fold of the catalytic domains is strictly conserved; thus, for each MMP, the structure having the highest resolution, preferring those cocrystallized with organic or peptidic inhibitors, was chosen (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HFC">1HFC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AYU">3AYU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H3X">4H3X</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2">3MA2</a>, respectively).</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Docking Simulations</h3><div class="NLM_p last">Molecular docking of <b>21</b> into the X-ray structures of ADAM-17 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47">2I47</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FV5">2FV5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ">3EWJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DDF">2DDF</a>) was carried out using the Glide 5.5 program.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Maestro 9.1.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> was employed as the graphical user interface, and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> representing the most probable binding mode of <b>21</b> was rendered by the Chimera software package.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Ligand and Protein Setup</h3><div class="NLM_p last">The 3D structures of the ligands were generated with the Maestro fragment Build tool.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Then a geometry-optimized ligand was prepared using Lig-Prep 2.3 as implemented in Maestro. The target proteins were prepared using the protein preparation wizard in Maestro 9.1. Water molecules were removed, and the resulting proteins were aligned based on the R-carbon trace. Hydrogen atoms were added. A +2 charge was assigned to the zinc ion in the active site, and the binding pocket was identified by placing a 20 Å cube around the catalytic ion.</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Docking Setting</h3><div class="NLM_p last">Molecular docking calculations were performed with the aid of Glide 5.5 in extra-precision (XP)<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> mode, using Glidescore for ligand ranking. A constraint that forced the interaction with the metal ion was included. The selected docking pose was further minimized using OPLSA2005 as force field, the PRCG methods until a gradient of 0.001 kcal mol<sup>–1</sup> Å<sup>–2</sup>, and the implicit water model implemented in Macromodel.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116"><a href="/doi/suppl/10.1021/jm4011753">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table reporting the HPLC purity analysis data of the final products. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4011753/suppl_file/jm4011753_si_001.pdf">jm4011753_si_001.pdf (127.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4011753" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando Rossello</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8899a879ba88e899a85c69d86819881c6819c"><span class="__cf_email__" data-cfemail="c1a0b3aeb281a7a0b3acefb4afa8b1a8efa8b5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Nuti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Casalini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Santamaria</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Fabbi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Terapie Oncologiche Integrate, IRCCS
AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grazia Carbotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Terapie Oncologiche Integrate, IRCCS
AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvano Ferrini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Terapie Oncologiche Integrate, IRCCS
AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luciana Marinelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica Farmaceutica e Tossicologica, Università di Napoli “Federico II”, Via Domenico Montesano 49, 80131 Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria La Pietra</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica Farmaceutica e Tossicologica, Università di Napoli “Federico II”, Via Domenico Montesano 49, 80131 Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Novellino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Chimica Farmaceutica e Tossicologica, Università di Napoli “Federico II”, Via Domenico Montesano 49, 80131 Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caterina Camodeca</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabetta Orlandini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susanna Nencetti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1425e5333-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants awarded by AIRC (Italian Association for Cancer Research to S.F. and M.F.), by Fondazione Compagnia di San Paolo, Torino and by MIUR (Prin 2007 to A.R.). We thank Simona Calcagnini for technical help in cell assays.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i120" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i120"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i121" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i121"> Abbreviations Used</h2><tr><td class="NLM_term">ADAM</td><td class="NLM_def"><p class="first last">a disintegrin and metalloproteinase</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TACE</td><td class="NLM_def"><p class="first last">tumor necrosis factor α converting enzyme</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">CAM</td><td class="NLM_def"><p class="first last">cell adhesion molecule</p></td></tr><tr><td class="NLM_term">ALCAM</td><td class="NLM_def"><p class="first last">activated leukocyte cell adhesion molecule</p></td></tr><tr><td class="NLM_term">EOC</td><td class="NLM_def"><p class="first last">epithelial ovarian cancer</p></td></tr><tr><td class="NLM_term">MMPI</td><td class="NLM_def"><p class="first last">matrix metalloproteinase inhibitor</p></td></tr><tr><td class="NLM_term">MSS</td><td class="NLM_def"><p class="first last">musculoskeletal syndrome</p></td></tr><tr><td class="NLM_term">sALCAM</td><td class="NLM_def"><p class="first last">soluble activated leukocyte cell adhesion molecule</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc-binding group</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PV</td><td class="NLM_def"><p class="first last">pervanadate</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">TK</td><td class="NLM_def"><p class="first last">tyrosine kinase</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethyltiazol-2-yl) 2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">APMA</td><td class="NLM_def"><p class="first last"><i>p</i>-aminophenylmercuric acetate</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydro-2<i>H</i>-pyran-2-yl</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unlu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepanski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteside, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, N. L.</span><span> </span><span class="NLM_article-title">Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2913</span><span class="NLM_x">–</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=2913-2922&author=L.+Geauthor=D.+Baskicauthor=P.+Basseauthor=L.+Vujanovicauthor=S.+Unluauthor=T.+Yoneyamaauthor=A.+Vujanovicauthor=J.+Hanauthor=D.+Bankovicauthor=M.+J.+Szczepanskiauthor=J.+L.+Huntauthor=R.+B.+Herbermanauthor=S.+M.+Gollinauthor=R.+L.+Ferrisauthor=T.+L.+Whitesideauthor=E.+N.+Myersauthor=N.+L.+Vujanovic&title=Sheddase+activity+of+tumor+necrosis+factor-alpha+converting+enzyme+is+increased+and+prognostically+valuable+in+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DL.%26aulast%3DBaskic%26aufirst%3DD.%26aulast%3DBasse%26aufirst%3DP.%26aulast%3DVujanovic%26aufirst%3DL.%26aulast%3DUnlu%26aufirst%3DS.%26aulast%3DYoneyama%26aufirst%3DT.%26aulast%3DVujanovic%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DBankovic%26aufirst%3DD.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DHunt%26aufirst%3DJ.%2BL.%26aulast%3DHerberman%26aufirst%3DR.%2BB.%26aulast%3DGollin%26aufirst%3DS.%2BM.%26aulast%3DFerris%26aufirst%3DR.%2BL.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26aulast%3DMyers%26aufirst%3DE.%2BN.%26aulast%3DVujanovic%26aufirst%3DN.%2BL.%26atitle%3DSheddase%2520activity%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520is%2520increased%2520and%2520prognostically%2520valuable%2520in%2520head%2520and%2520neck%2520cancer%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2009%26volume%3D18%26spage%3D2913%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Piazza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongarzone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargellesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">Internalization and recycling of ALCAM/CD166 detected by a fully human single chain recombinant antibody</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1242%2Fjcs.02280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=15769845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=1515-1525&author=T.+Piazzaauthor=E.+Chaauthor=I.+Bongarzoneauthor=S.+Canevariauthor=A.+Bolognesiauthor=L.+Politoauthor=A.+Bargellesiauthor=F.+Sassiauthor=S.+Ferriniauthor=M.+Fabbi&title=Internalization+and+recycling+of+ALCAM%2FCD166+detected+by+a+fully+human+single+chain+recombinant+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody</span></div><div class="casAuthors">Piazza, Tiziana; Cha, Emanuela; Bongarzone, Italia; Canevari, Silvana; Bolognesi, Andrea; Polito, Letizia; Bargellesi, Antonio; Sassi, Francesca; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1515-1525</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Activated leukocyte cell adhesion mol. (ALCAM/CD166), a member of the Ig superfamily with five extracellular Ig-like domains, promotes heterophilic (ALCAM-CD6) and homophilic (ALCAM-ALCAM) cell-cell interactions.  Here the authors describe a fully human single-chain antibody fragment (scFv) directed to ALCAM/CD166.  The authors selected the I/F8 scFv from a phage display library of human V-gene segments by cell panning and phage internalization into IGROV-I human ovary carcinoma cells.  The I/F8 specificity was identified as ALCAM/CD166 by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) peptide mass fingerprinting of the I/F8-immunopptd. protein.  The I/F8 scFv reacts with the human, monkey and murine ALCAM/CD166 mol., indicating that the recognized epitope is highly conserved.  The I/F8 scFv completely abolished binding of both ALCAM/Fc and CD6/Fc sol. ligands, whereas it did not compete with the anti-ALCAM/CD166 murine monoclonal antibodies J4-81 and 3A6 and therefore recognizes a different epitope.  Engagement through I/F8 scFv, 3A6 monoclonal antibody or CD6/Fc ligand induced ALCAM/CD166 internalization, with a kinetics slower than that of transferrin in the same cells.  Newly internalized I/F8-ALCAM complexes colocalized with clathrin but not with caveolin and the authors demonstrated, using surface biotinylation and recycling assays, that endocytosed ALCAM/CD166 recycles back to the cell surface.  Such an endocytic pathway allows the efficient delivery of an I/F8 scFv-saporin immunotoxin into tumor cells, as the conjugates are able to selectively kill cell lines expressing ALCAM/CD166.  Altogether these data provide evidence of the suitability of the I/F8 scFv for further functional anal. of ALCAM/CD166 and intracellular delivery of effector moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tqjVMkmHrbVg90H21EOLACvtfcHk0lgVk22IHAPKxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGkt74%253D&md5=927f397f81ac24300850dd9b6c78500a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02280%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DT.%26aulast%3DCha%26aufirst%3DE.%26aulast%3DBongarzone%26aufirst%3DI.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DA.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBargellesi%26aufirst%3DA.%26aulast%3DSassi%26aufirst%3DF.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DInternalization%2520and%2520recycling%2520of%2520ALCAM%252FCD166%2520detected%2520by%2520a%2520fully%2520human%2520single%2520chain%2520recombinant%2520antibody%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D1515%26epage%3D1525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rosso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongarzone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orengo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">The ALCAM shedding by the metalloprotease ADAM17/TACE is a tyrosine kinase-inducible process involved in motility of ovarian carcinoma cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1158%2F1541-7786.MCR-07-0060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=18171982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=1246-1253&author=O.+Rossoauthor=T.+Piazzaauthor=I.+Bongarzoneauthor=A.+Rosselloauthor=D.+Mezzanzanicaauthor=S.+Canevariauthor=A.+M.+Orengoauthor=A.+Puppoauthor=S.+Ferriniauthor=M.+Fabbi&title=The+ALCAM+shedding+by+the+metalloprotease+ADAM17%2FTACE+is+a+tyrosine+kinase-inducible+process+involved+in+motility+of+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells</span></div><div class="casAuthors">Rosso, Ombretta; Piazza, Tiziana; Bongarzone, Italia; Rossello, Armando; Mezzanzanica, Delia; Canevari, Silvana; Orengo, Anna Maria; Puppo, Andrea; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1246-1253</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Previous findings indicated that the activated leukocyte cell adhesion mol. (ALCAM) is expressed by tumors and plays a role in tumor biol.  In this study, we show that ALCAM is shed from epithelial ovarian cancer (EOC) cells in vitro, leading to the generation of a sol. ALCAM (sALCAM), consisting of most of the extracellular domain.  A similar sALCAM mol. was also found in the ascitic fluids and sera from EOC patients, suggesting that this process also occurs in vivo.  SALCAM is constitutively produced by EOC cells, and this process can be enhanced by cell treatment with pervanadate, phorbol 12-myristate 13-acetate (PMA), or epidermal growth factor (EGF), a known growth factor for EOC.  Pharmacol. inhibitors of matrix metalloproteinases (MMP) and of a disintegrin and metalloproteases (ADAM), and the tissue inhibitor of metalloproteinase-3, significantly inhibited sALCAM release by EOC cells.  The ADAM17/TACE mol. was expressed in EOC cell lines and ADAM17/TACE silencing by specific small interfering RNA-reduced ALCAM shedding.  In addn., inhibitors of ADAM function blocked EOC cell motility in a wound-healing assay.  Conversely, a recombinant antibody blocking ALCAM adhesive functions and inducing ALCAM internalization enhanced EOC cell motility.  Altogether, our data suggest that the disruption of ALCAM-mediated adhesion is a relevant step in EOC motility, and ADAM17/TACE takes part in this process, which may be relevant to EOC invasive potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2W5oZDfQDLVg90H21EOLACvtfcHk0lgVk22IHAPKxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVCgtg%253D%253D&md5=d54000fa718b3104e270d7d449761124</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-0060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-0060%26sid%3Dliteratum%253Aachs%26aulast%3DRosso%26aufirst%3DO.%26aulast%3DPiazza%26aufirst%3DT.%26aulast%3DBongarzone%26aufirst%3DI.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DOrengo%26aufirst%3DA.%2BM.%26aulast%3DPuppo%26aufirst%3DA.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DThe%2520ALCAM%2520shedding%2520by%2520the%2520metalloprotease%2520ADAM17%252FTACE%2520is%2520a%2520tyrosine%2520kinase-inducible%2520process%2520involved%2520in%2520motility%2520of%2520ovarian%2520carcinoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D1246%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Santiago-Josefat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech-Serra, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span> </span><span class="NLM_article-title">Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">8325</span><span class="NLM_x">–</span> <span class="NLM_lpage">8331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=8325-8331&author=B.+Santiago-Josefatauthor=C.+Esselensauthor=J.+J.+Bech-Serraauthor=J.+Arribas&title=Post-transcriptional+up-regulation+of+ADAM17+upon+epidermal+growth+factor+receptor+activation+and+in+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Josefat%26aufirst%3DB.%26aulast%3DEsselens%26aufirst%3DC.%26aulast%3DBech-Serra%26aufirst%3DJ.%2BJ.%26aulast%3DArribas%26aufirst%3DJ.%26atitle%3DPost-transcriptional%2520up-regulation%2520of%2520ADAM17%2520upon%2520epidermal%2520growth%2520factor%2520receptor%2520activation%2520and%2520in%2520breast%2520tumors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D8325%26epage%3D8331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kenny, P. A.</span><span> </span><span class="NLM_article-title">TACE: a new target in epidermal growth factor receptor dependent tumors</span> <span class="citation_source-journal">Differentiation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=800-808&author=P.+A.+Kenny&title=TACE%3A+a+new+target+in+epidermal+growth+factor+receptor+dependent+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BA.%26atitle%3DTACE%253A%2520a%2520new%2520target%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520dependent%2520tumors%26jtitle%3DDifferentiation%26date%3D2007%26volume%3D75%26spage%3D800%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercignani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2635</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901868z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2622-2635&author=E.+Nutiauthor=F.+Casaliniauthor=S.+I.+Avramovaauthor=S.+Santamariaauthor=M.+Fabbiauthor=S.+Ferriniauthor=L.+Marinelliauthor=V.+La+Pietraauthor=V.+Limongelliauthor=E.+Novellinoauthor=G.+Cercignaniauthor=E.+Orlandiniauthor=S.+Nencettiauthor=A.+Rossello&title=Potent+arylsulfonamide+inhibitors+of+tumor+necrosis+factor-alpha+converting+enzyme+able+to+reduce+activated+leukocyte+cell+adhesion+molecule+shedding+in+cancer+cell+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm901868z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901868z%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DAvramova%26aufirst%3DS.%2BI.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCercignani%26aufirst%3DG.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DPotent%2520arylsulfonamide%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520able%2520to%2520reduce%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520shedding%2520in%2520cancer%2520cell%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2622%26epage%3D2635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Carbotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orengo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizzolara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emionite, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centurioni, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors</span> <span class="citation_source-journal">Int. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2597</span><span class="NLM_x">–</span> <span class="NLM_lpage">2605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2Fijc.27948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=2597-2605&author=G.+Carbottiauthor=A.+M.+Orengoauthor=D.+Mezzanzanicaauthor=M.+Bagnoliauthor=A.+Brizzolaraauthor=L.+Emioniteauthor=A.+Puppoauthor=M.+G.+Centurioniauthor=M.+Bruzzoneauthor=P.+Marroniauthor=A.+Rosselloauthor=S.+Canevariauthor=S.+Ferriniauthor=M.+Fabbi&title=Activated+leukocyte+cell+adhesion+molecule+soluble+form%3A+a+potential+biomarker+of+epithelial+ovarian+cancer+is+increased+in+type+II+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors</span></div><div class="casAuthors">Carbotti, Grazia; Orengo, Anna Maria; Mezzanzanica, Delia; Bagnoli, Marina; Brizzolara, Antonella; Emionite, Laura; Puppo, Andrea; Centurioni, Maria Grazia; Bruzzone, Milena; Marroni, Paola; Rossello, Armando; Canevari, Silvana; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2597-2605</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Activated leukocyte cell adhesion mol. (ALCAM) is involved in cell-cell interactions in cancer.  Shedding of its ectodomain by the metalloprotease ADAM17/TACE generates a sol. form (sALCAM).  Here, we show that serum sALCAM levels were significantly higher in epithelial ovarian cancer (EOC) (p < 0.005) than in controls.  The performance of sALCAM as classifier, tested by receiver operating characteristic curve, resulted in an area under the curve (AUC) of 0.8067.  Serum sALCAM levels showed direct correlation with Carbohydrate Antigen-125 (CA125/MUC16).  Moreover, significantly higher levels were found in type II tumors, even in stage I/II, suggesting that elevated sALCAM is an early feature of aggressive EOC.  In addn., sALCAM levels were higher in ascites than in sera, suggesting local processing of ALCAM in the peritoneal cavity.  In immunodeficient mice, i.p. implanted with a human EOC cell line, human sALCAM progressively increased in serum and was even higher in the ascites.  The biochem. characterization of the sALCAM in EOC sera and ascites, showed two predominant forms of approx. 95 and 65 kDa but no EOC-specific isoform.  In addn., full-length transmembrane ALCAM but no sol. form was detected in tumor-derived exosomes found in ascites.  Finally, in vitro invasion assays showed that inhibition of ADAM17/TACE activity decreased EOC invasive properties, while opposite effects were mediated by a sALCAM-Fc chimera and by an antibody interfering with ALCAM/ALCAM interactions.  Altogether these data suggest that sALCAM is a marker of EOC, which correlates with more aggressive type II tumors, and that ADAM17/TACE activity and sALCAM itself mediate enhanced invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcHFdvzXEFHbVg90H21EOLACvtfcHk0lgOJhxeJatUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurjE&md5=4f47ed238e528a569379c7d8e7e4762e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.27948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27948%26sid%3Dliteratum%253Aachs%26aulast%3DCarbotti%26aufirst%3DG.%26aulast%3DOrengo%26aufirst%3DA.%2BM.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DBrizzolara%26aufirst%3DA.%26aulast%3DEmionite%26aufirst%3DL.%26aulast%3DPuppo%26aufirst%3DA.%26aulast%3DCenturioni%26aufirst%3DM.%2BG.%26aulast%3DBruzzone%26aufirst%3DM.%26aulast%3DMarroni%26aufirst%3DP.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DActivated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520soluble%2520form%253A%2520a%2520potential%2520biomarker%2520of%2520epithelial%2520ovarian%2520cancer%2520is%2520increased%2520in%2520type%2520II%2520tumors%26jtitle%3DInt.%2520J.%2520Cancer.%26date%3D2013%26volume%3D132%26spage%3D2597%26epage%3D2605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Becker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carron, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freskos, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munie, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span> </span><span class="NLM_article-title">Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6653</span><span class="NLM_x">–</span> <span class="NLM_lpage">6680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100669j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6653-6680&author=D.+P.+Beckerauthor=T.+E.+Bartaauthor=L.+J.+Bedellauthor=T.+L.+Boehmauthor=B.+R.+Bondauthor=J.+Carrollauthor=C.+P.+Carronauthor=G.+A.+DeCrescenzoauthor=A.+M.+Eastonauthor=J.+N.+Freskosauthor=C.+L.+Funckes-Shippyauthor=M.+Heronauthor=S.+Hockermanauthor=C.+P.+Howardauthor=J.+R.+Kieferauthor=M.+H.+Liauthor=K.+J.+Mathisauthor=J.+J.+McDonaldauthor=P.+P.+Mehtaauthor=G.+E.+Munieauthor=T.+Sunyerauthor=C.+A.+Swearingenauthor=C.+I.+Villamilauthor=D.+Welschauthor=J.+M.+Williamsauthor=Y.+Yuauthor=J.+Yao&title=Orally+active+MMP-1+sparing+%CE%B1-tetrahydropyranyl+and+%CE%B1-piperidinyl+sulfone+matrix+metalloproteinase+%28MMP%29+inhibitors+with+efficacy+in+cancer%2C+arthritis%2C+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease</span></div><div class="casAuthors">Becker, Daniel P.; Barta, Thomas E.; Bedell, Louis J.; Boehm, Terri L.; Bond, Brian R.; Carroll, Jeffery; Carron, Chris P.; De Crescenzo, Gary A.; Easton, Alan M.; Freskos, John N.; Funckes-Shippy, Chris L.; Heron, Marcia; Hockerman, Susan; Howard, Carol Pearcy; Kiefer, James R.; Li, Madeleine H.; Mathis, Karl J.; McDonald, Joseph J.; Mehta, Pramod P.; Munie, Grace E.; Sunyer, Teresa; Swearingen, Craig A.; Villamil, Clara I.; Welsch, Dean; Williams, Jennifer M.; Yu, Ying; Yao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6653-6680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides such as I (R = MeOCH2CH2, cyclopropyl) are prepd. as selective matrix metalloproteinase (MMP) inhibitors avoiding nonselective MMP (in particular, MMP-1) inhibition for use as antitumor, antiarthritic, and cardiovascular agents.  The inhibition of MMPs 1, 2, 3, 7, 8, 9, 13, and 14 by N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides is detd. as well as their calcd. lipophilicities; the pharmacokinetics, inhibition of human prostate, breast, and lung cancer cells, inhibition of cartilage degrdn., inhibition of ventricular dilation after myocardial infarction, and DSC calorimetric measurements for selected compds. are detd.  I (R = MeOCH2CH2) (SC-78080/SD-2590) was selected for development as an anticancer agent, while I (R = cyclopropyl) and an N-hydroxy trifluoromethylphenoxyphenylsulfonyl pyrancarboxamide were selected as backup compds.  The structure of I (R = MeOCH2CH2) bound to MMP-13 is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0b9GTt27EbVg90H21EOLACvtfcHk0lgOJhxeJatUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ&md5=0ee6c0fea7d5e86ff75095615dac8ec6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm100669j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100669j%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DD.%2BP.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DBedell%26aufirst%3DL.%2BJ.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DCarron%26aufirst%3DC.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEaston%26aufirst%3DA.%2BM.%26aulast%3DFreskos%26aufirst%3DJ.%2BN.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DHockerman%26aufirst%3DS.%26aulast%3DHoward%26aufirst%3DC.%2BP.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DMunie%26aufirst%3DG.%2BE.%26aulast%3DSunyer%26aufirst%3DT.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DVillamil%26aufirst%3DC.%2BI.%26aulast%3DWelsch%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DOrally%2520active%2520MMP-1%2520sparing%2520%25CE%25B1-tetrahydropyranyl%2520and%2520%25CE%25B1-piperidinyl%2520sulfone%2520matrix%2520metalloproteinase%2520%2528MMP%2529%2520inhibitors%2520with%2520efficacy%2520in%2520cancer%252C%2520arthritis%252C%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6653%26epage%3D6680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rossello, A.; Nuti, E.; Maresca, A.</span><span> </span><span class="NLM_article-title">ADAMs and ADAMTs Selective Synthetic Inhibitors</span>. In  <span class="citation_source-book">Drug Design of Zinc–Enzyme Inhibitors: Functional, Structural, and Disease Applications</span>; <span class="NLM_contrib-group">Supuran, C. T.; Winum, J.-Y.</span>, Eds.; Wiley Series in Drug Discovery and Development; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2F9780470508169.ch26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=591-645&author=A.+Rossello&author=E.+Nuti&author=A.+Marescaauthor=C.+T.+Supuran&author=J.-Y.+Winum&title=Drug+Design+of+Zinc%E2%80%93Enzyme+Inhibitors%3A+Functional%2C+Structural%2C+and+Disease+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2F9780470508169.ch26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470508169.ch26%26sid%3Dliteratum%253Aachs%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DADAMs%2520and%2520ADAMTs%2520Selective%2520Synthetic%2520Inhibitors%26btitle%3DDrug%2520Design%2520of%2520Zinc%25E2%2580%2593Enzyme%2520Inhibitors%253A%2520Functional%252C%2520Structural%252C%2520and%2520Disease%2520Applications%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2009%26spage%3D591%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Recent advances in MMP inhibitor design</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-136&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+advances+in+MMP+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0lhhNyzxkbo0gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520MMP%2520inhibitor%2520design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26spage%3D115%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Georgiadis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiotakis, A.</span><span> </span><span class="NLM_article-title">Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8781</span><span class="NLM_x">–</span> <span class="NLM_lpage">8794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8781-8794&author=D.+Georgiadisauthor=A.+Yiotakis&title=Specific+targeting+of+metzincin+family+members+with+small-molecule+inhibitors%3A+progress+toward+a+multifarious+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DYiotakis%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520metzincin%2520family%2520members%2520with%2520small-molecule%2520inhibitors%253A%2520progress%2520toward%2520a%2520multifarious%2520challenge%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8781%26epage%3D8794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rossello, A.; Nuti, E.; Casalini, F.; Orlandini, E.</span><span> </span><span class="NLM_article-title">Inibitori Altamente Selettivi dell'Attivita' di ADAMs</span>. Italian Patent Application PI2011A000007,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Rossello&author=E.+Nuti&author=F.+Casalini&author=E.+Orlandini&title=Inibitori+Altamente+Selettivi+dell%27Attivita%27+di+ADAMs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DInibitori%2520Altamente%2520Selettivi%2520dell%2527Attivita%2527%2520di%2520ADAMs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Maskos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourenkov, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H. R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerretti, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3408-3412&author=K.+Maskosauthor=C.+Fernandez-Catalanauthor=R.+Huberauthor=G.+P.+Bourenkovauthor=H.+Bartunikauthor=G.+A.+Ellestadauthor=P.+Reddyauthor=M.+F.+Wolfsonauthor=C.+T.+Rauchauthor=B.+J.+Castnerauthor=R.+Davisauthor=H.+R.+G.+Clarkeauthor=M.+Petersenauthor=J.+N.+Fitznerauthor=D.+P.+Cerrettiauthor=C.+J.+Marchauthor=R.+J.+Paxtonauthor=R.+A.+Blackauthor=W.+Bode&title=Crystal+structure+of+the+catalytic+domain+of+human+tumor+necrosis+factor-%CE%B1-converting+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBourenkov%26aufirst%3DG.%2BP.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DWolfson%26aufirst%3DM.%2BF.%26aulast%3DRauch%26aufirst%3DC.%2BT.%26aulast%3DCastner%26aufirst%3DB.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DH.%2BR.%2BG.%26aulast%3DPetersen%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DJ.%2BN.%26aulast%3DCerretti%26aufirst%3DD.%2BP.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520tumor%2520necrosis%2520factor-%25CE%25B1-converting%2520enzyme%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grootveld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M. F.</span><span> </span><span class="NLM_article-title">BMS-561392 (Bristol-Myers Squibb)</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=598-602&author=M.+Grootveldauthor=M.+F.+McDermott&title=BMS-561392+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrootveld%26aufirst%3DM.%26aulast%3DMcDermott%26aufirst%3DM.%2BF.%26atitle%3DBMS-561392%2520%2528Bristol-Myers%2520Squibb%2529%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D598%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madskuie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaris, J.</span><span> </span><span class="NLM_article-title">Pharmacological profile of DPC 333, a selective TACE inhibitor</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">A27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=A27&author=R.+Liuauthor=R.+Magoldaauthor=R.+Newtonauthor=J.+Duanauthor=K.+Vaddiauthor=T.+Madskuieauthor=M.+Qianauthor=R.+Collinsauthor=T.+Taylorauthor=J.+Giannaris&title=Pharmacological+profile+of+DPC+333%2C+a+selective+TACE+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DMadskuie%26aufirst%3DT.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DGiannaris%26aufirst%3DJ.%26atitle%3DPharmacological%2520profile%2520of%2520DPC%2520333%252C%2520a%2520selective%2520TACE%2520inhibitor%26jtitle%3DInflammation%2520Res.%26date%3D2002%26volume%3D51%26spage%3DA27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J.</span><span> </span><span class="NLM_article-title">Identification and characterization of Aprarastat (TMI-005), a potent, dual TACE/MMP inhibitor for the treatment of RA</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64 (Suppl 3)</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64+%28Suppl+3%29&publication_year=2005&pages=462-463&author=Y.+Zhangauthor=J.+Xuauthor=C.+Udataauthor=J.+McDevittauthor=T.+Cummonsauthor=L.+Sunauthor=Y.+Zhuauthor=G.+Liauthor=V.+Raoauthor=Q.+Wangauthor=J.+Gibbonsauthor=J.+Skotnickiauthor=L.+Linauthor=J.+Levin&title=Identification+and+characterization+of+Aprarastat+%28TMI-005%29%2C+a+potent%2C+dual+TACE%2FMMP+inhibitor+for+the+treatment+of+RA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DUdata%26aufirst%3DC.%26aulast%3DMcDevitt%26aufirst%3DJ.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DRao%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLevin%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520Aprarastat%2520%2528TMI-005%2529%252C%2520a%2520potent%252C%2520dual%2520TACE%252FMMP%2520inhibitor%2520for%2520the%2520treatment%2520of%2520RA%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2005%26volume%3D64%2520%2528Suppl%25203%2529%26spage%3D462%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levin, J.; Li, Z.; Diamantidis, G.; Lovering, F. E.; Wang, W.; Condon, J. S.; Lin, Y.; Skotnicki, J. S.; Park, K.</span><span> </span><span class="NLM_article-title">β-Sulfonamide Hydroxamic Acid Inhibitors of TACE/Matrix Metalloproteinase</span>. U.S. Patent Appl. Pub. 0211730,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Levin&author=Z.+Li&author=G.+Diamantidis&author=F.+E.+Lovering&author=W.+Wang&author=J.+S.+Condon&author=Y.+Lin&author=J.+S.+Skotnicki&author=K.+Park&title=%CE%B2-Sulfonamide+Hydroxamic+Acid+Inhibitors+of+TACE%2FMatrix+Metalloproteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Sulfonamide%2520Hydroxamic%2520Acid%2520Inhibitors%2520of%2520TACE%252FMatrix%2520Metalloproteinase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papamichelakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellstedt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noureldin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigneault, S.</span><span> </span><span class="NLM_article-title">Development of a suitable process for the preparation of a TNF-α converting enzyme inhibitor, WAY-281418</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/op800090s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1253-1260&author=Y.+Wangauthor=M.+Papamichelakisauthor=W.+Chewauthor=J.+Sellstedtauthor=R.+Noureldinauthor=S.+Tadayonauthor=S.+Daigneault&title=Development+of+a+suitable+process+for+the+preparation+of+a+TNF-%CE%B1+converting+enzyme+inhibitor%2C+WAY-281418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fop800090s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop800090s%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPapamichelakis%26aufirst%3DM.%26aulast%3DChew%26aufirst%3DW.%26aulast%3DSellstedt%26aufirst%3DJ.%26aulast%3DNoureldin%26aufirst%3DR.%26aulast%3DTadayon%26aufirst%3DS.%26aulast%3DDaigneault%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520a%2520suitable%2520process%2520for%2520the%2520preparation%2520of%2520a%2520TNF-%25CE%25B1%2520converting%2520enzyme%2520inhibitor%252C%2520WAY-281418%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1253%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=379-394&author=E.+Nutiauthor=S.+Santamariaauthor=F.+Casaliniauthor=K.+Yamamotoauthor=L.+Marinelliauthor=V.+La+Pietraauthor=E.+Novellinoauthor=E.+Orlandiniauthor=S.+Nencettiauthor=A.+M.+Mariniauthor=S.+Salernoauthor=S.+Talianiauthor=F.+Da+Settimoauthor=H.+Nagaseauthor=A.+Rossello&title=Arylsulfonamide+inhibitors+of+aggrecanases+as+potential+therapeutic+agents+for+osteoarthritis%3A+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DArylsulfonamide%2520inhibitors%2520of%2520aggrecanases%2520as%2520potential%2520therapeutic%2520agents%2520for%2520osteoarthritis%253A%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D379%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppert, D.</span><span> </span><span class="NLM_article-title">Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2004&pages=166-173&author=U.+Neumannauthor=H.+Kubotaauthor=K.+Freiauthor=V.+Ganuauthor=D.+Leppert&title=Characterization+of+Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2%2C+a+fluorogenic+substrate+with+increased+specificity+constants+for+collagenases+and+tumor+necrosis+factor+converting+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DKubota%26aufirst%3DH.%26aulast%3DFrei%26aufirst%3DK.%26aulast%3DGanu%26aufirst%3DV.%26aulast%3DLeppert%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2%252C%2520a%2520fluorogenic%2520substrate%2520with%2520increased%2520specificity%2520constants%2520for%2520collagenases%2520and%2520tumor%2520necrosis%2520factor%2520converting%2520enzyme%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D328%26spage%3D166%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2799-2803&author=J.+I.+Levinauthor=J.+M.+Chenauthor=K.+Cheungauthor=D.+Coleauthor=C.+Cragoauthor=E.+D.+Santosauthor=X.+Duauthor=G.+Khafizovaauthor=G.+MacEwanauthor=C.+Niuauthor=E.+J.+Salaskiauthor=A.+Zaskauthor=T.+Cummonsauthor=A.+Sungauthor=J.+Xuauthor=Y.+Zhangauthor=W.+Xuauthor=S.+Ayral-Kaloustianauthor=G.+Jinauthor=R.+Cowlingauthor=D.+Baroneauthor=K.+M.+Mohlerauthor=R.+A.+Blackauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+inhibitors.+Part+1.+SAR+of+the+acyclic+sulfonamide+hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCrago%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DE.%2BD.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSalaski%26aufirst%3DE.%2BJ.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSung%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DMohler%26aufirst%3DK.%2BM.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520inhibitors.%2520Part%25201.%2520SAR%2520of%2520the%2520acyclic%2520sulfonamide%2520hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2799%26epage%3D2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Brocker, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiliou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebert, D. W.</span><span> </span><span class="NLM_article-title">Evolutionary divergence and functions of the ADAM and ADAMTS gene families</span> <span class="citation_source-journal">Hum. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1186%2F1479-7364-4-1-43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1yrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=43-55&author=C.+N.+Brockerauthor=V.+Vasiliouauthor=D.+W.+Nebert&title=Evolutionary+divergence+and+functions+of+the+ADAM+and+ADAMTS+gene+families"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary divergence and functions of the ADAM and ADAMTS gene families</span></div><div class="casAuthors">Brocker, Chad N.; Vasiliou, Vasilis; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">HGUEAT</span>;
        ISSN:<span class="NLM_cas:issn">1479-7364</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">A review.  The "A-disintegrin and metalloproteinase" (ADAM) and "A-disintegrin and metalloproteinase with thrombospondin motifs" (ADAMTS) genes make up two similar, yet distinct, gene families.  The human and mouse genomes contain 21 and 24 putatively functional protein-coding ADAM genes, resp., and 24 vs. 32 putatively functional protein-coding ADAMTS genes, resp.  Anal. of evolutionary divergence shows that both families are unique.  Each of the two families can be sepd., if need be, into groups of more closely related members: six subfamilies for ADAM, four subfamilies for ADAMTS.  The presence of both disintegrin and peptidase domains within the ADAM and ADAMTS proteins implies multiple biol. roles within the cell.  Membrane-anchored ADAM proteins are best known for their role in activating zymogens - including tumor necrosis factor-α, epidermal growth factor (EGF) and amyloid precursor protein (APP).  ADAM proteins can also participate in cell adhesion via their interaction with integrins in neighboring cells.  ADAMTS are secreted proteins that participate in extracellular matrix maintenance by way of their cleavage of procollagen and proteoglycans.  ADAMTS proteins also are involved in coagulation by cleaving von Willibrand factor precursor protein.  ADAM and ADAMTS proteins participate in a wide range of cellular processes, including cell adhesion and migration, ectodomain shedding, proteolysis, development, ovulation and angiogenesis.  Because these enzymes are believed to play an important role in a no. of pathologies, including Alzheimer's disease, rheumatoid arthritis, atherosclerosis, asthma and cancer progression, the products of the ADAM and ADAMTS genes represent promising drug targets for the prevention and management of a no. of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd7gysy8efoLVg90H21EOLACvtfcHk0ljWZnxACfjWLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1yrtbs%253D&md5=aef32e4b68273d97c20fdfca77455dc2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1479-7364-4-1-43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-7364-4-1-43%26sid%3Dliteratum%253Aachs%26aulast%3DBrocker%26aufirst%3DC.%2BN.%26aulast%3DVasiliou%26aufirst%3DV.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DEvolutionary%2520divergence%2520and%2520functions%2520of%2520the%2520ADAM%2520and%2520ADAMTS%2520gene%2520families%26jtitle%3DHum.%2520Genomics%26date%3D2009%26volume%3D4%26spage%3D43%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bech-Serra, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago-Josefat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, F.</span><span> </span><span class="NLM_article-title">Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5086</span><span class="NLM_x">–</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1128%2FMCB.02380-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=16782893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVSlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=5086-5095&author=J.+J.+Bech-Serraauthor=B.+Santiago-Josefatauthor=C.+Esselensauthor=P.+Saftigauthor=J.+Baselgaauthor=J.+Arribasauthor=F.+Canals&title=Proteomic+identification+of+desmoglein+2+and+activated+leukocyte+cell+adhesion+molecule+as+substrates+of+ADAM17+and+ADAM10+by+difference+gel+electrophoresis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis</span></div><div class="casAuthors">Bech-Serra, Joan J.; Santiago-Josefat, Belen; Esselens, Cary; Saftig, Paul; Baselga, Jose; Arribas, Joaquin; Canals, Francesc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5086-5095</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In contrast with the early view of metalloproteases as simple extracellular matrix-degrading entities, recent findings show that they are highly specific modulators of different signaling pathways involved, pos. or neg., in tumor development.  Thus, before considering a given metalloprotease a therapeutic target, it seems advisable to characterize its function by identifying its repertoire of substrates.  Here, we present a proteomic approach to identify ADAM17 substrates by difference gel electrophoresis.  We found that the shedding of the extracellular domain of the transferrin receptor and those of two cell-cell adhesion mols., activated leukocyte cell adhesion mol. (ALCAM) and desmoglein 2 (Dsg-2), is increased in cells overexpressing ADAM17.  Genetic evidence shows that while ADAM17 is responsible for the shedding of ALCAM, both ADAM17 and ADAM10 can act on Dsg-2.  Activation of the epidermal growth factor receptor leads to the upregulation of the shedding of Dsg-2 and to the concomitant upregulation of ADAM17, but not ADAM10, supporting the ability of overexpressed ADAM17 to shed Dsg-2.  These results unveil a role of ADAM10 and ADAM17 in the shedding of cell-cell adhesion mols.  Since loss of cell adhesion is an early event in tumor development, these results suggest that ADAM17 is a useful target in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBtjGxmWi6LVg90H21EOLACvtfcHk0ljWZnxACfjWLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVSlu78%253D&md5=f6be4e3b06038a4d8315248849e8899f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FMCB.02380-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02380-05%26sid%3Dliteratum%253Aachs%26aulast%3DBech-Serra%26aufirst%3DJ.%2BJ.%26aulast%3DSantiago-Josefat%26aufirst%3DB.%26aulast%3DEsselens%26aufirst%3DC.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DCanals%26aufirst%3DF.%26atitle%3DProteomic%2520identification%2520of%2520desmoglein%25202%2520and%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520as%2520substrates%2520of%2520ADAM17%2520and%2520ADAM10%2520by%2520difference%2520gel%2520electrophoresis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D5086%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crawford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, M. L.</span><span> </span><span class="NLM_article-title">ADAM10 as a therapeutic target for cancer and inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.2174%2F138161209788682442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=19601831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1altrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2288-2299&author=H.+C.+Crawfordauthor=P.+J.+Dempseyauthor=G.+Brownauthor=L.+Adamauthor=M.+L.+Moss&title=ADAM10+as+a+therapeutic+target+for+cancer+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM10 as a therapeutic target for cancer and inflammation</span></div><div class="casAuthors">Crawford, Howard C.; Dempsey, Peter J.; Brown, Gordon; Adam, Liana; Moss, Marcia L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2288-2299</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Both cancer and chronic inflammatory diseases are often marked by homeostatic signal transduction pathways run amok.  Cleavage of membrane-bound substrates by extracellular metalloproteinases is frequently the rate limiting step in activating many of these pathways, resulting either in liberation of active ligands (shedding) or initiating further processing into bioactive cytoplasmic domains (regulated intramembrane proteolysis or RIP).  ADAM10 is a member of the ADAM (A Disintegrin And Metalloproteinase) family of transmembrane metalloproteinases implicated in the RIPing and shedding of dozens of substrates that drive cancer progression and inflammatory disease, including Notch, E-cadherin, EGF, ErbB2 and inflammatory cytokines.  ADAM10's emerging role as a significant contributor to these pathologies has led to intense interest in it as a potential drug target for disease treatment.  Here we discuss some of the established functions of ADAM10 and the implications of its inhibition in disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKa7I9rwEetrVg90H21EOLACvtfcHk0ljWZnxACfjWLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1altrk%253D&md5=eda0ed3ac06c70a6ea957206755535c6</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F138161209788682442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209788682442%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DH.%2BC.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DAdam%26aufirst%3DL.%26aulast%3DMoss%26aufirst%3DM.%2BL.%26atitle%3DADAM10%2520as%2520a%2520therapeutic%2520target%2520for%2520cancer%2520and%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D2288%26epage%3D2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span> </span><span class="NLM_article-title">ADAM10 as a target for anticancer therapy</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.2174%2F138920108783497613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=18289051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2-8&author=M.+L.+Mossauthor=A.+Stoeckauthor=W.+Yanauthor=P.+J.+Dempsey&title=ADAM10+as+a+target+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM10 as a target for anti-cancer therapy</span></div><div class="casAuthors">Moss, Marcia L.; Stoeck, Alexander; Yan, Wenbo; Dempsey, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is a great unmet medical need in the area of cancer treatment.  A potential therapeutic target for intervention in cancer is ADAM10.  ADAM10 is a disintegrin-metalloproteinase that processes membrane bound proteins from the cell surface to yield sol. forms.  Pharmaceutical companies are actively seeking out inhibitors of ADAM10 for treatments in cancer as the enzyme is known to release the ErbB receptor, HER2/ErbB2 from the cell membrane, an event that is necessary for HER2 pos. tumor cells to proliferate.  ADAM10 is also capable of processing betacellulin indicating that an inhibitor could be used against EGFR/ErbB1 and/or HER4/ErbB4 receptor pos. tumor cells that are betacellulin-dependent.  ADAM10 is the principle sheddase for several other mols. assocd. with cancer proliferation, differentiation, adhesion and migration such as Notch, E-cadherin, CD44 and L1 adhesion mol. indicating that targeting ADAM10 with specific inhibitors could be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6jcMgx5q2iLVg90H21EOLACvtfcHk0lhZX7iRCOhXig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVGjt7w%253D&md5=92664d5e739c466cd02d7246d0c0c16d</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.2174%2F138920108783497613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920108783497613%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26aulast%3DStoeck%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26atitle%3DADAM10%2520as%2520a%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2008%26volume%3D9%26spage%3D2%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span> <span class="citation_source-book">Glide</span>, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulvino, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">1.56 Å structure of mature truncated human fibroblast collagenase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=98-109&author=J.+C.+Spurlinoauthor=A.+M.+Smallwoodauthor=D.+D.+Carltonauthor=T.+M.+Banksauthor=K.+J.+Vavraauthor=J.+S.+Johnsonauthor=E.+R.+Cookauthor=J.+Falvoauthor=R.+C.+Wahlauthor=T.+A.+Pulvinoauthor=J.+J.+Wendoloskiauthor=D.+L.+Smith&title=1.56+%C3%85+structure+of+mature+truncated+human+fibroblast+collagenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DCarlton%26aufirst%3DD.%2BD.%26aulast%3DBanks%26aufirst%3DT.%2BM.%26aulast%3DVavra%26aufirst%3DK.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BS.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DFalvo%26aufirst%3DJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DPulvino%26aufirst%3DT.%2BA.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3D1.56%2520%25C3%2585%2520structure%2520of%2520mature%2520truncated%2520human%2520fibroblast%2520collagenase%26jtitle%3DProteins%26date%3D1994%26volume%3D19%26spage%3D98%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Grossman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tworowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dym, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, I.</span><span> </span><span class="NLM_article-title">The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6184</span><span class="NLM_x">–</span> <span class="NLM_lpage">6192</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi902141x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6184-6192&author=M.+Grossmanauthor=D.+Tworowskiauthor=O.+Dymauthor=M.+H.+Leeauthor=Y.+Levyauthor=G.+Murphyauthor=I.+Sagi&title=The+intrinsic+protein+flexibility+of+endogenous+protease+inhibitor+TIMP-1+controls+its+binding+interface+and+affects+its+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi902141x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi902141x%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DTworowski%26aufirst%3DD.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DLee%26aufirst%3DM.%2BH.%26aulast%3DLevy%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DThe%2520intrinsic%2520protein%2520flexibility%2520of%2520endogenous%2520protease%2520inhibitor%2520TIMP-1%2520controls%2520its%2520binding%2520interface%2520and%2520affects%2520its%2520function%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6184%26epage%3D6192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, S.</span><span> </span><span class="NLM_article-title">Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">33236</span><span class="NLM_x">–</span> <span class="NLM_lpage">33243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=33236-33243&author=H.+Hashimotoauthor=T.+Takeuchiauthor=K.+Komatsuauthor=K.+Miyazakiauthor=M.+Satoauthor=S.+Higashi&title=Structural+basis+for+matrix+metalloproteinase-2+%28MMP-2%29-selective+inhibitory+action+of+%CE%B2-amyloid+precursor+protein-derived+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520for%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529-selective%2520inhibitory%2520action%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein-derived%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D33236%26epage%3D33243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nuti, E.; Antoni, C.; Vera, L.; Devel, L.; Beau, F.; Da Pozzo, E.; Costa, B.; Giacomelli, C.; Orlandini, E.; Nencetti, S.; Rosalia, L.; Dive, V.; Stura, E. A.; Martini, C.; Rossello, A.</span><span> </span><span class="NLM_article-title">Powerful twin carboxylic inhibitors for MMP homodimeriation</span>. Manuscript to be published.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nuti%2C+E.%3B+Antoni%2C+C.%3B+Vera%2C+L.%3B+Devel%2C+L.%3B+Beau%2C+F.%3B+Da+Pozzo%2C+E.%3B+Costa%2C+B.%3B+Giacomelli%2C+C.%3B+Orlandini%2C+E.%3B+Nencetti%2C+S.%3B+Rosalia%2C+L.%3B+Dive%2C+V.%3B+Stura%2C+E.+A.%3B+Martini%2C+C.%3B+Rossello%2C+A.+Powerful+twin+carboxylic+inhibitors+for+MMP+homodimeriation.+Manuscript+to+be+published."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26atitle%3DPowerful%2520twin%2520carboxylic%2520inhibitors%2520for%2520MMP%2520homodimeriation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span> <span class="citation_source-book">SoftMax Pro</span>, version <span class="NLM_edition">4.7.1</span>; <span class="NLM_publisher-name">Molecular Devices</span>: <span class="NLM_publisher-loc">Sunnyvale, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SoftMax+Pro%2C+version+4.7.1%3B+Molecular+Devices%3A+Sunnyvale%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSoftMax%2520Pro%26pub%3DMolecular%2520Devices" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span> <span class="citation_source-book">GraFit</span>, version <span class="NLM_edition">4</span>; <span class="NLM_publisher-name">Erithecus Software</span>: <span class="NLM_publisher-loc">West Sussex, U.K.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraFit%2C+version+4%3B+Erithecus+Software%3A+West+Sussex%2C+U.K."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGraFit%26pub%3DErithecus%2520Software" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span> <span class="citation_source-book">Maestro</span>, version <span class="NLM_edition">9.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF chimera: a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+chimera%3A+a+visualization+system+for+exploratory+research+and+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0liXAgPUhTdHUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520chimera%253A%2520a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0liXAgPUhTdHUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein%E2%80%93ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Cantelmo</span>, <span class="hlFld-ContribAuthor ">Cristina  Gallo</span>, <span class="hlFld-ContribAuthor ">Antonino  Bruno</span>, <span class="hlFld-ContribAuthor ">Barbara  Bassani</span>, <span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Laura  Vera</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Orlandini</span>, <span class="hlFld-ContribAuthor ">Susanna  Nencetti</span>, <span class="hlFld-ContribAuthor ">Enrico A.  Stura</span>, <span class="hlFld-ContribAuthor ">Adriano  Martinelli</span>, <span class="hlFld-ContribAuthor ">Vincent  Dive</span>, <span class="hlFld-ContribAuthor ">Adriana  Albini</span>, and <span class="hlFld-ContribAuthor ">Armando  Rossello</span>  . </span><span class="cited-content_cbyCitation_article-title">N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (18)
                                     , 7224-7240. <a href="https://doi.org/10.1021/acs.jmedchem.5b00367" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-O-Isopropyl%252BSulfonamido-Based%252BHydroxamates%252Bas%252BMatrix%252BMetalloproteinase%252BInhibitors%25253A%252BHit%252BSelection%252Band%252Bin%252BVivo%252BAntiangiogenic%252BActivity%26aulast%3DNuti%26aufirst%3DElisa%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06032015%26date%3D28082015%26date%3D24092015%26date%3D11082015%26volume%3D58%26issue%3D18%26spage%3D7224%26epage%3D7240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Felicia  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Developments in Carbohydrate-Based Metzincin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (11)
                                     , 376. <a href="https://doi.org/10.3390/ph13110376" title="DOI URL">https://doi.org/10.3390/ph13110376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13110376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13110376%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DDevelopments%252Bin%252BCarbohydrate-Based%252BMetzincin%252BInhibitors%26aulast%3DCuffaro%26aufirst%3DDoretta%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D11%26spage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant R.  Murumkar</span>, <span class="hlFld-ContribAuthor ">Rahul B.  Ghuge</span>, <span class="hlFld-ContribAuthor ">Monica  Chauhan</span>, <span class="hlFld-ContribAuthor ">Rahul R.  Barot</span>, <span class="hlFld-ContribAuthor ">Sharmishtha  Sorathiya</span>, <span class="hlFld-ContribAuthor ">Kailash M.  Choudhary</span>, <span class="hlFld-ContribAuthor ">Karan D.  Joshi</span>, <span class="hlFld-ContribAuthor ">Mange Ram  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments and strategies for the discovery of TACE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (7)
                                     , 779-801. <a href="https://doi.org/10.1080/17460441.2020.1744559" title="DOI URL">https://doi.org/10.1080/17460441.2020.1744559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1744559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1744559%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Bdevelopments%252Band%252Bstrategies%252Bfor%252Bthe%252Bdiscovery%252Bof%252BTACE%252Binhibitors%26aulast%3DMurumkar%26aufirst%3DPrashant%2BR.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D7%26spage%3D779%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">ADAM Metalloproteinases as Potential Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (15)
                                     , 2661-2689. <a href="https://doi.org/10.2174/0929867325666180326164104" title="DOI URL">https://doi.org/10.2174/0929867325666180326164104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180326164104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180326164104%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DADAM%252BMetalloproteinases%252Bas%252BPotential%252BDrug%252BTargets%26aulast%3DCamodeca%26aufirst%3DCaterina%26date%3D2019%26volume%3D26%26issue%3D15%26spage%3D2661%26epage%3D2689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uwe  Schlomann</span>, <span class="hlFld-ContribAuthor ">Kristina  Dorzweiler</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>, <span class="hlFld-ContribAuthor ">Jörg W.  Bartsch</span>. </span><span class="cited-content_cbyCitation_article-title">Metalloprotease inhibitor profiles of human ADAM8
              in vitro
              and in cell-based assays. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2019,</strong> <em>400 </em>
                                    (6)
                                     , 801-810. <a href="https://doi.org/10.1515/hsz-2018-0396" title="DOI URL">https://doi.org/10.1515/hsz-2018-0396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2018-0396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2018-0396%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DMetalloprotease%252Binhibitor%252Bprofiles%252Bof%252Bhuman%252BADAM8%252Bin%252Bvitro%252Band%252Bin%252Bcell-based%252Bassays%26aulast%3DSchlomann%26aufirst%3DUwe%26date%3D2019%26date%3D2019%26volume%3D400%26issue%3D6%26spage%3D801%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip Kumar  Baidya</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of arylsulfonamide-based ADAM17 inhibitors through validated comparative multi-QSAR modelling studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1185 </em>, 128-142. <a href="https://doi.org/10.1016/j.molstruc.2019.02.081" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.02.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.02.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.02.081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DStructural%252Bexploration%252Bof%252Barylsulfonamide-based%252BADAM17%252Binhibitors%252Bthrough%252Bvalidated%252Bcomparative%252Bmulti-QSAR%252Bmodelling%252Bstudies%26aulast%3DBaidya%26aufirst%3DSandip%2BKumar%26date%3D2019%26volume%3D1185%26spage%3D128%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Sanyal</span>, <span class="hlFld-ContribAuthor ">S.A.  Amin</span>, <span class="hlFld-ContribAuthor ">N.  Adhikari</span>, <span class="hlFld-ContribAuthor ">T.  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR modelling on a series of arylsulfonamide-based hydroxamates as potent MMP-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2019,</strong> <em>30 </em>
                                    (4)
                                     , 247-263. <a href="https://doi.org/10.1080/1062936X.2019.1588159" title="DOI URL">https://doi.org/10.1080/1062936X.2019.1588159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2019.1588159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2019.1588159%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DQSAR%252Bmodelling%252Bon%252Ba%252Bseries%252Bof%252Barylsulfonamide-based%252Bhydroxamates%252Bas%252Bpotent%252BMMP-2%252Binhibitors%26aulast%3DSanyal%26aufirst%3DS.%26date%3D2019%26date%3D2019%26volume%3D30%26issue%3D4%26spage%3D247%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Francesca  Tosetti</span>, <span class="hlFld-ContribAuthor ">Alessandro  Poggi</span>, <span class="hlFld-ContribAuthor ">Cristina  D'Arrigo</span>, <span class="hlFld-ContribAuthor ">Maria Raffaella  Zocchi</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (19)
                                     , 2119-2131. <a href="https://doi.org/10.1002/cmdc.201800482" title="DOI URL">https://doi.org/10.1002/cmdc.201800482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800482%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252BEvaluation%252Bof%252BADAM10%252Band%252BADAM17%252BHighly%252BSelective%252BBioimaging%252BProbes%26aulast%3DCamodeca%26aufirst%3DCaterina%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D19%26spage%3D2119%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Oliviero</span>, <span class="hlFld-ContribAuthor ">Stefania  Mantovani</span>, <span class="hlFld-ContribAuthor ">Stefania  Varchetta</span>, <span class="hlFld-ContribAuthor ">Dalila  Mele</span>, <span class="hlFld-ContribAuthor ">Giulia  Grossi</span>, <span class="hlFld-ContribAuthor ">Serena  Ludovisi</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>, <span class="hlFld-ContribAuthor ">Mario U.  Mondelli</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2017,</strong> <em>66 </em>
                                    (6)
                                     , 1130-1137. <a href="https://doi.org/10.1016/j.jhep.2017.01.032" title="DOI URL">https://doi.org/10.1016/j.jhep.2017.01.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2017.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2017.01.032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DHepatitis%252BC%252Bvirus-induced%252BNK%252Bcell%252Bactivation%252Bcauses%252Bmetzincin-mediated%252BCD16%252Bcleavage%252Band%252Bimpaired%252Bantibody-dependent%252Bcytotoxicity%26aulast%3DOliviero%26aufirst%3DBarbara%26date%3D2017%26volume%3D66%26issue%3D6%26spage%3D1130%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takehiko  Takayanagi</span>, <span class="hlFld-ContribAuthor ">Steven J.  Forrester</span>, <span class="hlFld-ContribAuthor ">Tatsuo  Kawai</span>, <span class="hlFld-ContribAuthor ">Takashi  Obama</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Tsuji</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Elliott</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>, <span class="hlFld-ContribAuthor ">Hang Fai  Kwok</span>, <span class="hlFld-ContribAuthor ">Rosario  Scalia</span>, <span class="hlFld-ContribAuthor ">Victor  Rizzo</span>, <span class="hlFld-ContribAuthor ">Satoru  Eguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II. </span><span class="cited-content_cbyCitation_journal-name">Hypertension</span><span> <strong>2016,</strong> <em>68 </em>
                                    (4)
                                     , 949-955. <a href="https://doi.org/10.1161/HYPERTENSIONAHA.116.07620" title="DOI URL">https://doi.org/10.1161/HYPERTENSIONAHA.116.07620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/HYPERTENSIONAHA.116.07620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FHYPERTENSIONAHA.116.07620%26sid%3Dliteratum%253Aachs%26jtitle%3DHypertension%26atitle%3DVascular%252BADAM17%252Bas%252Ba%252BNovel%252BTherapeutic%252BTarget%252Bin%252BMediating%252BCardiovascular%252BHypertrophy%252Band%252BPerivascular%252BFibrosis%252BInduced%252Bby%252BAngiotensin%252BII%26aulast%3DTakayanagi%26aufirst%3DTakehiko%26date%3D2016%26volume%3D68%26issue%3D4%26spage%3D949%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guodong  Jia</span>, <span class="hlFld-ContribAuthor ">Xu  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Yan</span>, <span class="hlFld-ContribAuthor ">Wantao  Chen</span>, <span class="hlFld-ContribAuthor ">Ping  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">CD166-mediated epidermal growth factor receptor phosphorylation promotes the growth of oral squamous cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oral Oncology</span><span> <strong>2016,</strong> <em>59 </em>, 1-11. <a href="https://doi.org/10.1016/j.oraloncology.2016.05.010" title="DOI URL">https://doi.org/10.1016/j.oraloncology.2016.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.oraloncology.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.oraloncology.2016.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Oncology%26atitle%3DCD166-mediated%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Bphosphorylation%252Bpromotes%252Bthe%252Bgrowth%252Bof%252Boral%252Bsquamous%252Bcell%252Bcarcinoma%26aulast%3DJia%26aufirst%3DGuodong%26date%3D2016%26volume%3D59%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Raffaella  Zocchi</span>, <span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>, <span class="hlFld-ContribAuthor ">Roberta  Venè</span>, <span class="hlFld-ContribAuthor ">Francesca  Tosetti</span>, <span class="hlFld-ContribAuthor ">Irene  Dapino</span>, <span class="hlFld-ContribAuthor ">Delfina  Costa</span>, <span class="hlFld-ContribAuthor ">Alessandra  Musso</span>, <span class="hlFld-ContribAuthor ">Alessandro  Poggi</span>. </span><span class="cited-content_cbyCitation_article-title">ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing. </span><span class="cited-content_cbyCitation_journal-name">OncoImmunology</span><span> <strong>2016,</strong> <em>5 </em>
                                    (5)
                                     , e1123367. <a href="https://doi.org/10.1080/2162402X.2015.1123367" title="DOI URL">https://doi.org/10.1080/2162402X.2015.1123367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/2162402X.2015.1123367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F2162402X.2015.1123367%26sid%3Dliteratum%253Aachs%26jtitle%3DOncoImmunology%26atitle%3DADAM10%252Bnew%252Bselective%252Binhibitors%252Breduce%252BNKG2D%252Bligand%252Brelease%252Bsensitizing%252BHodgkin%252Blymphoma%252Bcells%252Bto%252BNKG2D-mediated%252Bkilling%26aulast%3DZocchi%26aufirst%3DMaria%2BRaffaella%26date%3D2016%26date%3D2015%26volume%3D5%26issue%3D5%26spage%3De1123367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Livia  Tepshi</span>, <span class="hlFld-ContribAuthor ">Silvia  Boero</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Enrico A.  Stura</span>, <span class="hlFld-ContribAuthor ">Alessandro  Poggi</span>, <span class="hlFld-ContribAuthor ">Maria Raffaella  Zocchi</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>111 </em>, 193-201. <a href="https://doi.org/10.1016/j.ejmech.2016.01.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnew%252Bselective%252Binhibitor%252Bof%252BA%252BDisintegrin%252BAnd%252BMetalloprotease%252B10%252B%252528ADAM-10%252529%252Bable%252Bto%252Breduce%252Bthe%252Bshedding%252Bof%252BNKG2D%252Bligands%252Bin%252BHodgkin%252527s%252Blymphoma%252Bcell%252Bmodels%26aulast%3DCamodeca%26aufirst%3DCaterina%26date%3D2016%26volume%3D111%26spage%3D193%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Progression of the SAR: from the hit compound <b>1</b> to the ADAM-17 selective inhibitor <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of ADAM-17 selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>3</b>–<b>13</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) the appropriate substituted benzyl bromide, NaOH, <i>i</i>-PrOH, 70 °C; (b) (COCl)<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) glycine, TEA, H<sub>2</sub>O, dioxane; (d) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (f) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (g) 4 N HCl, dioxane, MeOH.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>17</b> and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glycine <i>tert</i>-butyl ester hydrochloride, TEA, H<sub>2</sub>O, dioxane; (b) 3-pyridinylboronic acid or 4-methoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane/H<sub>2</sub>O, 85 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>15</b> and <b>19</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) sarcosine <i>tert</i>-butyl ester hydrochloride or H-<span class="smallcaps smallerCapital">d</span>-Orn(Z)-OH or H-<span class="smallcaps smallerCapital">d</span>-Orn(carbamoyl)-OH, TEA, H<sub>2</sub>O, dioxane; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (c) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (d) 4 N HCl, dioxane, MeOH; (e) NH<sub>3</sub> aq, CH<sub>3</sub>CN, 0 °C to rt; (f) (Boc)<sub>2</sub>O, TEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (g) <b>77</b>, PPh<sub>3</sub>, DIAD, THF; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (i) THPONH<sub>2</sub>, HOBT, NMM, EDC, DMF; (l) 4 N HCl, dioxane, MeOH; (m) TBDMSiONH<sub>2</sub>, EDC, CH<sub>2</sub>Cl<sub>2</sub>; (n) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of soluble ALCAM release. SKOV3-luc EOC cells were treated with the indicated amounts of compound <b>1</b> or <b>21</b> and then stimulated with pervanadate or EGF for 90 min or 18 h, respectively. Conditioned media were then harvested and tested by ELISA for sALCAM levels. Data are expressed as % of control cultures treated with solvent (DMSO). Whole cell assays were performed and tested in duplicates. A representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/medium/jm-2013-011753_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of <b>21</b> (gold sticks) within the active site of ADAM-17, from docking calculations (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0">2OI0</a>). H-bonds are depicted as dashed black lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm4011753/production/images/large/jm-2013-011753_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011753&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unlu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepanski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteside, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vujanovic, N. L.</span><span> </span><span class="NLM_article-title">Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer</span> <span class="citation_source-journal">Cancer Epidemiol., Biomarkers Prev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2913</span><span class="NLM_x">–</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=2913-2922&author=L.+Geauthor=D.+Baskicauthor=P.+Basseauthor=L.+Vujanovicauthor=S.+Unluauthor=T.+Yoneyamaauthor=A.+Vujanovicauthor=J.+Hanauthor=D.+Bankovicauthor=M.+J.+Szczepanskiauthor=J.+L.+Huntauthor=R.+B.+Herbermanauthor=S.+M.+Gollinauthor=R.+L.+Ferrisauthor=T.+L.+Whitesideauthor=E.+N.+Myersauthor=N.+L.+Vujanovic&title=Sheddase+activity+of+tumor+necrosis+factor-alpha+converting+enzyme+is+increased+and+prognostically+valuable+in+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DL.%26aulast%3DBaskic%26aufirst%3DD.%26aulast%3DBasse%26aufirst%3DP.%26aulast%3DVujanovic%26aufirst%3DL.%26aulast%3DUnlu%26aufirst%3DS.%26aulast%3DYoneyama%26aufirst%3DT.%26aulast%3DVujanovic%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DBankovic%26aufirst%3DD.%26aulast%3DSzczepanski%26aufirst%3DM.%2BJ.%26aulast%3DHunt%26aufirst%3DJ.%2BL.%26aulast%3DHerberman%26aufirst%3DR.%2BB.%26aulast%3DGollin%26aufirst%3DS.%2BM.%26aulast%3DFerris%26aufirst%3DR.%2BL.%26aulast%3DWhiteside%26aufirst%3DT.%2BL.%26aulast%3DMyers%26aufirst%3DE.%2BN.%26aulast%3DVujanovic%26aufirst%3DN.%2BL.%26atitle%3DSheddase%2520activity%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520is%2520increased%2520and%2520prognostically%2520valuable%2520in%2520head%2520and%2520neck%2520cancer%26jtitle%3DCancer%2520Epidemiol.%252C%2520Biomarkers%2520Prev.%26date%3D2009%26volume%3D18%26spage%3D2913%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Piazza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongarzone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargellesi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">Internalization and recycling of ALCAM/CD166 detected by a fully human single chain recombinant antibody</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1242%2Fjcs.02280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=15769845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=1515-1525&author=T.+Piazzaauthor=E.+Chaauthor=I.+Bongarzoneauthor=S.+Canevariauthor=A.+Bolognesiauthor=L.+Politoauthor=A.+Bargellesiauthor=F.+Sassiauthor=S.+Ferriniauthor=M.+Fabbi&title=Internalization+and+recycling+of+ALCAM%2FCD166+detected+by+a+fully+human+single+chain+recombinant+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody</span></div><div class="casAuthors">Piazza, Tiziana; Cha, Emanuela; Bongarzone, Italia; Canevari, Silvana; Bolognesi, Andrea; Polito, Letizia; Bargellesi, Antonio; Sassi, Francesca; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1515-1525</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Activated leukocyte cell adhesion mol. (ALCAM/CD166), a member of the Ig superfamily with five extracellular Ig-like domains, promotes heterophilic (ALCAM-CD6) and homophilic (ALCAM-ALCAM) cell-cell interactions.  Here the authors describe a fully human single-chain antibody fragment (scFv) directed to ALCAM/CD166.  The authors selected the I/F8 scFv from a phage display library of human V-gene segments by cell panning and phage internalization into IGROV-I human ovary carcinoma cells.  The I/F8 specificity was identified as ALCAM/CD166 by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) peptide mass fingerprinting of the I/F8-immunopptd. protein.  The I/F8 scFv reacts with the human, monkey and murine ALCAM/CD166 mol., indicating that the recognized epitope is highly conserved.  The I/F8 scFv completely abolished binding of both ALCAM/Fc and CD6/Fc sol. ligands, whereas it did not compete with the anti-ALCAM/CD166 murine monoclonal antibodies J4-81 and 3A6 and therefore recognizes a different epitope.  Engagement through I/F8 scFv, 3A6 monoclonal antibody or CD6/Fc ligand induced ALCAM/CD166 internalization, with a kinetics slower than that of transferrin in the same cells.  Newly internalized I/F8-ALCAM complexes colocalized with clathrin but not with caveolin and the authors demonstrated, using surface biotinylation and recycling assays, that endocytosed ALCAM/CD166 recycles back to the cell surface.  Such an endocytic pathway allows the efficient delivery of an I/F8 scFv-saporin immunotoxin into tumor cells, as the conjugates are able to selectively kill cell lines expressing ALCAM/CD166.  Altogether these data provide evidence of the suitability of the I/F8 scFv for further functional anal. of ALCAM/CD166 and intracellular delivery of effector moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tqjVMkmHrbVg90H21EOLACvtfcHk0liqRpiqXNd-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGkt74%253D&md5=927f397f81ac24300850dd9b6c78500a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02280%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DT.%26aulast%3DCha%26aufirst%3DE.%26aulast%3DBongarzone%26aufirst%3DI.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DA.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DBargellesi%26aufirst%3DA.%26aulast%3DSassi%26aufirst%3DF.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DInternalization%2520and%2520recycling%2520of%2520ALCAM%252FCD166%2520detected%2520by%2520a%2520fully%2520human%2520single%2520chain%2520recombinant%2520antibody%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D1515%26epage%3D1525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rosso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bongarzone, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orengo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">The ALCAM shedding by the metalloprotease ADAM17/TACE is a tyrosine kinase-inducible process involved in motility of ovarian carcinoma cells</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1158%2F1541-7786.MCR-07-0060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=18171982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=1246-1253&author=O.+Rossoauthor=T.+Piazzaauthor=I.+Bongarzoneauthor=A.+Rosselloauthor=D.+Mezzanzanicaauthor=S.+Canevariauthor=A.+M.+Orengoauthor=A.+Puppoauthor=S.+Ferriniauthor=M.+Fabbi&title=The+ALCAM+shedding+by+the+metalloprotease+ADAM17%2FTACE+is+a+tyrosine+kinase-inducible+process+involved+in+motility+of+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells</span></div><div class="casAuthors">Rosso, Ombretta; Piazza, Tiziana; Bongarzone, Italia; Rossello, Armando; Mezzanzanica, Delia; Canevari, Silvana; Orengo, Anna Maria; Puppo, Andrea; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1246-1253</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Previous findings indicated that the activated leukocyte cell adhesion mol. (ALCAM) is expressed by tumors and plays a role in tumor biol.  In this study, we show that ALCAM is shed from epithelial ovarian cancer (EOC) cells in vitro, leading to the generation of a sol. ALCAM (sALCAM), consisting of most of the extracellular domain.  A similar sALCAM mol. was also found in the ascitic fluids and sera from EOC patients, suggesting that this process also occurs in vivo.  SALCAM is constitutively produced by EOC cells, and this process can be enhanced by cell treatment with pervanadate, phorbol 12-myristate 13-acetate (PMA), or epidermal growth factor (EGF), a known growth factor for EOC.  Pharmacol. inhibitors of matrix metalloproteinases (MMP) and of a disintegrin and metalloproteases (ADAM), and the tissue inhibitor of metalloproteinase-3, significantly inhibited sALCAM release by EOC cells.  The ADAM17/TACE mol. was expressed in EOC cell lines and ADAM17/TACE silencing by specific small interfering RNA-reduced ALCAM shedding.  In addn., inhibitors of ADAM function blocked EOC cell motility in a wound-healing assay.  Conversely, a recombinant antibody blocking ALCAM adhesive functions and inducing ALCAM internalization enhanced EOC cell motility.  Altogether, our data suggest that the disruption of ALCAM-mediated adhesion is a relevant step in EOC motility, and ADAM17/TACE takes part in this process, which may be relevant to EOC invasive potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2W5oZDfQDLVg90H21EOLACvtfcHk0liqRpiqXNd-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVCgtg%253D%253D&md5=d54000fa718b3104e270d7d449761124</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-0060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-0060%26sid%3Dliteratum%253Aachs%26aulast%3DRosso%26aufirst%3DO.%26aulast%3DPiazza%26aufirst%3DT.%26aulast%3DBongarzone%26aufirst%3DI.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DOrengo%26aufirst%3DA.%2BM.%26aulast%3DPuppo%26aufirst%3DA.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DThe%2520ALCAM%2520shedding%2520by%2520the%2520metalloprotease%2520ADAM17%252FTACE%2520is%2520a%2520tyrosine%2520kinase-inducible%2520process%2520involved%2520in%2520motility%2520of%2520ovarian%2520carcinoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D1246%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Santiago-Josefat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech-Serra, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span> </span><span class="NLM_article-title">Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">8325</span><span class="NLM_x">–</span> <span class="NLM_lpage">8331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=8325-8331&author=B.+Santiago-Josefatauthor=C.+Esselensauthor=J.+J.+Bech-Serraauthor=J.+Arribas&title=Post-transcriptional+up-regulation+of+ADAM17+upon+epidermal+growth+factor+receptor+activation+and+in+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Josefat%26aufirst%3DB.%26aulast%3DEsselens%26aufirst%3DC.%26aulast%3DBech-Serra%26aufirst%3DJ.%2BJ.%26aulast%3DArribas%26aufirst%3DJ.%26atitle%3DPost-transcriptional%2520up-regulation%2520of%2520ADAM17%2520upon%2520epidermal%2520growth%2520factor%2520receptor%2520activation%2520and%2520in%2520breast%2520tumors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D8325%26epage%3D8331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kenny, P. A.</span><span> </span><span class="NLM_article-title">TACE: a new target in epidermal growth factor receptor dependent tumors</span> <span class="citation_source-journal">Differentiation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=800-808&author=P.+A.+Kenny&title=TACE%3A+a+new+target+in+epidermal+growth+factor+receptor+dependent+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BA.%26atitle%3DTACE%253A%2520a%2520new%2520target%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520dependent%2520tumors%26jtitle%3DDifferentiation%26date%3D2007%26volume%3D75%26spage%3D800%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramova, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercignani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2635</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901868z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2622-2635&author=E.+Nutiauthor=F.+Casaliniauthor=S.+I.+Avramovaauthor=S.+Santamariaauthor=M.+Fabbiauthor=S.+Ferriniauthor=L.+Marinelliauthor=V.+La+Pietraauthor=V.+Limongelliauthor=E.+Novellinoauthor=G.+Cercignaniauthor=E.+Orlandiniauthor=S.+Nencettiauthor=A.+Rossello&title=Potent+arylsulfonamide+inhibitors+of+tumor+necrosis+factor-alpha+converting+enzyme+able+to+reduce+activated+leukocyte+cell+adhesion+molecule+shedding+in+cancer+cell+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm901868z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901868z%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DAvramova%26aufirst%3DS.%2BI.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCercignani%26aufirst%3DG.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DPotent%2520arylsulfonamide%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520able%2520to%2520reduce%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520shedding%2520in%2520cancer%2520cell%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2622%26epage%3D2635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Carbotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orengo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizzolara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emionite, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centurioni, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbi, M.</span><span> </span><span class="NLM_article-title">Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors</span> <span class="citation_source-journal">Int. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2597</span><span class="NLM_x">–</span> <span class="NLM_lpage">2605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2Fijc.27948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=2597-2605&author=G.+Carbottiauthor=A.+M.+Orengoauthor=D.+Mezzanzanicaauthor=M.+Bagnoliauthor=A.+Brizzolaraauthor=L.+Emioniteauthor=A.+Puppoauthor=M.+G.+Centurioniauthor=M.+Bruzzoneauthor=P.+Marroniauthor=A.+Rosselloauthor=S.+Canevariauthor=S.+Ferriniauthor=M.+Fabbi&title=Activated+leukocyte+cell+adhesion+molecule+soluble+form%3A+a+potential+biomarker+of+epithelial+ovarian+cancer+is+increased+in+type+II+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors</span></div><div class="casAuthors">Carbotti, Grazia; Orengo, Anna Maria; Mezzanzanica, Delia; Bagnoli, Marina; Brizzolara, Antonella; Emionite, Laura; Puppo, Andrea; Centurioni, Maria Grazia; Bruzzone, Milena; Marroni, Paola; Rossello, Armando; Canevari, Silvana; Ferrini, Silvano; Fabbi, Marina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2597-2605</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Activated leukocyte cell adhesion mol. (ALCAM) is involved in cell-cell interactions in cancer.  Shedding of its ectodomain by the metalloprotease ADAM17/TACE generates a sol. form (sALCAM).  Here, we show that serum sALCAM levels were significantly higher in epithelial ovarian cancer (EOC) (p < 0.005) than in controls.  The performance of sALCAM as classifier, tested by receiver operating characteristic curve, resulted in an area under the curve (AUC) of 0.8067.  Serum sALCAM levels showed direct correlation with Carbohydrate Antigen-125 (CA125/MUC16).  Moreover, significantly higher levels were found in type II tumors, even in stage I/II, suggesting that elevated sALCAM is an early feature of aggressive EOC.  In addn., sALCAM levels were higher in ascites than in sera, suggesting local processing of ALCAM in the peritoneal cavity.  In immunodeficient mice, i.p. implanted with a human EOC cell line, human sALCAM progressively increased in serum and was even higher in the ascites.  The biochem. characterization of the sALCAM in EOC sera and ascites, showed two predominant forms of approx. 95 and 65 kDa but no EOC-specific isoform.  In addn., full-length transmembrane ALCAM but no sol. form was detected in tumor-derived exosomes found in ascites.  Finally, in vitro invasion assays showed that inhibition of ADAM17/TACE activity decreased EOC invasive properties, while opposite effects were mediated by a sALCAM-Fc chimera and by an antibody interfering with ALCAM/ALCAM interactions.  Altogether these data suggest that sALCAM is a marker of EOC, which correlates with more aggressive type II tumors, and that ADAM17/TACE activity and sALCAM itself mediate enhanced invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcHFdvzXEFHbVg90H21EOLACvtfcHk0lh7SokplwVuzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurjE&md5=4f47ed238e528a569379c7d8e7e4762e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.27948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27948%26sid%3Dliteratum%253Aachs%26aulast%3DCarbotti%26aufirst%3DG.%26aulast%3DOrengo%26aufirst%3DA.%2BM.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DBrizzolara%26aufirst%3DA.%26aulast%3DEmionite%26aufirst%3DL.%26aulast%3DPuppo%26aufirst%3DA.%26aulast%3DCenturioni%26aufirst%3DM.%2BG.%26aulast%3DBruzzone%26aufirst%3DM.%26aulast%3DMarroni%26aufirst%3DP.%26aulast%3DRossello%26aufirst%3DA.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DFabbi%26aufirst%3DM.%26atitle%3DActivated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520soluble%2520form%253A%2520a%2520potential%2520biomarker%2520of%2520epithelial%2520ovarian%2520cancer%2520is%2520increased%2520in%2520type%2520II%2520tumors%26jtitle%3DInt.%2520J.%2520Cancer.%26date%3D2013%26volume%3D132%26spage%3D2597%26epage%3D2605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Becker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carron, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freskos, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munie, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swearingen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span> </span><span class="NLM_article-title">Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6653</span><span class="NLM_x">–</span> <span class="NLM_lpage">6680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100669j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6653-6680&author=D.+P.+Beckerauthor=T.+E.+Bartaauthor=L.+J.+Bedellauthor=T.+L.+Boehmauthor=B.+R.+Bondauthor=J.+Carrollauthor=C.+P.+Carronauthor=G.+A.+DeCrescenzoauthor=A.+M.+Eastonauthor=J.+N.+Freskosauthor=C.+L.+Funckes-Shippyauthor=M.+Heronauthor=S.+Hockermanauthor=C.+P.+Howardauthor=J.+R.+Kieferauthor=M.+H.+Liauthor=K.+J.+Mathisauthor=J.+J.+McDonaldauthor=P.+P.+Mehtaauthor=G.+E.+Munieauthor=T.+Sunyerauthor=C.+A.+Swearingenauthor=C.+I.+Villamilauthor=D.+Welschauthor=J.+M.+Williamsauthor=Y.+Yuauthor=J.+Yao&title=Orally+active+MMP-1+sparing+%CE%B1-tetrahydropyranyl+and+%CE%B1-piperidinyl+sulfone+matrix+metalloproteinase+%28MMP%29+inhibitors+with+efficacy+in+cancer%2C+arthritis%2C+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease</span></div><div class="casAuthors">Becker, Daniel P.; Barta, Thomas E.; Bedell, Louis J.; Boehm, Terri L.; Bond, Brian R.; Carroll, Jeffery; Carron, Chris P.; De Crescenzo, Gary A.; Easton, Alan M.; Freskos, John N.; Funckes-Shippy, Chris L.; Heron, Marcia; Hockerman, Susan; Howard, Carol Pearcy; Kiefer, James R.; Li, Madeleine H.; Mathis, Karl J.; McDonald, Joseph J.; Mehta, Pramod P.; Munie, Grace E.; Sunyer, Teresa; Swearingen, Craig A.; Villamil, Clara I.; Welsch, Dean; Williams, Jennifer M.; Yu, Ying; Yao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6653-6680</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides such as I (R = MeOCH2CH2, cyclopropyl) are prepd. as selective matrix metalloproteinase (MMP) inhibitors avoiding nonselective MMP (in particular, MMP-1) inhibition for use as antitumor, antiarthritic, and cardiovascular agents.  The inhibition of MMPs 1, 2, 3, 7, 8, 9, 13, and 14 by N-hydroxy aryloxyarylsulfonyl pyrancarboxamides and piperidinecarboxamides is detd. as well as their calcd. lipophilicities; the pharmacokinetics, inhibition of human prostate, breast, and lung cancer cells, inhibition of cartilage degrdn., inhibition of ventricular dilation after myocardial infarction, and DSC calorimetric measurements for selected compds. are detd.  I (R = MeOCH2CH2) (SC-78080/SD-2590) was selected for development as an anticancer agent, while I (R = cyclopropyl) and an N-hydroxy trifluoromethylphenoxyphenylsulfonyl pyrancarboxamide were selected as backup compds.  The structure of I (R = MeOCH2CH2) bound to MMP-13 is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0b9GTt27EbVg90H21EOLACvtfcHk0liVIoRiFEH1Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGjtbnJ&md5=0ee6c0fea7d5e86ff75095615dac8ec6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm100669j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100669j%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DD.%2BP.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DBedell%26aufirst%3DL.%2BJ.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DCarroll%26aufirst%3DJ.%26aulast%3DCarron%26aufirst%3DC.%2BP.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DEaston%26aufirst%3DA.%2BM.%26aulast%3DFreskos%26aufirst%3DJ.%2BN.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DHeron%26aufirst%3DM.%26aulast%3DHockerman%26aufirst%3DS.%26aulast%3DHoward%26aufirst%3DC.%2BP.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DMunie%26aufirst%3DG.%2BE.%26aulast%3DSunyer%26aufirst%3DT.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DVillamil%26aufirst%3DC.%2BI.%26aulast%3DWelsch%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26atitle%3DOrally%2520active%2520MMP-1%2520sparing%2520%25CE%25B1-tetrahydropyranyl%2520and%2520%25CE%25B1-piperidinyl%2520sulfone%2520matrix%2520metalloproteinase%2520%2528MMP%2529%2520inhibitors%2520with%2520efficacy%2520in%2520cancer%252C%2520arthritis%252C%2520and%2520cardiovascular%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6653%26epage%3D6680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rossello, A.; Nuti, E.; Maresca, A.</span><span> </span><span class="NLM_article-title">ADAMs and ADAMTs Selective Synthetic Inhibitors</span>. In  <span class="citation_source-book">Drug Design of Zinc–Enzyme Inhibitors: Functional, Structural, and Disease Applications</span>; <span class="NLM_contrib-group">Supuran, C. T.; Winum, J.-Y.</span>, Eds.; Wiley Series in Drug Discovery and Development; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2F9780470508169.ch26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=591-645&author=A.+Rossello&author=E.+Nuti&author=A.+Marescaauthor=C.+T.+Supuran&author=J.-Y.+Winum&title=Drug+Design+of+Zinc%E2%80%93Enzyme+Inhibitors%3A+Functional%2C+Structural%2C+and+Disease+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2F9780470508169.ch26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470508169.ch26%26sid%3Dliteratum%253Aachs%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DADAMs%2520and%2520ADAMTs%2520Selective%2520Synthetic%2520Inhibitors%26btitle%3DDrug%2520Design%2520of%2520Zinc%25E2%2580%2593Enzyme%2520Inhibitors%253A%2520Functional%252C%2520Structural%252C%2520and%2520Disease%2520Applications%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2009%26spage%3D591%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Recent advances in MMP inhibitor design</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-136&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+advances+in+MMP+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0ljGMfS0nlzgCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520MMP%2520inhibitor%2520design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26spage%3D115%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Georgiadis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiotakis, A.</span><span> </span><span class="NLM_article-title">Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8781</span><span class="NLM_x">–</span> <span class="NLM_lpage">8794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8781-8794&author=D.+Georgiadisauthor=A.+Yiotakis&title=Specific+targeting+of+metzincin+family+members+with+small-molecule+inhibitors%3A+progress+toward+a+multifarious+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DYiotakis%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520metzincin%2520family%2520members%2520with%2520small-molecule%2520inhibitors%253A%2520progress%2520toward%2520a%2520multifarious%2520challenge%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8781%26epage%3D8794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rossello, A.; Nuti, E.; Casalini, F.; Orlandini, E.</span><span> </span><span class="NLM_article-title">Inibitori Altamente Selettivi dell'Attivita' di ADAMs</span>. Italian Patent Application PI2011A000007,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Rossello&author=E.+Nuti&author=F.+Casalini&author=E.+Orlandini&title=Inibitori+Altamente+Selettivi+dell%27Attivita%27+di+ADAMs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DInibitori%2520Altamente%2520Selettivi%2520dell%2527Attivita%2527%2520di%2520ADAMs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Maskos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourenkov, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H. R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerretti, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3408-3412&author=K.+Maskosauthor=C.+Fernandez-Catalanauthor=R.+Huberauthor=G.+P.+Bourenkovauthor=H.+Bartunikauthor=G.+A.+Ellestadauthor=P.+Reddyauthor=M.+F.+Wolfsonauthor=C.+T.+Rauchauthor=B.+J.+Castnerauthor=R.+Davisauthor=H.+R.+G.+Clarkeauthor=M.+Petersenauthor=J.+N.+Fitznerauthor=D.+P.+Cerrettiauthor=C.+J.+Marchauthor=R.+J.+Paxtonauthor=R.+A.+Blackauthor=W.+Bode&title=Crystal+structure+of+the+catalytic+domain+of+human+tumor+necrosis+factor-%CE%B1-converting+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBourenkov%26aufirst%3DG.%2BP.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DWolfson%26aufirst%3DM.%2BF.%26aulast%3DRauch%26aufirst%3DC.%2BT.%26aulast%3DCastner%26aufirst%3DB.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DH.%2BR.%2BG.%26aulast%3DPetersen%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DJ.%2BN.%26aulast%3DCerretti%26aufirst%3DD.%2BP.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520tumor%2520necrosis%2520factor-%25CE%25B1-converting%2520enzyme%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grootveld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, M. F.</span><span> </span><span class="NLM_article-title">BMS-561392 (Bristol-Myers Squibb)</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=598-602&author=M.+Grootveldauthor=M.+F.+McDermott&title=BMS-561392+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrootveld%26aufirst%3DM.%26aulast%3DMcDermott%26aufirst%3DM.%2BF.%26atitle%3DBMS-561392%2520%2528Bristol-Myers%2520Squibb%2529%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D598%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madskuie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaris, J.</span><span> </span><span class="NLM_article-title">Pharmacological profile of DPC 333, a selective TACE inhibitor</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">A27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=A27&author=R.+Liuauthor=R.+Magoldaauthor=R.+Newtonauthor=J.+Duanauthor=K.+Vaddiauthor=T.+Madskuieauthor=M.+Qianauthor=R.+Collinsauthor=T.+Taylorauthor=J.+Giannaris&title=Pharmacological+profile+of+DPC+333%2C+a+selective+TACE+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DMadskuie%26aufirst%3DT.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%26aulast%3DGiannaris%26aufirst%3DJ.%26atitle%3DPharmacological%2520profile%2520of%2520DPC%2520333%252C%2520a%2520selective%2520TACE%2520inhibitor%26jtitle%3DInflammation%2520Res.%26date%3D2002%26volume%3D51%26spage%3DA27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J.</span><span> </span><span class="NLM_article-title">Identification and characterization of Aprarastat (TMI-005), a potent, dual TACE/MMP inhibitor for the treatment of RA</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64 (Suppl 3)</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64+%28Suppl+3%29&publication_year=2005&pages=462-463&author=Y.+Zhangauthor=J.+Xuauthor=C.+Udataauthor=J.+McDevittauthor=T.+Cummonsauthor=L.+Sunauthor=Y.+Zhuauthor=G.+Liauthor=V.+Raoauthor=Q.+Wangauthor=J.+Gibbonsauthor=J.+Skotnickiauthor=L.+Linauthor=J.+Levin&title=Identification+and+characterization+of+Aprarastat+%28TMI-005%29%2C+a+potent%2C+dual+TACE%2FMMP+inhibitor+for+the+treatment+of+RA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DUdata%26aufirst%3DC.%26aulast%3DMcDevitt%26aufirst%3DJ.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DRao%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLevin%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520Aprarastat%2520%2528TMI-005%2529%252C%2520a%2520potent%252C%2520dual%2520TACE%252FMMP%2520inhibitor%2520for%2520the%2520treatment%2520of%2520RA%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2005%26volume%3D64%2520%2528Suppl%25203%2529%26spage%3D462%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levin, J.; Li, Z.; Diamantidis, G.; Lovering, F. E.; Wang, W.; Condon, J. S.; Lin, Y.; Skotnicki, J. S.; Park, K.</span><span> </span><span class="NLM_article-title">β-Sulfonamide Hydroxamic Acid Inhibitors of TACE/Matrix Metalloproteinase</span>. U.S. Patent Appl. Pub. 0211730,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Levin&author=Z.+Li&author=G.+Diamantidis&author=F.+E.+Lovering&author=W.+Wang&author=J.+S.+Condon&author=Y.+Lin&author=J.+S.+Skotnicki&author=K.+Park&title=%CE%B2-Sulfonamide+Hydroxamic+Acid+Inhibitors+of+TACE%2FMatrix+Metalloproteinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Sulfonamide%2520Hydroxamic%2520Acid%2520Inhibitors%2520of%2520TACE%252FMatrix%2520Metalloproteinase%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papamichelakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellstedt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noureldin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigneault, S.</span><span> </span><span class="NLM_article-title">Development of a suitable process for the preparation of a TNF-α converting enzyme inhibitor, WAY-281418</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/op800090s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1253-1260&author=Y.+Wangauthor=M.+Papamichelakisauthor=W.+Chewauthor=J.+Sellstedtauthor=R.+Noureldinauthor=S.+Tadayonauthor=S.+Daigneault&title=Development+of+a+suitable+process+for+the+preparation+of+a+TNF-%CE%B1+converting+enzyme+inhibitor%2C+WAY-281418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fop800090s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop800090s%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPapamichelakis%26aufirst%3DM.%26aulast%3DChew%26aufirst%3DW.%26aulast%3DSellstedt%26aufirst%3DJ.%26aulast%3DNoureldin%26aufirst%3DR.%26aulast%3DTadayon%26aufirst%3DS.%26aulast%3DDaigneault%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520a%2520suitable%2520process%2520for%2520the%2520preparation%2520of%2520a%2520TNF-%25CE%25B1%2520converting%2520enzyme%2520inhibitor%252C%2520WAY-281418%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1253%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nuti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlandini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossello, A.</span><span> </span><span class="NLM_article-title">Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=379-394&author=E.+Nutiauthor=S.+Santamariaauthor=F.+Casaliniauthor=K.+Yamamotoauthor=L.+Marinelliauthor=V.+La+Pietraauthor=E.+Novellinoauthor=E.+Orlandiniauthor=S.+Nencettiauthor=A.+M.+Mariniauthor=S.+Salernoauthor=S.+Talianiauthor=F.+Da+Settimoauthor=H.+Nagaseauthor=A.+Rossello&title=Arylsulfonamide+inhibitors+of+aggrecanases+as+potential+therapeutic+agents+for+osteoarthritis%3A+synthesis+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DCasalini%26aufirst%3DF.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DArylsulfonamide%2520inhibitors%2520of%2520aggrecanases%2520as%2520potential%2520therapeutic%2520agents%2520for%2520osteoarthritis%253A%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D379%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppert, D.</span><span> </span><span class="NLM_article-title">Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2004&pages=166-173&author=U.+Neumannauthor=H.+Kubotaauthor=K.+Freiauthor=V.+Ganuauthor=D.+Leppert&title=Characterization+of+Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2%2C+a+fluorogenic+substrate+with+increased+specificity+constants+for+collagenases+and+tumor+necrosis+factor+converting+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DKubota%26aufirst%3DH.%26aulast%3DFrei%26aufirst%3DK.%26aulast%3DGanu%26aufirst%3DV.%26aulast%3DLeppert%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2%252C%2520a%2520fluorogenic%2520substrate%2520with%2520increased%2520specificity%2520constants%2520for%2520collagenases%2520and%2520tumor%2520necrosis%2520factor%2520converting%2520enzyme%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D328%26spage%3D166%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2799-2803&author=J.+I.+Levinauthor=J.+M.+Chenauthor=K.+Cheungauthor=D.+Coleauthor=C.+Cragoauthor=E.+D.+Santosauthor=X.+Duauthor=G.+Khafizovaauthor=G.+MacEwanauthor=C.+Niuauthor=E.+J.+Salaskiauthor=A.+Zaskauthor=T.+Cummonsauthor=A.+Sungauthor=J.+Xuauthor=Y.+Zhangauthor=W.+Xuauthor=S.+Ayral-Kaloustianauthor=G.+Jinauthor=R.+Cowlingauthor=D.+Baroneauthor=K.+M.+Mohlerauthor=R.+A.+Blackauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+inhibitors.+Part+1.+SAR+of+the+acyclic+sulfonamide+hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCrago%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DE.%2BD.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSalaski%26aufirst%3DE.%2BJ.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSung%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DMohler%26aufirst%3DK.%2BM.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520inhibitors.%2520Part%25201.%2520SAR%2520of%2520the%2520acyclic%2520sulfonamide%2520hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2799%26epage%3D2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Brocker, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiliou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebert, D. W.</span><span> </span><span class="NLM_article-title">Evolutionary divergence and functions of the ADAM and ADAMTS gene families</span> <span class="citation_source-journal">Hum. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1186%2F1479-7364-4-1-43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1yrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=43-55&author=C.+N.+Brockerauthor=V.+Vasiliouauthor=D.+W.+Nebert&title=Evolutionary+divergence+and+functions+of+the+ADAM+and+ADAMTS+gene+families"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary divergence and functions of the ADAM and ADAMTS gene families</span></div><div class="casAuthors">Brocker, Chad N.; Vasiliou, Vasilis; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">HGUEAT</span>;
        ISSN:<span class="NLM_cas:issn">1479-7364</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">A review.  The "A-disintegrin and metalloproteinase" (ADAM) and "A-disintegrin and metalloproteinase with thrombospondin motifs" (ADAMTS) genes make up two similar, yet distinct, gene families.  The human and mouse genomes contain 21 and 24 putatively functional protein-coding ADAM genes, resp., and 24 vs. 32 putatively functional protein-coding ADAMTS genes, resp.  Anal. of evolutionary divergence shows that both families are unique.  Each of the two families can be sepd., if need be, into groups of more closely related members: six subfamilies for ADAM, four subfamilies for ADAMTS.  The presence of both disintegrin and peptidase domains within the ADAM and ADAMTS proteins implies multiple biol. roles within the cell.  Membrane-anchored ADAM proteins are best known for their role in activating zymogens - including tumor necrosis factor-α, epidermal growth factor (EGF) and amyloid precursor protein (APP).  ADAM proteins can also participate in cell adhesion via their interaction with integrins in neighboring cells.  ADAMTS are secreted proteins that participate in extracellular matrix maintenance by way of their cleavage of procollagen and proteoglycans.  ADAMTS proteins also are involved in coagulation by cleaving von Willibrand factor precursor protein.  ADAM and ADAMTS proteins participate in a wide range of cellular processes, including cell adhesion and migration, ectodomain shedding, proteolysis, development, ovulation and angiogenesis.  Because these enzymes are believed to play an important role in a no. of pathologies, including Alzheimer's disease, rheumatoid arthritis, atherosclerosis, asthma and cancer progression, the products of the ADAM and ADAMTS genes represent promising drug targets for the prevention and management of a no. of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd7gysy8efoLVg90H21EOLACvtfcHk0lj3zrvUCbqeHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1yrtbs%253D&md5=aef32e4b68273d97c20fdfca77455dc2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1479-7364-4-1-43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-7364-4-1-43%26sid%3Dliteratum%253Aachs%26aulast%3DBrocker%26aufirst%3DC.%2BN.%26aulast%3DVasiliou%26aufirst%3DV.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DEvolutionary%2520divergence%2520and%2520functions%2520of%2520the%2520ADAM%2520and%2520ADAMTS%2520gene%2520families%26jtitle%3DHum.%2520Genomics%26date%3D2009%26volume%3D4%26spage%3D43%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bech-Serra, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago-Josefat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, F.</span><span> </span><span class="NLM_article-title">Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5086</span><span class="NLM_x">–</span> <span class="NLM_lpage">5095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1128%2FMCB.02380-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=16782893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVSlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=5086-5095&author=J.+J.+Bech-Serraauthor=B.+Santiago-Josefatauthor=C.+Esselensauthor=P.+Saftigauthor=J.+Baselgaauthor=J.+Arribasauthor=F.+Canals&title=Proteomic+identification+of+desmoglein+2+and+activated+leukocyte+cell+adhesion+molecule+as+substrates+of+ADAM17+and+ADAM10+by+difference+gel+electrophoresis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis</span></div><div class="casAuthors">Bech-Serra, Joan J.; Santiago-Josefat, Belen; Esselens, Cary; Saftig, Paul; Baselga, Jose; Arribas, Joaquin; Canals, Francesc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5086-5095</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In contrast with the early view of metalloproteases as simple extracellular matrix-degrading entities, recent findings show that they are highly specific modulators of different signaling pathways involved, pos. or neg., in tumor development.  Thus, before considering a given metalloprotease a therapeutic target, it seems advisable to characterize its function by identifying its repertoire of substrates.  Here, we present a proteomic approach to identify ADAM17 substrates by difference gel electrophoresis.  We found that the shedding of the extracellular domain of the transferrin receptor and those of two cell-cell adhesion mols., activated leukocyte cell adhesion mol. (ALCAM) and desmoglein 2 (Dsg-2), is increased in cells overexpressing ADAM17.  Genetic evidence shows that while ADAM17 is responsible for the shedding of ALCAM, both ADAM17 and ADAM10 can act on Dsg-2.  Activation of the epidermal growth factor receptor leads to the upregulation of the shedding of Dsg-2 and to the concomitant upregulation of ADAM17, but not ADAM10, supporting the ability of overexpressed ADAM17 to shed Dsg-2.  These results unveil a role of ADAM10 and ADAM17 in the shedding of cell-cell adhesion mols.  Since loss of cell adhesion is an early event in tumor development, these results suggest that ADAM17 is a useful target in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBtjGxmWi6LVg90H21EOLACvtfcHk0lj3zrvUCbqeHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVSlu78%253D&md5=f6be4e3b06038a4d8315248849e8899f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FMCB.02380-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02380-05%26sid%3Dliteratum%253Aachs%26aulast%3DBech-Serra%26aufirst%3DJ.%2BJ.%26aulast%3DSantiago-Josefat%26aufirst%3DB.%26aulast%3DEsselens%26aufirst%3DC.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DArribas%26aufirst%3DJ.%26aulast%3DCanals%26aufirst%3DF.%26atitle%3DProteomic%2520identification%2520of%2520desmoglein%25202%2520and%2520activated%2520leukocyte%2520cell%2520adhesion%2520molecule%2520as%2520substrates%2520of%2520ADAM17%2520and%2520ADAM10%2520by%2520difference%2520gel%2520electrophoresis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D5086%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Crawford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, M. L.</span><span> </span><span class="NLM_article-title">ADAM10 as a therapeutic target for cancer and inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2288</span><span class="NLM_x">–</span> <span class="NLM_lpage">2299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.2174%2F138161209788682442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=19601831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1altrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2288-2299&author=H.+C.+Crawfordauthor=P.+J.+Dempseyauthor=G.+Brownauthor=L.+Adamauthor=M.+L.+Moss&title=ADAM10+as+a+therapeutic+target+for+cancer+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM10 as a therapeutic target for cancer and inflammation</span></div><div class="casAuthors">Crawford, Howard C.; Dempsey, Peter J.; Brown, Gordon; Adam, Liana; Moss, Marcia L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2288-2299</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Both cancer and chronic inflammatory diseases are often marked by homeostatic signal transduction pathways run amok.  Cleavage of membrane-bound substrates by extracellular metalloproteinases is frequently the rate limiting step in activating many of these pathways, resulting either in liberation of active ligands (shedding) or initiating further processing into bioactive cytoplasmic domains (regulated intramembrane proteolysis or RIP).  ADAM10 is a member of the ADAM (A Disintegrin And Metalloproteinase) family of transmembrane metalloproteinases implicated in the RIPing and shedding of dozens of substrates that drive cancer progression and inflammatory disease, including Notch, E-cadherin, EGF, ErbB2 and inflammatory cytokines.  ADAM10's emerging role as a significant contributor to these pathologies has led to intense interest in it as a potential drug target for disease treatment.  Here we discuss some of the established functions of ADAM10 and the implications of its inhibition in disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKa7I9rwEetrVg90H21EOLACvtfcHk0lj3zrvUCbqeHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1altrk%253D&md5=eda0ed3ac06c70a6ea957206755535c6</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F138161209788682442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209788682442%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DH.%2BC.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DAdam%26aufirst%3DL.%26aulast%3DMoss%26aufirst%3DM.%2BL.%26atitle%3DADAM10%2520as%2520a%2520therapeutic%2520target%2520for%2520cancer%2520and%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D2288%26epage%3D2299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span> </span><span class="NLM_article-title">ADAM10 as a target for anticancer therapy</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.2174%2F138920108783497613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=18289051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2-8&author=M.+L.+Mossauthor=A.+Stoeckauthor=W.+Yanauthor=P.+J.+Dempsey&title=ADAM10+as+a+target+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM10 as a target for anti-cancer therapy</span></div><div class="casAuthors">Moss, Marcia L.; Stoeck, Alexander; Yan, Wenbo; Dempsey, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is a great unmet medical need in the area of cancer treatment.  A potential therapeutic target for intervention in cancer is ADAM10.  ADAM10 is a disintegrin-metalloproteinase that processes membrane bound proteins from the cell surface to yield sol. forms.  Pharmaceutical companies are actively seeking out inhibitors of ADAM10 for treatments in cancer as the enzyme is known to release the ErbB receptor, HER2/ErbB2 from the cell membrane, an event that is necessary for HER2 pos. tumor cells to proliferate.  ADAM10 is also capable of processing betacellulin indicating that an inhibitor could be used against EGFR/ErbB1 and/or HER4/ErbB4 receptor pos. tumor cells that are betacellulin-dependent.  ADAM10 is the principle sheddase for several other mols. assocd. with cancer proliferation, differentiation, adhesion and migration such as Notch, E-cadherin, CD44 and L1 adhesion mol. indicating that targeting ADAM10 with specific inhibitors could be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6jcMgx5q2iLVg90H21EOLACvtfcHk0li-ohcN61nLOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVGjt7w%253D&md5=92664d5e739c466cd02d7246d0c0c16d</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.2174%2F138920108783497613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920108783497613%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26aulast%3DStoeck%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26atitle%3DADAM10%2520as%2520a%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2008%26volume%3D9%26spage%3D2%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span> <span class="citation_source-book">Glide</span>, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulvino, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">1.56 Å structure of mature truncated human fibroblast collagenase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=98-109&author=J.+C.+Spurlinoauthor=A.+M.+Smallwoodauthor=D.+D.+Carltonauthor=T.+M.+Banksauthor=K.+J.+Vavraauthor=J.+S.+Johnsonauthor=E.+R.+Cookauthor=J.+Falvoauthor=R.+C.+Wahlauthor=T.+A.+Pulvinoauthor=J.+J.+Wendoloskiauthor=D.+L.+Smith&title=1.56+%C3%85+structure+of+mature+truncated+human+fibroblast+collagenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DCarlton%26aufirst%3DD.%2BD.%26aulast%3DBanks%26aufirst%3DT.%2BM.%26aulast%3DVavra%26aufirst%3DK.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BS.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DFalvo%26aufirst%3DJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DPulvino%26aufirst%3DT.%2BA.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3D1.56%2520%25C3%2585%2520structure%2520of%2520mature%2520truncated%2520human%2520fibroblast%2520collagenase%26jtitle%3DProteins%26date%3D1994%26volume%3D19%26spage%3D98%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Grossman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tworowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dym, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, I.</span><span> </span><span class="NLM_article-title">The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6184</span><span class="NLM_x">–</span> <span class="NLM_lpage">6192</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi902141x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6184-6192&author=M.+Grossmanauthor=D.+Tworowskiauthor=O.+Dymauthor=M.+H.+Leeauthor=Y.+Levyauthor=G.+Murphyauthor=I.+Sagi&title=The+intrinsic+protein+flexibility+of+endogenous+protease+inhibitor+TIMP-1+controls+its+binding+interface+and+affects+its+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi902141x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi902141x%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DTworowski%26aufirst%3DD.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DLee%26aufirst%3DM.%2BH.%26aulast%3DLevy%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DThe%2520intrinsic%2520protein%2520flexibility%2520of%2520endogenous%2520protease%2520inhibitor%2520TIMP-1%2520controls%2520its%2520binding%2520interface%2520and%2520affects%2520its%2520function%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6184%26epage%3D6192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, S.</span><span> </span><span class="NLM_article-title">Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">33236</span><span class="NLM_x">–</span> <span class="NLM_lpage">33243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=33236-33243&author=H.+Hashimotoauthor=T.+Takeuchiauthor=K.+Komatsuauthor=K.+Miyazakiauthor=M.+Satoauthor=S.+Higashi&title=Structural+basis+for+matrix+metalloproteinase-2+%28MMP-2%29-selective+inhibitory+action+of+%CE%B2-amyloid+precursor+protein-derived+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520for%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529-selective%2520inhibitory%2520action%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein-derived%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D33236%26epage%3D33243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nuti, E.; Antoni, C.; Vera, L.; Devel, L.; Beau, F.; Da Pozzo, E.; Costa, B.; Giacomelli, C.; Orlandini, E.; Nencetti, S.; Rosalia, L.; Dive, V.; Stura, E. A.; Martini, C.; Rossello, A.</span><span> </span><span class="NLM_article-title">Powerful twin carboxylic inhibitors for MMP homodimeriation</span>. Manuscript to be published.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nuti%2C+E.%3B+Antoni%2C+C.%3B+Vera%2C+L.%3B+Devel%2C+L.%3B+Beau%2C+F.%3B+Da+Pozzo%2C+E.%3B+Costa%2C+B.%3B+Giacomelli%2C+C.%3B+Orlandini%2C+E.%3B+Nencetti%2C+S.%3B+Rosalia%2C+L.%3B+Dive%2C+V.%3B+Stura%2C+E.+A.%3B+Martini%2C+C.%3B+Rossello%2C+A.+Powerful+twin+carboxylic+inhibitors+for+MMP+homodimeriation.+Manuscript+to+be+published."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26atitle%3DPowerful%2520twin%2520carboxylic%2520inhibitors%2520for%2520MMP%2520homodimeriation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span> <span class="citation_source-book">SoftMax Pro</span>, version <span class="NLM_edition">4.7.1</span>; <span class="NLM_publisher-name">Molecular Devices</span>: <span class="NLM_publisher-loc">Sunnyvale, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SoftMax+Pro%2C+version+4.7.1%3B+Molecular+Devices%3A+Sunnyvale%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSoftMax%2520Pro%26pub%3DMolecular%2520Devices" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span> <span class="citation_source-book">GraFit</span>, version <span class="NLM_edition">4</span>; <span class="NLM_publisher-name">Erithecus Software</span>: <span class="NLM_publisher-loc">West Sussex, U.K.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GraFit%2C+version+4%3B+Erithecus+Software%3A+West+Sussex%2C+U.K."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGraFit%26pub%3DErithecus%2520Software" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span> <span class="citation_source-book">Maestro</span>, version <span class="NLM_edition">9.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF chimera: a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4011753&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4011753&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+chimera%3A+a+visualization+system+for+exploratory+research+and+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0ljSw948N9DQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520chimera%253A%2520a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4011753&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljSw948N9DQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanschagrin, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span> </span><span class="NLM_article-title">Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6177</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+Glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein%E2%80%93ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520Glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2I47','PDB','2I47'); return false;">PDB: 2I47</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OI0','PDB','2OI0'); return false;">PDB: 2OI0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EDZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EDZ','PDB','3EDZ'); return false;">PDB: 3EDZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EWJ','PDB','3EWJ'); return false;">PDB: 3EWJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DDF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DDF','PDB','2DDF'); return false;">PDB: 2DDF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AYU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AYU','PDB','3AYU'); return false;">PDB: 3AYU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H3X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H3X','PDB','4H3X'); return false;">PDB: 4H3X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HFC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1HFC','PDB','1HFC'); return false;">PDB: 1HFC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2','PDB','3MA2'); return false;">PDB: 3MA2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FV5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FV5','PDB','2FV5'); return false;">PDB: 2FV5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i116"><a href="/doi/suppl/10.1021/jm4011753">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21104"></div></div></div></div></div><hr /></hr><p class="last">Table reporting the HPLC purity analysis data of the final products. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4011753/suppl_file/jm4011753_si_001.pdf">jm4011753_si_001.pdf (127.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4011753&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm4011753%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4011753" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a83769453291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
